Topic index

593

Topic Index

ACAT Inhibitors 501 (Th-P15:39), 544 (Th-P15:232, Th-P15:236), 547 (Th-P16:249), 548

(Th-P16:250, Th-P16:251, Th-P16:252, Th-P16:253)

Acute Coronary Syndromes 11 (Mo-WI:2), 22 (Mo-W6:7), 24 (Mo-W7:7), 29 (Mo-W10:5), 58

(Mo-P1:56), 66 (Mo-P1:92), 78 (Mo-P1:146), 83 (Mo-P2:168, Mo-P2:169, Mo-P2:170), 84 (Mo-P2:171, Mo-P2:172, Mo-P2:173, Mo-P2:174, Mo-P2:175), 85 (Mo-P2:176, Mo-P2:177, Mo-P2:178, Mo-P2:179), 86 (Mo-P2:180, Mo-P2:182, Mo-P2:184), 87 (Mo-P2:185, Mo-P2:186), 91 (Mo-P2:207), 92 (Mo-P2:208), 95 (Mo-P3:221), 98 (Mo-P4:235, Mo-P4:236), 117 (Mo-P5:324, Mo-P5:327), 121 (Mo-P5:343), 122 (Mo-P5:349), 143 (Mo-P6:443), 157 (Tu-W18:4), 162 (Tu-W20:8), 171 (Tu-W25:6), 204 (Tu-P7:89), 211 (Tu-P7:123), 237 (Tu-P7:241), 244 (Tu-P7:270), 246 (Tu-P7:279), 268 (Tu-P9:380), 278 (Tu-P10:425, Tu-P10:428), 285 (Tu-P10:460), 286 (Tu-P10:461), 288 (Tu-P10:470), 297 (Tu-P10:510), 301 (We-PL3:2), 310 (We-W32:6), 314 (We-W35:2), 316 (We-W35:6), 332 (We-W44:3), 335 (We-W45:4), 390 (We-P11:200), 393 (We-P11:214), 396 We-P11:231), 397 (We-P11:233), 398 (We-P11:237, We-P11:239), 423 (We-P13:349), 448 (We-P14:463), 460 (Th-W46:7), 486 (Th-W59:4), 533 (Th-P15:184), 535 (Th-P15:192), 551 (Th-P16:264), 553 (Th-P16:274), 563 (Th-P16:319), 569 (Th-P16:343), 581 (Th-P16:399), 588 (Th-P17:430)

Adipose Tissue 13 (Mo-W2:I), 40 (Mo-$4:1, Mo-$4:3), 55 (Mo-P1:46), 97 (Mo-P3:232), 114

(Mo-P5:311), 164 (Tu-W22:l, Tu-W22:2, Tu-W22:3), 165 (Tu-W22:4, Tu-W22:5, Tu-W22:6, Tu-W22:7), 185 (Tu-P7:I, Tu-P7:2, Tu-P7:3, Tu-P7:4, Tu-P7:5), 186 (Tu-P7:6, Tu-P7:7, Tu-P7:8, Tu-P7:9), 187 (Tu-P7:12, Tu-P7:14), 188 (Tu-P7:15), 192 (Tu-P7:36), 195 (Tu-P7:49), 196 (Tu-P7:53), 202 (Tu-P7:82), 206 (Tu-P7:97), 214 (Tu-P7:136), 221 (Tu-P7:165), 282 (Tu-P10:445), 301 (We-PL3:I), 311 (We-W33:3, We-W33:5), 312 (We-W33:7), 320 (We-W37:7), 330 (We-W42:7), 341 (We-S14:4), 362 (We-P11:77), 363 (We-P11:79), 368 (We-Pll:103), 371 (We-Pll:115), 374 (We-Pll:130), 375 (We-Pll:135), 377 (We-P11:142), 378 (We-Pll:148), 380 (We-P11:157), 408 (We-P12:285), 415 (We-P13:315), 416 (We-P13:319), 417 (We-P13:323), 420 (We-P13:335), 431 (We-P14:383), 463 (Th-W48:5), 484 (Th-W58:6), 498 (Th-P15:29), 516 (Th-P15:108), 520 (Th-P15:125)

Ageing 35 (Mo-W14:1), 50 (Mo-P1:23), 65 (Mo-P1:87), 73 (Mo-P1:123), 77

(Mo-P1:140), 82 (Mo-P1:165), 106 (Mo-P4:275), 107 (Mo-P4:280), 108 (Mo-P4:284), 109 (Mo-P4:287), 128 (Mo-P5:375), 129 (Mo-P6:379), 188 (Tu-P7:17, Tu-P7:18), 189 (Tu-P7:19, Tu-P7:20, Tu-P7:22, Tu-P7:23), 193 (Tu-P7:39), 200 (Tu-P7:69), 209 (Tu-P7:112), 250 (Tu-P8:296), 258 (Tu-P9:335), 264 (Tu-P9:365), 273 (Tu-P10:405), 292 (Tu-P10:488), 294 (Tu-P10:498), 303 (We-ML7:I), 317 (We-W36:3), 323 (We-W39:4), 346 (We-P11:2), 352 (We-P11:31), 401 (We-P11:253), 402 (We-P11:255), 411 (We-P12:294), 415 (We-P13:313), 424 (We-P13:354), 438 (We-P14:414), 447 (We-P14:458), 463 (Th-W48:5), 470 (Th-W52:1), 471 (Th-W52:4, Th-W52:5, Th-W52:6), 472 (Th-W52:7), 474 (Th-W54:2), 480 (Th-W56:6), 487 (Th-W60:4), 492 (Th-P15:5), 539 (Th-P15:212), 542 (Th-P15:224), 590 (Th-P17:443)

Aggressive versus Non-Aggressive Cholesterol Lowering 36 (Mo-W14:2), 43 (Mo-$7:1), 122 (Mo-P5:348), 161 (Tu-W20:4,

Tu-W20:5), 178 (Tu-W29:5), 179 (Tu-W29:7), 181 (Tu-S10:I), 182 (Tu-S10:2), 286 (Tu-P10:463, Tu-P10:464), 551 (Th-P16:264), 569 (Th-P16:346), 582 (Th-P16:406)

AIDS as an Atherogenic Disease 162 (Tu-W21:2), 163 (Tu-W21:3, Tu-W21:5), 399 (We-P11:240,

We-P11:241, We-P11:242, We-P11:243, We-P11:244), 400 (We-P11:245, We-P11:246, We-P11:248), 416 (We-P13:318), 544 (Th-P15:233)

Algorithms for Risk Evaluation 6 (Su-$3:4), 37 (Mo-W14:4), 46 (Mo-PI:I, Mo-PI:2, Mo-PI:3, Mo-PI:4,

Mo-PI:5), 47 (Mo-PI:8), 53 (Mo-P1:34), 54 (Mo-P1:39), 58 (Mo-P1:58), 61 (Mo-PI:70), 65 (Mo-PI:90), 66 (Mo-P1:91), 70 (Mo-P1:112), 74 (Mo-P1:129), 81 (Mo-P1:162), 100 (Mo-P4:248), 114 (Mo-P5:312), 261 (Tu-P9:350), 265 (Tu-P9:368), 301 (We-PL3:3), 369 (We-P11:106), 376 (We-P11:137), 424 (We-P13:352), 466 (Th-W50:I), 467 (Th-W50:3, Th-W50:4), 480 (Th-W56:8), 483 (Th-W58:1, Th-W58:2), 504 (Th-P15:53)

Ancil lary Properties of Lipid Lowering Drugs 9 (Mo-MLI:I), 32 (Mo-Wll:7), 122 (Mo-PS:348), 126 (Mo-PS:366), 250

(Tu-PS:300), 466 (Th-W49:6), 468 (Th-W51:2), 514 (Th-P15:99), 549 (Th-P16:256, Th-P16:257), 558 (Th-P16:293), 569 (Th-P16:344), 577 (Th-P16:381), 582 (Th-P16:406)

Angina 69 (Mo-P1:108), 74 (Mo-P1:129), 78 (Mo-P1:145), 84 (Mo-P2:174), 85

(Mo-P2:178), 89 (Mo-P2:195), 93 (Mo-P2:215), 97 (Mo-P4:234), 98 (Mo-P4:235, Mo-P4:236, Mo-P4:238, Mo-P4:239), 100 (Mo-P4:246), 114 (Mo-P5:312), 117 (Mo-P5:324, Mo-P5:327), 127 (Mo-P5:373), 131 (Mo-P6:387), 146 (Mo-P6:455), 217 (Tu-P7:145), 266 (Tu-P9:372), 270 (Tu-P10:391), 276 (Tu-P10:420), 278 (Tu-P10:429), 279 (Tu-P10:432), 281 (Tu-P10:439), 282 (Tu-P10:444), 286 (Tu-P10:462), 288 (Tu-P10:470), 291 (Tu-P10:483), 357 (We-P11:51, We-P11:53)

Angiogenesis: Stimulation and Antagonism 33 (Mo-W12:5), 34 (Mo-W13:2), 94 (Mo-P3:217), 97 (Mo-P3:232), 106

(Mo-P4:272), 110 (Mo-P4:292), 114 (Mo-P5:312), 185 (Tu-P7:5), 190 (Tu-P7:25, Tu-P7:26, Tu-P7:27, Tu-P7:28), 191 (Tu-P7:29, Tu-P7:30, Tu-P7:31, Tu-P7:32), 192 (Tu-P7:33, Tu-P7:34, Tu-P7:35, Tu-P7:36, Tu-P7:37), 198 (Tu-P7:64), 199 (Tu-P7:68), 215 (Tu-P7:137), 241 (Tu-P7:258), 251 (Tu-PS:304), 295 (Tu-P10:503), 307 (We-W31:3), 312 (We-W34:1), 352 (We-P11:32), 408 (We-P12:283), 462 (Th-W48:1), 490 (Th-W61:8), 571 (Th-P16:351)

Animal Models 12 (Mo-WI:6), 13 (Mo-W2:I), 18 (Mo-W4:7), 22 (Mo-W6:7), 25 (Mo-W8:4,

Mo-W8:6), 28 (Mo-W10:I), 32 (Mo-W12:3), 33 (Mo-W12:6), 38 (Mo-W15:4), 39 (Mo-W15:5, Mo-W15:6), 40 (Mo-$4:3), 87 (Mo-P2:185), 95 (Mo-P3:222), 96 (Mo-P3:226, Mo-P3:229), 111 (Mo-P5:298), 144 (Mo-P6:447), 151 (Tu-ML5:I), 152 (Tu-W16:2), 153 (Tu-W16:6), 162 (Tu-W21:1), 170 (Tu-W25:5), 185 (Tu-P7:1, Tu-P7:3), 190 (Tu-P7:24, Tu-P7:25), 191 (Tu-P7:29), 193 (Tu-P7:39, Tu-P7:40, Tu-P7:41, Tu-P7:42), 194 (Tu-P7:43, Tu-P7:45, Tu-P7:46), 195 (Tu-P7:47, Tu-P7:48, Tu-P7:50), 196 (Tu-P7:51, Tu-P7:52, Tu-P7:54), 197 (Tu-P7:56, Tu-P7:58), 198 (Tu-P7:61, Tu-P7:63, Tu-P7:64), 199 (Tu-P7:65, Tu-P7:66, Tu-P7:67, Tu-P7:68), 200 (Tu-P7:69, Tu-P7:70, Tu-P7:71, Tu-P7:72), 201 (Tu-P7:73, Tu-P7:74, Tu-P7:76, Tu-P7:77), 202 (Tu-P7:79, Tu-P7:81), 203 (Tu-P7:83), 205 (Tu-P7:93, Tu-P7:94), 218 (Tu-P7:153), 219 (Tu-P7:155, Tu-P7:157), 220 (Tu-P7:159), 224 (Tu-P7:181), 227 (Tu-P7:194), 228 (Tu-P7:196, Tu-P7:197, Tu-P7:199), 236 (Tu-P7:236), 237 (Tu-P7:240), 242 (Tu-P7:262), 243 (Tu-P7:267), 244 (Tu-P7:273), 245 (Tu-P7:277), 250

XIV bztetTtational Symposium on Atherosclerosis, Rome, Italy, June 18-22, 2006

594 Topic bulex

(Tu-P8:297), 252 (Tu-P8:305), 253 (Tu-P8:311), 254 (Tu-P8:317), 255 (Tu-P8:320), 256 (Tu-P8:324, Tu-P8:325), 267 (Tu-P9:379), 270 (Tu-P10:389, Tu-P10:390), 271 (Tu-P10:394), 276 (Tu-P10:418), 278 (Tu-PlO:426), 288 (Tu-P10:471), 296 (Tu-P10:507), 298 (Tu-P10:516), 306 (We-W30:7), 312 (We-W33:7), 315 (We-W35:5), 318 (We-W37:l, We-W37:2), 319 (We-W37:3, We-W37:4), 320 (We-W37:7), 322 (We-W38:7), 325 (We-W40:5), 326 (We-W41:I), 327 (We-W41:5, We-W41:6), 331 (We-W43:3, We-W43:6, We-W43:7), 343 (We-S16:2), 352 (We-P11:29), 354 (We-P11:40), 355 (We-P11:42), 362 (We-P11:77), 372 (We-Pll:121), 373 (We-P11:123), 388 (We-P11:192), 390 (We-P11:203), 393 (We-Pll:218), 407 (We-P11:276), 409 (We-P12:287, We-P12:288), 429 (We-P13:376), 431 (We-P14:383), 433 (We-P14:393), 434 (We-P14:397), 435 (We-P14:404), 436 (We-P14:405, We-P14:406), 438 (We-P14:416), 441 (We-P14:429), 446 (We-P14:450, We-P14:451), 448 (We-P14:460), 450 (We-P14:470), 454 (We-P14:485, We-P14:486), 460 (Th-W46:4), 462 (Th-W48:l), 463 (Th-W48:2, Th-W48:3, Th-W48:4, Th-W48:5, Th-W48:6), 464 (Th-W48:8), 465 (Th-W49:5), 466 (Th-W49:7), 469 (Th-W51:3), 470 (Th-W51:7), 482 (Th-W57:5, Th-W57:6), 484 (Th-W58:5), 486 (Th-W59:5), 487 (Th-W60:I, Th-W60:5), 488 (Th-W60:6, Th-W61:I), 489 (Th-W61:2, Th-W61:3, Th-W61:4, Th-W61:5), 490 (Th-W61:7), 495 (Th-P15:15), 498 (Th-P15:26), 505 (Th-P15:58), 516 (Th-P15:105), 518 (Th-P15:117), 521 (Th-P15:129), 523 (Th-P15:139), 535 (Th-P15:194), 538 (Th-P15:206), 542 (Th-P15:223), 543 (Th-P15:227), 544 (Th-P15:236), 547 (Th-P16:249), 549 (Th-P16:255, Th-P16:256), 550 (Th-P16:263), 556 (Th-P16:286, Th-P16:287), 560 (Th-P16:304, Th-P16:306), 565 (Th-P16:327), 566 (Th-P16:329, Th-P16:333), 569 (Th-P16:345), 570 (Th-P16:347, Th-P16:348), 573 (Th-P16:364), 583 (Th-P16:408), 585 (Th-P17:418), 586 (Th-P17:421), 588 (Th-P17:433), 589 (Th-P17:436)

Animal Models of Thrombosis 28 (Mo-W10:2), 89 (Mo-P2:198), 390 (We-Pll:202, We-Pll:203), 583

(Th-P16:408)

Anti-HIV Agents 163 (Tu-W21:3, Tu-W21:4, Tu-W21:5), 399 (We-P11:240), 400

(We-P11:246, We-P11:248, We-P11:249), 401 (We-P11:250, We-Pll:251), 544 (Th-P15:233)

Approaches to the Nutritional Control of Obesity 66 (Mo-Pl:94), 79 (Mo-PI:150), 176 (Tu-W28:2), 329 (We-W42:4), 380

(We-P11:156, We-P11:157), 381 (We-P11:159), 386 (We-P11:185), 430 (We-P14:378, We-P14:380), 431 (We-P14:383, We-P14:384, We-P14:385, We-P14:386), 432 (We-P14:389), 434 (We-P14:395, We-P14:396), 435 (We-P14:402), 437 (We-P14:413), 440 (We-P14:423, We-P14:427), 441 (We-P14:431), 449 (We-P14:464), 454 (We-P14:488), 458 (Th-PL4:4), 477 (Th-W55:5), 509 (Th-P15:78), 567 (Th-P16:334)

Arrhythmias 99 (Mo-P4:240, Mo-P4:241), 181 (Tu-S9:3), 395 (We-Pll:227), 473

(Th-W53:6), 549 (Th-P16:255)

Atherosclerosis 21 (Mo-W6:2), 23 (Mo-W7:2), 32 (Mo-W12:I), 77 (Mo-Pl:143), 149

(Tu-PL2:I), 156 (Tu-W18:3), 326 (We-W41:2), 412 (We-P12:300), 452 (We-P14:479), 454 (We-P14:487), 459 (Th-W46:l)

B-Mode Ultrasound 18 (Mo-W4:6), 41 (Mo-S6:I), 42 (Mo-$6:2, Mo-$6:4), 52 (Mo-Pl:32), 65

(Mo-PI:90), 75 (Mo-PI:131, Mo-Pl:132), 79 (Mo-PI :151), 83 (Mo-Pl:462), 102 (Mo-P4:254), 104 (Mo-P4:266), 107 (Mo-P4:279, Mo-P4:280), 108 (Mo-P4:285), 123 (Mo-P5:353), 125 (Mo-P5:363), 161 (Tu-W20:5), 163 (Tu-W21:4, Tu-W21:6), 204 (Tu-P7:87), 207 (Tu-P7:101), 209 (Tu-P7:110, Tu-P7:ll 1), 238 (Tu-P7:245), 257 (Tu-P9:332), 258 (Tu-P9:333, Tu-P9:334, Tu-P9:335, Tu-P9:336), 259 (Tu-P9:337, Tu-P9:338, Tu-P9:339, Tu-P9:340, Tu-P9:341), 260 (Tu-P9:342, Tu-P9:343, Tu-P9:344, Tu-P9:345), 261 (Tu-P9:349, Tu-P9:350, Tu-P9:351, Tu-P9:352), 262 (Tu-P9:353, Tu-P9:354, Tu-P9:355, Tu-P9:356), 264 (Tu-P9:364), 265 (Tu-P9:367), 268 (Tu-P9:382, Tu-P9:384), 269 (Tu-P9:387), 277 (Tu-PlO:423), 283 (Tu-P10:451), 285 (Tu-P10:457, Tu-P10:459), 289 (Tu-P10:474), 295 (Tu-P10:504), 298 (Tu-P10:514), 307 (We-W31:1, We-W31:2, We-W31:3), 308 (We-W31:4, We-W31:5, We-W31:6), 318 (We-W36:7), 323 (We-W39:2), 324 (We-W39:6, We-W39:7), 349 (We-P11:17), 350 (We-P11:20), 357 (We-P11:54), 372 (We-Pll:122), 378 (We-P11:147), 379 (We-P11:153), 389 (We-Pll:195), 397 (We-Pll:233), 420 (We-P13:335), 434 (We-P14:399), 442 (We-P14:434), 474 (Th-W53:7), 475 (Th-W54:3), 484 (Th-W58:4), 546 (Th-P15:244)

Antioxidative Effect 128 (Mo-P5:376), 556 (Th-P16:288)

Antisense DNA Strategies 96 (Mo-P3:227), 465 (Th-W49:5), 466 (Th-W49:6), 532 (Th-P15:180), 549

(Th-P16:258), 552 (Th-P16:268)

Antithrombotic Properties of Hypolipidemic Agents 147 (Mo-P6:460), 194 (Tu-P7:45), 230 (Tu-P7:205), 332 (We-W44:3), 378

(We-P11:146), 391 (We-P11:204, We-P11:207), 392 (We-P11:209), 398 (We-P11:236), 571 (Th-P16:353)

Antithrombotic Therapy 29 (Mo-W10:5, Mo-W10:6), 90 (Mo-P2:201), 91 (Mo-P2:205), 122

(Mo-P5:351), 284 (Tu-P10:453), 325 (We-W40:2, We-W40:3), 392 (We-P11:210), 581 (Th-P16:399), 591 (Th-P17:444)

Apoptosis 21 (Mo-W6:2), 30 (Mo-W10:7), 33 (Mo-W12:5), 91 (Mo-P2:203), 101

(Mo-P4:249), 157 (Tu-W18:7), 190 (Tu-P7:24), 217 (Tu-P7:147, Tu-P7:148, Tu-P7:149), 223 (Tu-P7:173, Tu-P7:174, Tu-P7:175), 224 (Tu-P7:177), 231 (Tu-P7:212), 252 (Tu-P8:305), 253 (Tu-P8:311), 270 (Tu-PlO:389, Tu-P10:390, Tu-P10:391, Tu-P10:392, Tu-P10:393), 271 (Tu-PlO:394, Tu-P10:395, Tu-P10:396), 278 (Tu-P10:426), 292 (Tu-PlO:490), 295 (Tu-PIO:503), 328 (We-W41:7), 371 (We-Pll:118), 372 (We-Pll:121), 486 (Th-W59:4), 501 (Th-P15:39), 513 (Th-P15:94), 529 (Th-P15:166), 534 (Th-P15:187), 587 (Th-P17:425)

Basic Science 18 (Mo-W4:5), 22 (Mo-W6:6), 91 (Mo-P2:203), 111 (Mo-P5:297), 118

(Mo-P5:331), 121 (Mo-P5:343), 146 (Mo-P6:457), 190 (Tu-P7:24), 191 (Tu-P7 :30), 193 (Tu-P7 :41), 198 (Tu-P7:62), 200 (Tu-P7:71), 201 (Tu-P7:73, Tu-P7:77), 206 (Tu-P7:98), 209 (Tu-P7:113), 210 (Tu-P7:116), 221 (Tu-P7:166), 231 (Tu-P7:212), 234 (Tu-P7:225, Tu-P7:227), 238 (Tu-P7:243), 239 (Tu-P7:249), 241 (Tu-P7:258), 246 (Tu-P7:281), 247 (Tu-P7:286), 255 (Tu-P8:319), 267 (Tu-P9:377), 312 (We-W33:7), 323 (We-W39:4), 327 (We-W41:6), 352 (We-P11:29), 362 (We-P11:77), 390 (We-P11:202), 396 (We-P11:229), 441 (We-P14:429)

Biological and Clinical Markers 24 (Mo-W8:I), 25 (Mo-W8:2, Mo-W8:3), 37 (Mo-W14:5), 55 (Mo-Pl:43,

Mo-P1:46), 69 (Mo-P1:106), 76 (Mo-P1:138), 98 (Mo-P4:236), 111 (Mo-P5:298), 137 (Mo-P6:416, Mo-P6:417), 139 (Mo-P6:426), 141 (Mo-P6:432), 155 (Tu-W17:4, Tu-W17:5), 164 (Tu-W22:1), 188 (Tu-P7:16), 203 (Tu-P7:83), 206 (Tu-P7:100), 209 (Tu-P7:113), 247 (Tu-P7:286), 256 (Tu-PS:323), 265 (Tu-P9:369), 274 (Tu-P10:409), 280 (Tu-P10:435), 295 (Tu-P10:500), 298 (Tu-P10:516, Tu-P10:517), 309 (We-W32:2), 310 (We-W32:6), 329 (We-W42:6), 352 (We-P11:31), 353 (We-P11:34), 358 (We-P11:55), 361 (We-P11:72), 363 (We-P11:79, We-P11:81), 366 (We-P11:94), 367 (We-P11:100, We-P11:98), 368 (We-P11:101, We-P11:102, We-P11:103), 370 (We-P11:113), 371 (We-P11:115), 375 (We-P11:136), 376 (We-P11:138), 378 (We-P11:147), 380 (We-P11:155, We-P11:157), 381 (We-P11:162), 382 (We-P11:163, We-P11:165), 387 (We-P11:187), 388 (We-P11:194), 401 (We-P11:252), 415 (We-P13:312, We-P13:315), 416 (We-P13:316, We-P13:317, We-P13:318, We-P13:319, We-P13:320), 417 (We-P13:321, We-P13:322,

XIV IntetTtational Symposium on Atherosclerosis, Rome, Italy, June 18-22, 2006

Topic bulex 595

We-P13:324), 418 (We-P13:325, We-P13:326, We-P13:327, We-P13:328), 419 (We-P13:329, We-P13:331, We-P13:332, We-P13:333), 420 (We-P13:335, We-P13:336, We-P13:337), 421 (We-P13:338), 422 (We-P13:343, We-P13:344, We-P13:345), 424 (We-P13:351, We-P13:353), 426 (We-P13:363), 427 (We-P13:365, We-P13:366), 428 (We-P13:372), 429 (We-P13:374), 450 (We-P14:468), 469 (Th-W51:6), 475 (Th-W54:5), 503 (Th-P15:50), 504 (Th-P15:52), 506 (Th-P15:64), 516 (Th-P15:106), 518 (Th-P15:118), 519 (Th-P15:122), 587 (Th-P17:428), 588 (Th-P17:430)

Biomarkers 42 (Mo-$6:2), 73 (Mo-Pl:123), 85 (Mo-P2:179), 103 (Mo-P4:258), 146

(Mo-P6:454), 164 (Tu-W21:7), 187 (Tu-P7:13), 204 (Tu-P7:89), 245 (Tu-P7:277), 269 (Tu-P9:385), 273 (Tu-PIO:404), 282 (Tu-PlO:445), 285 (Tu-PlO:459, Tu-P10:460), 289 (Tu-PlO:476), 294 (Tu-PlO:498), 295 (Tu-PIO:500), 297 (Tu-P10:510), 298 (Tu-P10:513, Tu-P10:515), 309 (We-W32:5), 310 (We-W32:6), 362 (We-P11:76), 400 (We-P11:246), 402 (We-P11:254), 419 (We-P13:330), 422 (We-P13:344), 430 (We-P14:381), 460 (Th-W46:7), 466 (Th-W50:I), 479 (Th-W56:2), 480 (Th-W56:5, Th-W56:7, Th-W56:8), 512 (Th-P15:91, Th-P15:92), 524 (Th-P15:143), 587 (Th-P17:424), 589 (Th-P17:437), 590 (Th-P17:442)

Blood Pressure Control in the Metabolic Syndrome 62 (Mo-Pl:75), 76 (Mo-Pl:138), 77 (Mo-PI:141), 79 (Mo-PI:150), 120

(Mo-P5:337), 252 (Tu-P8:309), 367 (We-P11:99), 373 (We-Pll:126), 376 (We-P11:137, We-Pll:138, We-Pll:139, We-P11:140), 379 (We-Pll:151), 383 (We-Pll:169), 384 (We-Pll:175), 385 (We-P11:178), 425 (We-P13:358), 428 (We-P13:369), 454 (We-P14:486), 506

(Th-P15:64), 507 (Th-P15:67)

Cmmabinoid 1 Receptor Antagonists 40 (Mo-$4:3), 41 (Mo-$4:4), 329 (We-W42:3)

Carbohydrates with Different Glycemic Indices 177 (Tu-W28:6), 263 (Tu-P9:358), 432 (We-P14:388, We-P14:389), 458

(Th-PL4:4)

Cardiovascular Risk Factors and Obesity 3 (Su-$2:2, Su-$2:4), 28 (Mo-W9:7), 41 (Mo-$4:4), 42 (Mo-$6:3), 47

(Mo-P1:12), 57 (Mo-P1:52), 58 (Mo-P1:58), 61 (Mo-P1:72), 78 (Mo-P1:144), 84 (Mo-P2:173), 100 (Mo-P4:248), 103 (Mo-P4:261), 114 (Mo-P5:309), 120 (Mo-P5:337, Mo-P5:340), 138 (Mo-P6:418), 144 (Mo-P6:446), 145 (Mo-P6:450), 194 (Tu-P7:43), 204 (Tu-P7:89), 206 (Tu-P7:97), 214 (Tu-P7:136), 215 (Tu-P7:139), 270 (Tu-P10:390, Tu-P10:391), 287 (Tu-P10:468), 295 (Tu-P10:501), 298 (Tu-P10:515, Tu-P10:516), 303 (We-ML6:I, We-ML7:I), 311 (We-W33:4, We-W33:5), 312 (We-W33:6), 328 (We-W42:2), 329 (We-W42:3, We-W42:4, We-W42:5, We-W42:6), 330 (We-W42:7), 340 (We-$14:3), 341 (We-$14:4), 346 (We-P11:5), 347 (We-P11:6, We-P11:7), 349 (We-P11:19), 358 (We-P11:55), 363 (We-P11:78), 367 (We-P11:100, We-P11:99), 373 (We-P11:126), 374 (We-P11:130), 375 (We-P11:133), 377 (We-P11:141, We-P11:142, We-P11:143, We-P11:144), 378 (We-P11:145, We-P11:146, We-P11:149), 379 (We-P11:150, We-P11:152, We-P11:153, We-P11:154), 380 (We-P11:157, We-P11:158), 381 (We-P11:160, We-P11:161, We-P11:162), 382 (We-P11:163, We-P11:164, We-P11:165), 383 (We-P11:169), 385 (We-P11:180), 386 (We-P11:183, We-P11:186), 405 (We-P11:268), 408 (We-P12:282), 409 (We-P12:286), 415 (We-P13:314), 418 (We-P13:326, We-P13:327), 419 (We-P13:333), 421 (We-P13:338), 425 (We-P13:357), 432 (We-P14:389), 454 (We-P14:488), 502 (Th-P15:43), 512 (Th-P15:91), 516 (Th-P15:106), 519 (Th-P15:122), 526 (Th-P15:153), 535 (Th-P15:193), 537 (Th-P15:203), 556 (Th-P16:285), 571 (Th-P16:355), 585 (Th-P17:418)

CAT Technology 14 (Mo-W2:6), 41 (Mo-S6:I), 109 (Mo-P4:289), 127 (Mo-P5:373), 262

(Tu-P9:353)

Cell Proliferation 30 (Mo-W10:7), 33 (Mo-W12:5), 144 (Mo-P6:447), 159 (Tu-W19:5), 164

(Tu-W22:3), 171 (Tu-W25:7), 173 (Tu-W26:6), 186 (Tu-P7:8), 190 (Tu-P7:25, Tu-P7:27), 191 (Tu-P7:30, Tu-P7:31), 192 (Tu-P7:36), 194 (Tu-P7:45), 195 (Tu-P7:50), 196 (Tu-P7:52), 203 (Tu-P7:85), 206 (Tu-P7:IO0), 208 (Tu-P7:109), 212 (Tu-P7:127), 215 (Tu-P7:137), 224 (Tu-P7:180), 230 (Tu-P7:206), 239 (Tu-P7:248), 241 (Tu-P7:258), 243 (Tu-P7:265), 245 (Tu-P7:277), 249 (Tu-P8:291, Tu-P8:292, Tu-P8:293, Tu-P8:294, Tu-P8:295), 250 (Tu-P8:296, Tu-P8:297, Tu-P8:298, Tu-P8:299, Tu-P8:300), 251 (Tu-P8:304), 252 (Tu-P8:305, Tu-P8:306, Tu-P8:307, Tu-P8:308), 253 (Tu-P8:311, Tu-P8:312), 270 (Tu-PlO:393), 280 (Tu-PlO:437), 312 (We-W34:l), 372 (We-P11:120), 394 (We-P11:220), 404 (We-P11:265), 406 (We-P11:274), 454 (We-P14:484), 464 (Th-W48:8, Th-W49:2), 487 (Th-W60:5), 528 (Th-P15:161), 568 (Th-P16:340), 571 (Th-P16:354)

CETP Antagonists 11 (Mo-WI:I, Mo-WI:3), 180 (Tu-S8:I, Tu-S8:3), 322 (We-W38:5), 465

(Th-W49:3), 489 (Th-W61:5), 549 (Th-P16:259), 550 (Th-P16:260, Th-P16:261, Th-P16:262), 560 (Th-P16:306)

Chronic Liver Disease 556 (Th-P16:288)

Clinical Aspects 98 (Mo-P4:237), 109 (Mo-P4:286), 118 (Mo-P5:328), 390 (We-Pll:200), 413

(We-P12:306), 520 (Th-P15:124), 572 (Th-P16:360)

Clinical Practice 62 (Mo-Pl:74), 81 (Mo-PI:160), 107 (Mo-P4:276), 112 (Mo-P5:301), 115

(Mo-P5:316), 116 (Mo-P5:321), 120 (Mo-P5:337, Mo-P5:341), 122 (Mo-P5:349), 177 (Tu-W28:4), 268 (Tu-P9:381), 324 (We-W39:7), 461 (Th-W47:3), 480 (Th-W56:8)

Clinical Trials 1 (Su-SI:I, Su-SI:3), 2 (Su-SI:4), 12 (Mo-WI:4), 25 (Mo-W8:3), 43

(Mo-$6:5, Mo-$7:1), 44 (Mo-$7:4, Mo-$7:5), 82 (Mo-P1:165), 85 (Mo-P2:176), 100 (Mo-P4:248), 116 (Mo-P5:321), 144 (Mo-P6:445), 159 (Tu-W19:4), 160 (Tu-W20:3), 161 (Tu-W20:4, Tu-W20:5, Tu-W20:6, Tu-W20:7), 162 (Tu-W20:8), 163 (Tu-W21:4), 173 (Tu-W26:5, Tu-W27:1), 174 (Tu-W27:4), 179 (Tu-W29:7), 180 (Tu-S8:3), 181 (Tu-S10:I, Tu-S9:4), 182 (Tu-S 10:2, Tu-S10:3, Tu-S11:1), 189 (Tu-P7:23), 192 (Tu-P7:33), 209 (Tu-P7:110), 213 (Tu-P7:130), 272 (Tu-P10:400), 298 (Tu-P10:514), 303 (We-ML8:I), 307 (We-W31:1), 324 (We-W39:7), 329 (We-W42:3), 342 (We-S15:1, We-S 15:2, We-$15:3), 346 (We-P11:1), 350 (We-P11:20), 352 (We-P11:30, We-P11:31), 353 (We-P11:35), 356 (We-P11:46, We-P11:47), 357 (We-P11:50, We-P11:51, We-P11:54), 360 (We-P11:68), 361 (We-P11:70), 362 (We-P11:75), 366 (We-P11:93), 370 (We-P11:111), 372 (We-P11:122), 373 (We-P11:125), 375 (We-P11:132), 432 (We-P14:387), 434 (We-P14:396), 435 (We-P14:402), 436 (We-P14:407), 437 (We-P14:409), 438 (We-P14:417), 444 (We-P14:442), 445 (We-P14:445), 447 (We-P14:456), 450 (We-P14:468, We-P14:469), 466 (Th-W49:6), 495 (Th-P15:17), 502 (Th-P15:46), 506 (Th-P15:61), 509 (Th-P15:78), 510 (Th-P15:80), 530 (Th-P15:172), 549 (Th-P16:259), 550 (Th-P16:260, Th-P16:261), 551 (Th-P16:264, Th-P16:265, Th-P16:266, Th-P16:267), 552 (Th-P16:268, Th-P16:270), 553 (Th-P16:274), 554 (Th-P16:278, Th-P16:280), 555 (Th-P16:281, Th-P16:282, Th-P16:283), 557 (Th-P16:290), 558 (Th-P16:297), 559 (Th-P16:301), 562 (Th-P16:315), 563 (Th-P16:316), 564 (Th-P16:322, Th-P16:324), 565 (Th-P16:325, Th-P16:326, Th-P16:328), 567 (Th-P16:336), 571 (Th-P16:355), 574 (Th-P16:369), 575 (Th-P16:370), 576 (Th-P16:378), 577 (Th-P16:379, Th-P16:381, Th-P16:382), 578 (Th-P16:384, Th-P16:387, Th-P16:388), 580 (Th-P16:394, Th-P16:397), 581 (Th-P16:399), 583 (Th-P16:409), 584 (Th-P16:412), 586 (Th-P17:422)

Clinical Trials: Macro versus Micro Trials 51 (Mo-Pl:28), 91 (Mo-P2:204), 100 (Mo-P4:247), 174 (Tu-W27:2)


596 Topic bulex

Cognitive FmlOion 77 (Mo-Pl:140),193 (Tu-P7:39),267 (Tu-P9:376),276(Tu-PlO:419),283

(Tu-P10:447), 358(We-Pll:57), 401(We-Pll:253), 402(We-Pll:255, We-Pll:256),590 (Th-P17:443)

Combination Therapy 44 (Mo-$7:3, Mo-$7:5), 53 (Mo-Pl:36), 94 (Mo-P3:219), 99 (Mo-P4:244),

116 (Mo-P5:320), 117 (Mo-P5:325), 121 (Mo-P5:346), 161 (Tu-W20:5), 174 (Tu-W27:4), 175 (Tu-W27:7), 178 (Tu-W29:3, Tu-W29:4), 182 (Tu-Sll:I), 189 (Tu-P7:23), 232 (Tu-P7:215), 329 (We-W42:5), 338 (We-S13:I), 343 (We-S15:4), 366 (We-P11:93), 476 (Th-W54:7), 482 (Th-W57:6), 530 (Th-P15:172), 544 (Th-P15:232, Th-P15:236), 548 (Th-P16:250), 549 (Th-P16:259), 550 (Th-P16:261), 552 (Th-P16:269, Th-P16:271), 553 (Th-P16:273, Th-P16:274, Th-P16:275), 554 (Th-P16:276, Th-P16:277, Th-P16:278, Th-P16:280), 555 (Th-P16:281, Th-P16:282, Th-P16:283, Th-P16:284), 557 (Th-P16:289), 558 (Th-P16:294), 565 (Th-P16:326), 567 (Th-P16:336), 572 (Th-P16:357), 578 (Th-P16:388)

Conjugated Dienes 526 (Th-P15:153)

Conjugated Linoleic Acid 222 (Tu-P7:171), 381 (We-Pll:159), 433 (We-P14:391, We-P14:392,

We-P14:393)

Definition of Metabolic Syndrome 2 (Su-S2:I), 24 (Mo-W8:I), 36 (Mo-W14:2), 155 (Tu-W17:3, Tu-W17:4,

Tu-W17:7), 340 (We-S14:I, We-S14:3), 367 (We-P11:97), 369 (We-Pll:106), 376 (We-Pll:138), 383 (We-Pll:169), 401 (We-Pll:252), 407 (We-P12:280), 417 (We-P13:322), 418 (We-P13:327), 419 (We-P13:333), 420 (We-P13:334), 423 (We-P13:349), 424 (We-P13:352, We-P13:353), 425 (We-P13:356), 427 (We-P13:366)

Detection of Impaired Vasodilation 41 (Mo-S6:I), 88 (Mo-P2:192), 93 (Mo-P2:214), 151 (Tu-ML4:I), 163

(Tu-W21:5, Tu-W21:6), 209 (Tu-P7:ll 1), 212 (Tu-P7:126), 214 (Tu-P7:133), 219 (Tu-P7:155), 259 (Tu-P9:338), 263 (Tu-P9:358, Tu-P9:360, Tu-P9:361), 264 (Tu-P9:362, Tu-P9:363, Tu-P9:364, Tu-P9:365, Tu-P9:366), 265 (Tu-P9:367), 313 (We-W34:3), 322 (We-W39:l), 400 (We-P11:249), 405 (We-P11:268), 410 (We-P12:290), 436 (We-P14:405)

(Th-P15:132), 526 (Th-P15:153), 527 (Th-P15:155), 528 (Th-P15:163), 537 (Th-P15:202), 541 (Th-P15:218), 556 (Th-P16:286, Th-P16:287), 566 (Th-P16:329, Th-P16:333), 585 (Th-P16:416), 587 (Th-P17:424)

Diagnostic Technologies for Arterial Diseases 98 (Mo-P4:238), 112 (Mo-P5:300), 129 (Mo-P6:381), 170 (Tu-W25:4), 259

(Tu-P9:339), 260 (Tu-P9:347), 261 (Tu-P9:351), 263 (Tu-P9:357, Tu-P9:359, Tu-P9:360, Tu-P9:361), 264 (Tu-P9:365), 266 (Tu-P9:375), 267 (Tu-P9:378), 268 (Tu-P9:383), 269 (Tu-P9:386, Tu-P9:388), 323 (We-W39:4), 324 (We-W39:7), 400 (We-P11:246), 442 (We-P14:434), 466 (Th-W50:I), 587 (Th-P17:426), 588 (Th-P17:429, Th-P17:432)

Dietary Approach to Cardiovascular Prevention 10 (Mo-ML3:2), 56 (Mo-Pl:47), 77 (Mo-PI:140), 84 (Mo-P2:171), 112

(Mo-P5:299), 125 (Mo-P5:364), 131 (Mo-P6:388), 175 (Tu-W28:l), 176 (Tu-W28:3), 177 (Tu-W28:5, Tu-W28:6, Tu-W28:7), 180 (Tu-S9:I), 196 (Tu-P7:54, Tu-P7:55), 198 (Tu-P7:60), 206 (Tu-P7:98), 241 (Tu-P7:257), 252 (Tu-P8:306), 275 (Tu-PIO:412), 295 (Tu-P10:500), 303 (We-ML6:I), 316 (We-W36:1, We-W36:2), 317 (We-W36:3, We-W36:4), 334 (We-W45:2), 337 (We-S12:2, We-S12:3), 338 (We-S 12:4), 344 (We-S16:5), 351 (We-P11:25), 376 (We-Pll:140), 380 (We-Pll:156), 381 (We-P11:159, We-P11:162), 385 (We-P11:178), 390 (We-P11:201), 430 (We-P14:377), 431 (We-P14:383, We-P14:384, We-P14:386), 432 (We-P14:389), 433 (We-P14:393, We-P14:394), 434 (We-P14:395, We-P14:396, We-P14:397, We-P14:398, We-P14:399), 435 (We-P14:400, We-P14:401, We-P14:402, We-P14:404), 436 (We-P14:405, We-P14:406, We-P14:407, We-P14:408), 437 (We-P14:409, We-P14:410, We-P14:411, We-P14:412), 438 (We-P14:414, We-P14:415, We-P14:416, We-P14:417, We-P14:418), 439 (We-P14:419, We-P14:421, We-P14:422), 440 (We-P14:423, We-P14:424, We-P14:425, We-P14:426, We-P14:427), 441 (We-P14:428, We-P14:429, We-P14:430, We-P14:431), 442 (We-P14:432, We-P14:433, We-P14:434, We-P14:435), 443 (We-P14:436, We-P14:437, We-P14:438, We-P14:439, We-P14:440), 444 (We-P14:441, We-P14:442, We-P14:443, We-P14:444), 445 (We-P14:445, We-P14:446), 446 (We-P14:450, We-P14:452), 447 (We-P14:454), 448 (We-P14:461, We-P14:463), 449 (We-P14:464, We-P14:465, We-P14:466), 450 (We-P14:470), 452 (We-P14:476, We-P14:477, We-P14:478), 453 (We-P14:483), 454 (We-P14:488), 458 (Th-PL4:4), 473 (Th-W53:3, Th-W53:4), 476 (Th-W55:l, Th-W55:2), 477 (Th-W55:5), 478 (Th-W55:6, Th-W55:7), 509 (Th-P15:78), 510 (Th-P15:80), 511 (Th-P15:84, Th-P15:85), 512 (Th-P15:89, Th-P15:90), 522 (Th-P15:136), 529 (Th-P15:168), 561 (Th-P16:309), 582 (Th-P16:406), 588 (Th-P17:433)

Diabetes and Atherosclerosis 13 (Mo-W2:3), 14 (Mo-W2:5, Mo-W2:6, Mo-W2:7), 15 (Mo-W3:3), 25

(Mo-W8:4), 50 (Mo-PI:21), 57 (Mo-PI :51), 58 (Mo-Pl:59), 66 (Mo-Pl:92), 71 (Mo-PI:ll3, Mo-PI:114), 75 (Mo-Pl:133), 76 (Mo-Pl:138), 83 (Mo-Pl:462), 91 (Mo-P2:204, Mo-P2:205), 103 (Mo-P4:259, Mo-P4:260), 108 (Mo-P4:281), 110 (Mo-P4:293), 117 (Mo-P5:323), 128 (Mo-P5:374), 131 (Mo-P6:388), 139 (Mo-P6:423, Mo-P6:425), 145 (Mo-P6:453), 165 (Tu-W22:4, Tu-W22:5), 172 (Tu-W26:3), 177 (Tu-W28:4), 186 (Tu-P7:6), 194 (Tu-P7:44), 208 (Tu-P7:108), 210 (Tu-P7:115), 214 (Tu-P7:136), 232 (Tu-P7:215), 244 (Tu-P7:270), 251 (Tu-P8:304), 253 (Tu-P8:311), 278 (Tu-PlO:427), 281 (Tu-P10:441), 295 (Tu-P10:500, Tu-P10:503), 303 (We-ML7:I), 313 (We-W34:4), 322 (We-W38:7), 329 (We-W42:6), 346 (We-P11:2, We-P11:3, We-P11:4, We-P11:5), 347 (We-P11:8, We-P11:9), 348 (We-P11:10, We-P11:11, We-Pll:12, We-Pll:13, We-P11:14), 349 (We-P11 : 15, We-P11:17, We-P11:18), 350 (We-P11:21, We-P11:22, We-P11:23), 351 (We-P11:24, We-P11:25, We-P11:26, We-P11:27, We-Pll:28), 352 (We-P11:29, We-Pll:32), 353 (We-Pll:33, We-P11:34, We-P11:35, We-P11:36), 354 (We-P11:37, We-P11:38, We-P11:39, We-P11:40, We-P11:41), 355 (We-P11:42, We-Pll:43, We-P11:44), 357 (We-Pll:53), 358 (We-P11:55), 365 (We-Pll:91), 366 (We-P11:92), 369 (We-Pll:108), 375 (We-Pll:132, We-Pll:135), 385 (We-Pll:177), 404 (We-P11:266), 424 (We-P13:354, We-P13:355), 439 (We-P14:421), 471 (Th-W52:3), 475 (Th-W54:5), 479 (Th-W56:4), 506 (Th-P15:61), 508 (Th-P15:70), 511 (Th-P15:84), 519 (Th-P15:120), 520 (Th-P15:124), 521

Dietary Approach to Cardiovascular Protection 10 (Mo-ML3:I), 382 (We-P11:166)

Drug Eluting Stents 30 (Mo-W10:7), 250 (Tu-P8:299), 252 (Tu-P8:308), 402 (We-Pll:258), 403

(We-P11:259, We-P11:260, We-P11:261, We-Pll:262, We-P11:263), 404 (We-P11:264), 482 (Th-W57:4)

Drug Interactions 183 (Tu-S 11:2), 251 (Tu-P8:301), 373 (We-P11:126), 408 (We-P12:285), 464

(Th-W48:8), 494 (Th-P15:10), 524 (Th-P15:141), 549 (Th-P16:258), 569 (Th-P16:346), 576 (Th-P16:377)

Drugs Affecting Lipids and Appetite 40 (Mo-$4:3), 369 (We-P11:107), 408 (We-P12:285), 562 (Th-P16:312), 564

(Th-P16:324), 566 (Th-P16:329), 567 (Th-P16:334)

Early Markers of Cardiovascular Disease 5 (Su-S3:I, Su-$3:3), 6 (Su-$3:4), 14 (Mo-W2:6), 16 (Mo-W3:6), 23

(Mo-W7:3, Mo-W7:5), 37 (Mo-W14:5), 57 (Mo-Pl:52), 70 (Mo-PI:ll0), 73 (Mo-Pl:123), 74 (Mo-PI:130), 75 (Mo-PI :131, Mo-Pl:132), 76 (Mo-Pl:136), 77 (Mo-PI:141), 78 (Mo-Pl:144, Mo-Pl:147), 81 (Mo-Pl:158), 89 (Mo-P2:195), 107 (Mo-P4:279), 111 (Mo-P5:296), 117 (Mo-P5:323), 131 (Mo-P6:387), 133 (Mo-P6:399), 134 (Mo-P6:402), 142 (Mo-P6:436, Mo-P6:437, Mo-P6:439), 143 (Mo-P6:441), 144 (Mo-P6:445), 145 (Mo-P6:452), 146 (Mo-P6:455), 163 (Tu-W21:6), 169


Topic bulex 597

(Tu-W24:6), 170 (Tu-W25:2), 175 (Tu-W27:7), 187 (Tu-P7:14), 195 (Tu-P7:49), 203 (Tu-P7:86), 204 (Tu-P7:87, Tu-P7:88, Tu-P7:89, Tu-P7:90), 205 (Tu-P7:91, Tu-P7:92, Tu-P7:93, Tu-P7:94, Tu-P7:95), 206 (Tu-P7:100, Tu-P7:96, Tu-P7:97), 207 (Tu-P7:101, Tu-P7:102, Tu-P7:103, Tu-P7:104, Tu-P7:105), 208 (Tu-P7:107), 209 (Tu-P7:111, Tu-P7:ll2, Tu-P7:ll3, Tu-P7:114), 210 (Tu-P7:116), 213 (Tu-P7:128), 214 (Tu-P7:132, Tu-P7:133), 216 (Tu-P7:143), 218 (Tu-P7:150, Tu-P7:151), 219 (Tu-P7:155), 220 (Tu-P7:158), 221 (Tu-P7:163, Tu-P7:164, Tu-P7:167), 223 (Tu-P7:176), 224 (Tu-P7:180), 229 (Tu-P7:204), 230 (Tu-P7:206), 231 (Tu-P7:210), 232 (Tu-P7:217, Tu-P7:218, Tu-P7:219), 241 (Tu-P7:257), 243 (Tu-P7:268), 245 (Tu-P7:274), 247 (Tu-P7:286), 249 (Tu-P8:292), 251 (Tu-P8:303), 252 (Tu-P8:305), 257 (Tu-P9:332), 258 (Tu-P9:333, Tu-P9:336), 259 (Tu-P9:340), 261 (Tu-P9:348, Tu-P9:351), 262 (Tu-P9:356), 264 (Tu-P9:366), 267 (Tu-P9:377, Tu-P9:378), 279 (Tu-PlO:432), 280 (Tu-P10:437), 282 (Tu-P10:445), 283 (Tu-P10:447), 284 (Tu-P10:453, Tu-P10:455), 285 (Tu-P10:459), 287 (Tu-P10:466), 288 (Tu-PlO:472, Tu-P10:473), 289 (Tu-P10:477), 291 (Tu-P10:483), 293 (Tu-P10:493), 295 (Tu-P10:503), 306 (We-W30:5), 307 (We-W31:2), 308 (We-W31:6), 311 (We-W33:3) , 313 (We-W34:4, We-W34:5), 323 (We-W39:2), 329 (We-W42:6), 330 (We-W42:7), 349 (We-P11:19), 358 (We-Pll:55), 365 (We-P11:88), 367 (We-Pll:99), 375 (We-P11:135), 378 (We-Pll:147), 382 (We-Pll:164), 387 (We-Pll:188), 389 (We-P11:195), 395 (We-Pll:224, We-Pll:225, We-Pll:226), 406 (We-P11:274), 412 (We-P12:300), 418 (We-P13:328), 421 (We-P13:338), 422 (We-P13:344), 434 (We-P14:399), 437 (We-P14:412), 468 (Th-W50:6), 474 (Th-W53:7), 475 (Th-W54:3), 484 (Th-W58:6), 504 (Th-P15:54), 506 (Th-P15:65), 508 (Th-P15:72), 512 (Th-P15:92), 516 (Th-P15:106, Th-P15:108), 522 (Th-P15:134), 526 (Th-P15:153), 529 (Th-P15:167), 531 (Th-P15:173), 543 (Th-P15:231), 545 (Th-P15:237), 557 (Th-P16:292), 569 (Th-P16:342), 570 (Th-P16:349), 572 (Th-P16:357, Th-P16:358), 576 (Th-P16:378), 586 (Th-P17:423), 587 (Th-P17:428), 588 (Th-P17:429, Th-P17:430, Th-P17:432, Th-P17:433), 590 (Th-P17:438)

EBT 170 (Tu-W25:4), 218 (Tu-P7:150), 261 (Tu-P9:348), 265 (Tu-P9:368,

Tu-P9:369), 269 (Tu-P9:385), 307 (We-W31:1), 323 (We-W39:4), 419 (We-P13:332)

Endothel ia l Cells 14 (Mo-W2:5), 24 (Mo-W7:7), 29 (Mo-W10:3, Mo-W10:5), 33 (Mo-W12:5),

87 (Mo-P2:185, Mo-P2:188), 88 (Mo-P2:189, Mo-P2:191, Mo-P2:192), 92 (Mo-P2:209), 96 (Mo-P3:229, Mo-P3:230), 101 (Mo-P4:249), 126 (Mo-P5:366), 159 (Tu-W19:6), 190 (Tu-P7:26), 193 (Tu-P7:41), 195 (Tu-P7:47), 210 (Tu-P7:117), 213 (Tu-P7:131), 214 (Tu-P7:135), 215 (Tu-P7:138, Tu-P7:140), 216 (Tu-P7:141, Tu-P7:142, Tu-P7:144), 217 (Tu-P7:148, Tu-P7:149), 219 (Tu-P7:155), 220 (Tu-P7:158, Tu-P7:159), 223 (Tu-P7:172, Tu-P7:175, Tu-P7:176), 265 (Tu-P9:367), 277 (Tu-PlO:423), 291 (Tu-P10:485), 292 (Tu-P10:490), 295 (Tu-PIO:502), 297 (Tu-P10:511), 315 (We-W35:3) , 355 (We-Pl l :45) , 403 (We-P11:259, We-Pll:262), 415 (We-P13:314), 469 (Th-W51:4), 485 (Th-W59:3), 486 (Th-W59:5), 488 (Th-W60:8), 536 (Th-P15:197), 571 (Th-P16:351)

Endothel ia l Funct ion 14 (Mo-W2:5), 21 (Mo-W6:4, Mo-W6:5), 23 (Mo-W7:2), 29 (Mo-W10:4), 30

(Mo-Wll:2), 74 (Mo-PI:130), 75 (Mo-Pl:134, Mo-Pl:135), 76 (Mo-Pl:136), 87 (Mo-P2:187), 88 (Mo-P2:193), 92 (Mo-P2:209, Mo-P2:210), 96 (Mo-P3:230), 99 (Mo-P4:244), 106 (Mo-P4:273), 125 (Mo-P5:363, Mo-P5:364), 144 (Mo-P6:447), 152 (Tu-W16:3), 158 (Tu-W19:3), 159 (Tu-W19:4, Tu-W19:6), 162 (Tu-W21:I), 163 (Tu-W21:5, Tu-W21:6), 164 (Tu-W22:2), 187 (Tu-P7:10), 189 (Tu-P7:21), 190 (Tu-P7:26), 191 (Tu-P7:30, Tu-P7:31), 192 (Tu-P7:35, Tu-P7:37), 195 (Tu-P7:47), 200 (Tu-P7:69), 201 (Tu-P7:77), 202 (Tu-P7:78), 204 (Tu-P7:88), 207 (Tu-P7:104, Tu-P7:105), 210 (Tu-P7:117, Tu-P7:118), 211 (Tu-P7:119, Tu-P7:120, Tu-P7:121, Tu-P7:122, Tu-P7:123), 212 (Tu-P7:124, Tu-P7:125, Tu-P7:126), 213 (Tu-P7:128, Tu-P7:129, Tu-P7:130, Tu-P7:131), 214 (Tu-P7:132, Tu-P7:133, Tu-P7:134, Tu-P7:135, Tu-P7:136), 215 (Tu-P7:137, Tu-P7:138, Tu-P7:139, Tu-P7:140), 216 (Tu-P7:141, Tu-P7:142, Tu-P7:143, Tu-P7:144), 217

(Tu-P7:145, Tu-P7:146, Tu-P7:147), 218 (Tu-P7:150, Tu-P7:152), 219 (Tu-P7:154, Tu-P7:155, Tu-P7:156, Tu-P7:157), 220 (Tu-P7:158, Tu-P7:159, Tu-P7:160, Tu-P7:161, Tu-P7:162), 221 (Tu-P7:163, Tu-P7:164, Tu-P7:165, Tu-P7:166, Tu-P7:167), 222 (Tu-P7:168, Tu-P7:169, Tu-P7:170, Tu-P7:171), 223 (Tu-P7:172, Tu-P7:173, Tu-P7:174, Tu-P7:176), 224 (Tu-P7:177, Tu-P7:180), 230 (Tu-P7:206), 232 (Tu-P7:218), 234 (Tu-P7:226), 244 (Tu-P7:269), 250 (Tu-P8:297), 251 (Tu-P8:302, Tu-P8:303, Tu-P8:304), 252 (Tu-P8:308), 257 (Tu-P8:329), 261 (Tu-P9:351), 263 (Tu-P9:358, Tu-P9:359), 264 (Tu-P9:362, Tu-P9:365, Tu-P9:366), 265 (Tu-P9:367), 266 (Tu-P9:372), 267 (Tu-P9:377), 276 (Tu-P10:419), 278 (Tu-P10:427), 281 (Tu-P10:441), 285 (Tu-P10:457), 288 (Tu-P10:472), 291 (Tu-P10:483), 294 (Tu-P10:497), 295 (Tu-P10:502), 296 (Tu-P10:507), 298 (Tu-P10:513, Tu-P10:515), 310 (We-W32:7), 311 (We-W33:4) , 312 (We-W34:2), 313 (We-W34:3, We-W34:4, We-W34:6), 314 (We-W34:7), 320 (We-W37:6) , 324 (We-W39:5), 344 (We-S16:4), 348 (We-Pll:I 1), 349 (We-P11:19), 353 (We-P11:33), 355 (We-P11:42, We-Pll:43), 357 (We-P11:52, We-P11:54), 372 (We-P11:122), 375 (We-Pl l :134) , 379 (We-Pl l :152) , 381 (We-P11:162), 389 (We-P11:198), 392 (We-P11:211), 397 (We-Pll:233), 400 (We-P11:249), 410 (We-P12:290), 428 (We-P13:369), 436 (We-P14:405), 437 (We-P14:409), 443 (We-P14:440), 448 (We-P14:462), 454 (We-P14:486), 462 (Th-W48: l ) , 471 (Th-W52:6), 483 (Th-W58:l), 486 (Th-W59:4), 487 (Th-W60:I) , 488 (Th-W60:7), 512 (Th-P15:91, Th-P15:92), 521 (Th-P15:129), 523 (Th-P15:137), 534 (Th-P15:187), 535 (Th-P15:192), 556 (Th-P16:288), 567 (Th-P16:335), 569 (Th-P16:345), 571 (Th-P16:351, Th-P16:352, Th-P16:353), 572 (Th-P16:359), 578 (Th-P16:385), 590 (Th-P17:438)

Epidemio logy - Intervent ion 44 (Mo-$7:5), 46 (Mo-PI:3), 47 (Mo-PI:6, Mo-PI:8, Mo-PI:9), 53

(Mo-Pl:34), 54 (Mo-PI:40), 55 (Mo-Pl:44), 56 (Mo-Pl:49), 57 (Mo-PI:51), 58 (Mo-Pl:59), 61 (Mo-Pl:69), 62 (Mo-Pl:75), 64 (Mo-Pl:86), 65 (Mo-Pl:88), 69 (Mo-PI:107), 74 (Mo-PI:130), 81 (Mo-Pl:162), 102 (Mo-P4:257), 112 (Mo-P5:300), 114 (Mo-P5:308), 115 (Mo-P5:313), 116 (Mo-P5:321), 117 (Mo-P5:324, Mo-P5:327), 121 (Mo-P5:345), 122 (Mo-P5:350), 123 (Mo-P5:352), 143 (Mo-P6:441), 198 (Tu-P7:60), 229 (Tu-P7:204), 290 (Tu-P10:478), 316 (We-W36: l ) , 317 (We-W36:4), 318 (We-W36:7) , 334 (We-W45:2), 384 (We-P11:176), 385 (We-P11:177), 389 (We-P11:196), 399 (We-P11:241), 413 (We-P12:303), 414 (We-P12:311), 429 (We-P13:375), 445 (We-P14:445), 446 (We-P14:452), 553 (Th-P16:272)

Epidemio logy - Risk Factor Inc idence 16 (Mo-W4:I) , 34 (Mo-W13:4) , 35 (Mo-W13:5) , 46 (Mo-PI:2, Mo-PI:3), 47

(Mo-PI:6, Mo-PI:8), 48 (Mo-PI:14, Mo-PI:15, Mo-PI:16), 49 (Mo-PI:17, Mo-PI:18, Mo-PI:19, Mo-PI:20), 50 (Mo-Pl:22, Mo-Pl:23, Mo-Pl:24), 51 (Mo-Pl:25, Mo-Pl:26, Mo-Pl:27, Mo-Pl:29), 52 (Mo-PI:30, Mo-PI:31, Mo-Pl:32, Mo-Pl:33), 53 (Mo-Pl:35, Mo-Pl:36, Mo-Pl:37), 54 (Mo-Pl:39, Mo-PI:40, Mo-PI:41, Mo-Pl:42), 55 (Mo-Pl:43, Mo-Pl:44, Mo-Pl:45, Mo-Pl:46), 56 (Mo-Pl:48, Mo-PI:50), 57 (Mo-Pl:52, Mo-Pl:53, Mo-Pl:54, Mo-Pl:55), 58 (Mo-Pl:56, Mo-Pl:57, Mo-Pl:58), 59 (Mo-PI:60, Mo-PI:61, Mo-Pl:62, Mo-Pl:63), 60 (Mo-Pl:64, Mo-Pl:65, Mo-Pl:66, Mo-Pl:67, Mo-Pl:68), 61 (Mo-Pl:69, Mo-PI:70, Mo-PI:71, Mo-Pl:73), 62 (Mo-Pl:75, Mo-Pl:76, Mo-Pl:77), 63 (Mo-Pl:78, Mo-Pl:79, Mo-PI:81), 64 (Mo-Pl:82, Mo-Pl:83, Mo-Pl:84), 66 (Mo-PI:91, Mo-Pl:92, Mo-Pl:93), 68 (Mo-PI:102, Mo-PI:103, Mo-PI:104), 69 (Mo-PI:107, Mo-PI:108), 71 (Mo-PI:115), 72 (Mo-PI:120), 73 (Mo-Pl:122, Mo-Pl:125), 78 (Mo-Pl:144, Mo-Pl:146), 79 (Mo-Pl:152), 80 (Mo-Pl:154, Mo-Pl:157), 81 (Mo-PI:161, Mo-Pl:162), 82 (Mo-Pl:163, Mo-Pl:164, Mo-Pl:165, Mo-Pl:461" 84 (Mo-P2:171), 90 (Mo-P2:199), 102 (Mo-P4:255, Mo-P4:256 103 (Mo-P4:259, Mo-P4:260), 104 (Mo-P4:264), 109 (Mo-P4:289), 110 (Mo-P4:291, Mo-P4:294), 114 (Mo-P5:310), 115 (Mo-P5:316), 117 (Mo-P5:327), 118 (Mo-P5:332), 119 (Mo-P5:333), 121 (Mo-P5:345), 123 (Mo-P5:354), 124 (Mo-P5:359), 129 (Mo-P6:380), 130 (Mo-P6:386), 131 (Mo-P6:390), 132 (Mo-P6:393, Mo-P6:394), 133 (Mo-P6:399), 134 (Mo-P6:401, Mo-P6:402), 143 (Mo-P6:442), 145 (Mo-P6:450), 162 (Tu-W21:I), 163 (Tu-W21:3), 170 (Tu-W25:2), 177


598 Topic bulex

(Tu-W28:5), 178 (Tu-W29:6), 211 (Tu-P7:122), 217 (Tu-P7:145), 260 (Tu-P9:344), 263 (Tu-P9:359), 265 (Tu-P9:368), 272 (Tu-P10:401), 280 (Tu-P10:435), 287 (Tu-P10:466), 293 (Tu-P10:491, Tu-P10:493), 307 (We-W31:3), 313 (We-W34:3), 334 (We-W45:l), 335 (We-W45:3), 336 (We-W45:7), 342 (We-S15:I), 346 (We-P11:2), 350 (We-P11:20), 353 (We-Pll:36), 354 (We-P11:37, We-Pll:38), 358 (We-P11:57), 361 (We-P11:73), 363 (We-P11:79), 364 (We-P11:82, We-Pll:85, We-P11:86), 365 (We-Pll:87), 370 (We-P11:113), 371 (We-P11:114), 378 (We-P11 : 148), 380 (We-P11 : 155), 382 (We-P11 : 164), 383 (We-P11:168, We-Pll:171), 387 (We-Pll:189), 388 (We-Pll:194), 389 (We-Pll:195), 400 (We-P11:245), 401 (We-Pll:252, We-Pll:253), 408 (We-P12:282, We-P12:284), 411 (We-P12:294), 412 (We-P12:301), 413 (We-P12:304), 418 (We-P13:328), 420 (We-P13:334, We-P13:335), 423 (We-P13:348), 424 (We-P13:352, We-P13:353), 425 (We-P13:357, We-P13:358, We-P13:359), 426 (We-P13:362), 427 (We-P13:367), 441 (We-P14:428, We-P14:431), 461 (Th-W47:l, Th-W47:2), 467 (Th-W50:5), 468 (Th-W50:6, Th-W50:7), 470 (Th-W52:2), 471 (Th-W52:4), 475 (Th-W54:5), 483 (Th-W58:3), 484 (Th-W58:5, Th-W58:7), 501 (Th-P15:41), 506 (Th-P15:62), 518 (Th-P15:ll5), 520 (Th-P15:123), 530 (Th-P15:171), 532 (Th-P15:179), 534 (Th-P15:188), 545 (Th-P15:238), 568 (Th-P16:339)

Epidemiology of Cardiovascular Disease 46 (Mo-PI:5), 48 (Mo-PI:14, Mo-PI:15), 50 (Mo-PI:21), 51 (Mo-Pl:29), 52

(Mo-PI:31, Mo-Pl:33), 54 (Mo-PI:40), 60 (Mo-Pl:65), 63 (Mo-PI:80, Mo-PI:81), 66 (Mo-Pl:92, Mo-Pl:93), 67 (Mo-Pl:97, Mo-Pl:98), 73 (Mo-Pl:125), 74 (Mo-Pl:127), 75 (Mo-Pl:133), 76 (Mo-Pl:136), 78 (Mo-Pl:145), 79 (Mo-Pl:153), 82 (Mo-Pl:167, Mo-Pl:461), 84 (Mo-P2:174), 102 (Mo-P4:256), 104 (Mo-P4:264), 107 (Mo-P4:277), 109 (Mo-P4:286), 118 (Mo-P5:331), 139 (Mo-P6:423), 143 (Mo-P6:442), 180 (Tu-S8:2, Tu-S9:I), 189 (Tu-P7:19), 260 (Tu-P9:342), 290 (Tu-P10:480), 317 (We-W36:5, We-W36:6), 326 (We-W41:I), 335 (We-W45:3, We-W45:6), 336 (We-W45:7), 348 (We-P11:13), 367 (We-P11:97), 399 (We-Pll:241), 419 (We-P13:332), 423 (We-P13:348), 424 (We-P13:354, We-P13:355), 432 (We-P14:387), 447 (We-P14:456), 467 (Th-W50:4), 475 (Th-W54:5), 519 (Th-P15:120)

Erectile Dysfunction 215 (Tu-P7:140), 404 (We-P11:266, We-Pll:267), 405 (We-Pll:268,

We-P11:269), 438 (We-P14:417)

Exercise 100 (Mo-P4:246), 106 (Mo-P4:273), 111 (Mo-P5:298), 112 (Mo-P5:299,

Mo-P5:300, Mo-P5:301, Mo-P5:302), 113 (Mo-P5:303, Mo-P5:304, Mo-P5:305, Mo-P5:306, Mo-P5:307), 120 (Mo-P5:338, Mo-P5:341), 141 (Mo-P6:435), 162 (Tu-W21:I, Tu-W21:2), 207 (Tu-P7:101), 380 (We-Pll:158), 386 (We-Pll:185), 417 (We-P13:323), 428 (We-P13:369, We-P13:370, We-P13:371, We-P13:372), 431 (We-P14:385), 526 (Th-P15:154), 527 (Th-P15:155)

Ezetimibe 44 (Mo-$7:3, Mo-$7:4, Mo-$7:5), 117 (Mo-P5:325), 122 (Mo-P5:347), 146

(Mo-P6:457), 174 (Tu-W27:3, Tu-W27:4), 178 (Tu-W29:3), 188 (Tu-P7:18), 356 (We-P11:49), 482 (Th-W57:5, Th-W57:6), 552 (Th-P16:270), 553 (Th-P16:273, Th-P16:274, Th-P16:275), 554 (Th-P16:276, Th-P16:277, Th-P16:280), 555 (Th-P16:281, Th-P16:282, Th-P16:283, Th-P16:284), 557 (Th-P16:289), 558 (Th-P16:293, Th-P16:294, Th-P16:295, Th-P16:296, Th-P16:297), 561 (Th-P16:308), 569 (Th-P16:342)

Familial Hyper- and Hypolipidemias 18 (Mo-W5:I), 19 (Mo-W5:2, Mo-W5:3), 20 (Mo-W5:4), 21 (Mo-W6:3), 34

(Mo-W13:4), 36 (Mo-W14:3), 38 (Mo-W15:2), 50 (Mo-P1:22), 61 (Mo-P1:69), 90 (Mo-P2:200), 94 (Mo-P3:220), 113 (Mo-P5:306), 123 (Mo-P5:355), 128 (Mo-P6:378), 129 (Mo-P6:382), 130 (Mo-P6:383, Mo-P6:384, Mo-P6:385, Mo-P6:386), 131 (Mo-P6:390), 132 (Mo-P6:392), 133 (Mo-P6:400), 134 (Mo-P6:404), 135 (Mo-P6:405, Mo-P6:406, Mo-P6:407, Mo-P6:409), 136 (Mo-P6:411, Mo-P6:412, Mo-P6:413), 137

(Mo-P6:414), 145 (Mo-P6:451), 152 (Tu-W16:3), 166 (Tu-W23:2), 169 (Tu-W24:6), 192 (Tu-P7:37), 197 (Tu-P7:59), 200 (Tu-P7:72), 225 (Tu-P7:183), 231 (Tu-P7:211), 251 (Tu-P8:303), 253 (Tu-P8:313), 260 (Tu-P9:345), 261 (Tu-P9:349), 262 (Tu-P9:353, Tu-P9:354, Tu-P9:355), 263 (Tu-P9:357), 288 (Tu-PlO:472), 305 (We-W30:2, We-W30:3), 306 (We-W30:4), 313 (We-W34:3), 315 (We-W35:4), 319 (We-W37:3), 330 (We-W43:2), 333 (We-W44:5, We-W44:6), 397 (We-P11:234), 406 (We-P11:275), 450 (We-P14:470), 465 (Th-W49:4), 476 (Th-W54:7, Th-W55:l), 495 (Th-P15:16), 507 (Th-P15:68, Th-P15:69), 510 (Th-P15:81), 515 (Th-P15:101), 536 (Th-P15:195, Th-P15:198), 544 (Th-P15:235), 545 (Th-P15:237, Th-P15:238, Th-P15:239, Th-P15:240, Th-P15:241), 546 (Th-P15:242, Th-P15:243, Th-P15:244), 547 (Th-P15:246, Th-P15:247), 554 (Th-P16:277), 563 (Th-P16:319), 564 (Th-P16:320, Th-P16:322), 584 (Th-P16:412, Th-P16:415)

Fermented Milk 452 (We-P14:479)

Fibrates and the PPAR System 7 (Mo-PLI:2), 174 (Tu-W27:3), 254 (Tu-P8:315), 342 (We-S15:3), 343

(We-S15:4), 344 (We-S16:3), 358 (We-P11:58), 359 (We-P11:62), 370 (We-P11:111), 554 (Th-P16:278), 556 (Th-P16:287), 557 (Th-P16:290), 559 (Th-P16:299, Th-P16:300, Th-P16:301, Th-P16:302), 560 (Th-P16:303, Th-P16:304, Th-P16:305), 561 (Th-P16:307, Th-P16:308, Th-P16:309), 568 (Th-P16:339), 570 (Th-P16:350), 584 (Th-P16:412)

Fibrinolysis 72 (Mo-PI:117), 87 (Mo-P2:188), 88 (Mo-P2:189, Mo-P2:193), 89

(Mo-P2:194), 90 (Mo-P2:202), 158 (Tu-W19:2, Tu-W19:3), 159 (Tu-W19:4), 314 (We-W35:2), 350 (We-P11:23), 373 (We-P11:125), 394 (We-Pll:222), 420 (We-P13:336), 434 (We-P14:397), 447 (We-P14:457)

Gene and Call Therapy 95 (Mo-P3:221), 96 (Mo-P3:227, Mo-P3:229), 97 (Mo-P3:232), 190

(Tu-P7:26), 246 (Tu-P7:281), 404 (We-P11:265), 482 (Th-W57:4)

Gene Environment Interactions 5 (Su-$3:2), 17 (Mo-W4:3), 18 (Mo-W4:5), 35 (Mo-W13:6, Mo-W13:7), 68

(Mo-PI:101), 89 (Mo-P2:195), 113 (Mo-P5:303), 129 (Mo-P6:379), 131 (Mo-P6:387, Mo-P6:389), 132 (Mo-P6:395), 133 (Mo-P6:397, Mo-P6:399), 135 (Mo-P6:408), 137 (Mo-P6:415), 138 (Mo-P6:418, Mo-P6:419), 143 (Mo-P6:441), 146 (Mo-P6:455, Mo-P6:456), 175 (Tu-W28:l), 188 (Tu-P7:17), 204 (Tu-P7:87), 207 (Tu-P7:102), 213 (Tu-P7:131), 246 (Tu-P7:281), 255 (Tu-P8:322), 301 (We-PL3:3), 314 (We-W35:2), 333 (We-W44:7), 335 (We-W45:5), 357 (We-P11:50), 368 (We-P11:102), 383 (We-P11:171), 397 (We-Pll:232), 448 (We-P14:461), 486 (Th-W59:6), 546 (Th-P15:242), 585 (Th-P17:419), 586 (Th-P17:420)

Gene Polymorphisms 12 (Mo-WI:4), 16 (Mo-W3:7), 18 (Mo-W4:4), 29 (Mo-W10:4), 34

(Mo-W13:1), 37 (Mo-W14:6), 69 (Mo-P1:106), 73 (Mo-P1:125), 74 (Mo-P1:128), 89 (Mo-P2:196), 129 (Mo-P6:379, Mo-P6:380), 130 (Mo-P6:383), 131 (Mo-P6:390), 133 (Mo-P6:397), 135 (Mo-P6:408), 136 (Mo-P6:410, Mo-P6:412), 137 (Mo-P6:417), 138 (Mo-P6:418), 140 (Mo-P6:427, Mo-P6:429, Mo-P6:430), 141 (Mo-P6:433), 142 (Mo-P6:436, Mo-P6:438, Mo-P6:440), 144 (Mo-P6:445), 145 (Mo-P6:449), 147 (Mo-P6:458), 305 (We-W30:1), 308 (We-W31:4), 316 (We-W35:6), 332 (We-W44:2, We-W44:3), 333 (We-W44:4, We-W44:5), 337 (We-S12:1), 349 (We-P11:15), 370 (We-P11:110), 378 (We-P11:145), 380 (We-P11:155), 383 (We-P11:171), 384 (We-P11:175), 387 (We-P11:190), 396 (We-P11:228, We-P11:229, We-P11:230, We-P11:231), 397 (We-P11:232, We-P11:233, We-P11:234), 419 (We-P13:331), 474 (Th-W54:2), 530 (Th-P15:170), 531 (Th-P15:176)

Gene Therapy 19 (Mo-W5:2), 94 (Mo-P3:217, Mo-P3:218, Mo-P3:219, Mo-P3:220), 95

(Mo-P3:221, Mo-P3:222, Mo-P3:223, Mo-P3:224), 96 (Mo-P3:225, Mo-P3:226, Mo-P3:227), 97 (Mo-P3:231), 153 (Tu-W16:6), 190


Topic bulex 599

(Tu-P7:28), 198 (Tu-P7:61), 221 (Tu-P7:167), 244 (Tu-P7:273), 253 (Tu-P8:312), 318 (We-W37:2), 481 (Th-W57:2), 490 (Th-W61:8), 532 (Th-P15:180)

Gene Therapy and Stem Cells 94 (Mo-P3:217), 302 (We-PL3:4), 352 (We-P11:32)

Genetic Factors in Vascular Syndromes 18 (Mo-W4:4), 29 (Mo-W10:4), 34 (Mo-W13:2, Mo-W13:3), 89 (Mo-P2:194,

Mo-P2:195, Mo-P2:196), 98 (Mo-P4:235), 129 (Mo-P6:379), 133 (Mo-P6:399), 137 (Mo-P6:416), 138 (Mo-P6:419), 140 (Mo-P6:427), 142 (Mo-P6:440), 143 (Mo-P6:443), 144 (Mo-P6:447), 149 (Tu-PL2:3), 158 (Tu-W19:I), 207 (Tu-P7:101), 246 (Tu-P7:281), 301 (We-PL3:3), 311 (We-W33:5), 314 (We-W35:l, We-W35:2), 315 (We-W35:3), 316 (We-W35:6), 333 (We-W44:7), 336 (We-W45:7), 387 (We-P11:190), 396 (We-P11:230), 397 (We-Pll:232), 531 (Th-P15:176)

Geographical and Social Impact 48 (Mo-PI:14), 49 (Mo-PI:20), 50 (Mo-Pl:23), 52 (Mo-PI:30), 53

(Mo-Pl:34), 55 (Mo-Pl:45), 62 (Mo-Pl:74, Mo-Pl:75), 63 (Mo-Pl:78), 64 Mo-Pl:82, Mo-Pl:83, Mo-Pl:84, Mo-Pl:86), 65 (Mo-Pl:87), 68

(Mo-PI:103), 79 (Mo-Pl:149, Mo-Pl:152), 82 (Mo-Pl:461), 102 (Mo-P4:256), 118 (Mo-P5:332), 119 (Mo-P5:333), 124 (Mo-P5:356), 131 (Mo-P6:389), 144 (Mo-P6:445), 170 (Tu-W25:2), 178 (Tu-W29:6), 252 (Tu-P8:306), 335 (We-W45:3), 461 (Th-W47:2), 484 (Th-W58:7), 545 (Th-P15:238)

Global Risk Assessment 24 (Mo-W8:I), 44 (Mo-$7:2), 46 (Mo-PI:2, Mo-PI:4), 47 (Mo-PI:6), 48

(Mo-PI:16), 49 (Mo-PI:18), 54 (Mo-Pl:39), 58 (Mo-Pl:59), 61 (Mo-PI:70), 65 (Mo-Pl:89), 70 (Mo-PI :112), 72 (Mo-PI:121), 74 (Mo-Pl:129), 78 (Mo-Pl:146), 85 (Mo-P2:178), 100 (Mo-P4:246), 102 (Mo-P4:254, Mo-P4:255), 105 (Mo-P4:268, Mo-P4:269), 106 (Mo-P4:273, Mo-P4:274), 108 (Mo-P4:282), 111 (Mo-P4:295), 114 (Mo-P5:308, Mo-P5:309, Mo-P5:310, Mo-P5:311, Mo-P5:312), 115 (Mo-P5:313), 116 (Mo-P5:322), 119 (Mo-P5:335), 123 (Mo-P5:355), 125 (Mo-P5:361), 140 (Mo-P6:427), 161 (Tu-W20:7), 218 (Tu-P7:151), 258 (Tu-P9:334), 261 (Tu-P9:350), 262 (Tu-P9:353, Tu-P9:354, Tu-P9:356), 281 (Tu-PlO:440), 283 (Tu-PlO:449), 286 (Tu-PlO:461), 301 (We-PL3:3), 324 (We-W39:7), 340 (We-S14:I), 378 (We-Pll:147), 405 (We-P11:268), 423 (We-P13:346, We-P13:347), 427 (We-P13:366), 483 (Th-W58:2), 484 (Th-W58:4), 546 (Th-P15:242)

Global Risk Evaluation 5 (Su-$3:3), 6 (Su-$3:4), 37 (Mo-W14:4), 46 (Mo-PI:2, Mo-PI:3, Mo-PI:4),

47 (Mo-PI:6), 49 (Mo-PI:19), 50 (Mo-Pl:23), 51 (Mo-Pl:26, Mo-Pl:28), 53 (Mo-Pl:34), 54 (Mo-PI:40), 55 (Mo-Pl:45), 58 (Mo-Pl:56, Mo-Pl:59), 60 (Mo-Pl:65), 61 (Mo-PI:71), 65 (Mo-Pl:88, Mo-Pl:89, Mo-PI:90), 66 (Mo-PI:91, Mo-Pl:93), 68 (Mo-PI:102, Mo-PI:104), 71 (Mo-PI:ll5), 74 (Mo-Pl:129), 78 (Mo-Pl:148), 80 (Mo-Pl:157), 81 (Mo-Pl:162), 82 (Mo-Pl:167), 84 (Mo-P2:171), 100 (Mo-P4:246, Mo-P4:248), 105 Mo-P4:268, Mo-P4:269), 107 (Mo-P4:279), 109 (Mo-P4:287), 111

(Mo-P5:297), 114 (Mo-P5:308), 115 (Mo-P5:313), 116 (Mo-P5:322), 119 (Mo-P5:335), 126 (Mo-P5:367), 163 (Tu-W21:3), 170 (Tu-W25:4), 208 (Tu-P7:106), 259 (Tu-P9:341), 264 (Tu-P9:362, Tu-P9:364), 269 (Tu-P9:386), 280 (Tu-PlO:435), 307 (We-W31:2), 311 (We-W33:3), 323 (We-W39:2), 333 (We-W44:7), 335 (We-W45:4), 340 (We-S14:3), 346 (We-Pll:I), 364 (We-Pll:85), 378 (We-P11:145), 387 (We-P11:189), 389 We-Pll:199), 399 (We-Pll:241), 413 (We-P12:306), 419 (We-P13:333), 467 (Th-W50:4), 470 (Th-W52:l, Th-W52:2), 478 (Th-W56:l), 483 (Th-W58:3), 484 (Th-W58:4, Th-W58:7), 553 (Th-P16:272)

Guidelines and Treatment Targets 44 (Mo-S 7:2), 46 (Mo-P 1:2), 70 (Mo-P 1:112), 80 (Mo-P 1:154), 101

(Mo-P4:250, Mo-P4:251), 107 (Mo-P4:278), 114 (Mo-P5:308, Mo-P5:310, Mo-P5:311), 115 (Mo-P5:314, Mo-P5:315, Mo-P5:316), 116 (Mo-P5:317, Mo-P5:318, Mo-P5:320, Mo-P5:321), 117 (Mo-P5:324, Mo-P5:325, Mo-P5:326, Mo-P5:327), 118 (Mo-P5:329, Mo-P5:330), 120 (Mo-P5:341),

121 (Mo-P5:344), 160 (Tu-W20:I), 161 (Tu-W20:5), 169 (Tu-W25:l), 178 (Tu-W29:3), 182 (Tu-S11:1), 323 (We-W39:3), 340 (We-S14:2), 343 (We-S16:I), 357 (We-P11:51), 358 (We-P11:57), 405 (We-P11:268), 427 (We-P13:366), 461 (Th-W47:l), 462 (Th-W47:4), 466 (Th-W50:I, Th-W50:2), 468 (Th-W50:6), 485 (Th-W59:2), 580 (Th-P16:394)

HDL 11 (Mo-WI:I), 35 (Mo-W14:I), 40 (Mo-$4:2), 149 (Tu-PL2:2), 155

(Tu-W17:5), 162 (Tu-W21:2), 165 (Tu-W23:l), 166 (Tu-W23:2), 305 (We-W30:2), 320 (We-W38:l), 321 (We-W38:3), 332 (We-W44:2), 452 (We-P14:479), 457 (Th-PL4:I), 459 (Th-W46:2), 547 (Th-P15:248)

HDL (Metabolism, Pleiotropic Effects) 11 (Mo-WI:3), 12 (Mo-WI:5), 16 (Mo-W3:5), 25 (Mo-W8:4), 28

(Mo-W9:6), 30 (Mo-W11:1), 35 (Mo-W13:5, Mo-W13:6), 37 (Mo-W14:5), 39 (Mo-W15:8), 49 (Mo-PI:19), 53 (Mo-Pl:38), 57 (Mo-Pl:52), 59 (Mo-Pl:62), 61 (Mo-Pl:69), 63 (Mo-Pl:79), 68 (Mo-PI:102), 69 (Mo-PI:105), 70 (Mo-PI:111), 71 (Mo-PI:ll3), 83 (Mo-P2:170), 89 (Mo-P2:198), 94 (Mo-P3:218, Mo-P3:219), 95 (Mo-P3:223), 116 (Mo-P5:320), 132 (Mo-P6:396), 133 (Mo-P6:397, Mo-P6:398, Mo-P6:400), 134 (Mo-P6:402), 136 (Mo-P6:413), 137 (Mo-P6:415), 149 (Tu-PL2:I), 152 (Tu-W16:2, Tu-W16:3, Tu-W16:4), 153 (Tu-W16:5, Tu-W16:6, Tu-W16:7, Tu-W16:8), 166 (Tu-W23:3), 167 (Tu-W23:5, Tu-W23:7), 175 (Tu-W27:6), 180 (Tu-S8:I, Tu-S8:2), 225 (Tu-P7:185), 227 (Tu-P7:194), 232 (Tu-P7:219), 236 (Tu-P7:237), 254 (Tu-P8:318), 255 (Tu-P8:319), 256 (Tu-P8:324), 275 (Tu-P10:414), 289 (Tu-P10:476), 292 (Tu-P10:489), 311 (We-W33:4), 319 (We-W37:4), 320 (We-W37:6), 322 (We-W38:5, We-W38:7), 331 (We-W43:7), 333 (We-W44:4, We-W44:5), 358 (We-P11:58), 366 (We-P11:94), 371 (We-P11:117), 415 (We-P13:313), 423 (We-P13:349), 475 (Th-W54:4), 484 (Th-W58:6), 489 (Th-W61:5), 493 (Th-P15:7), 494 (Th-P15:13), 495 (Th-P15:15), 496 (Th-P15:20), 499 (Th-P15:31), 500 (Th-P15:37), 502 (Th-P15:43), 505 (Th-P15:60), 506 (Th-P15:65), 507 (Th-P15:66), 508 (Th-P15:74), 511 (Th-P15:87), 517 (Th-P15:ll 1, Th-P15:112), 518 (Th-P15:ll8), 524 (Th-P15:144), 525 (Th-P15:145), 526 (Th-P15:154), 527 (Th-P15:155, Th-P15:157), 528 (Th-P15:160, Th-P15:161), 532 (Th-P15:181), 533 (Th-P15:182, Th-P15:183, Th-P15:185), 534 (Th-P15:186, Th-P15:187, Th-P15:188, Th-P15:190), 535 (Th-P15:191, Th-P15:192, Th-P15:193, Th-P15:194), 536 (Th-P15:195, Th-P15:196, Th-P15:197, Th-P15:198), 537 (Th-P15:199, Th-P15:200, Th-P15:201, Th-P15:202, Th-P15:203), 538 (Th-P15:206, Th-P15:207, Th-P15:208), 539 (Th-P15:209, Th-P15:210, Th-P15:211), 540 (Th-P15:214, Th-P15:216), 541 (Th-P15:218, Th-P15:219, Th-P15:220), 542 (Th-P15:223, Th-P15:224, Th-P15:225), 543 (Th-P15:226, Th-P15:229), 550 (Th-P16:263), 556 (Th-P16:285), 557 (Th-P16:290), 560 (Th-P16:306), 561 (Th-P16:307, Th-P16:310, Th-P16:311), 562 (Th-P16:312, Th-P16:313), 563 (Th-P16:319), 564 (Th-P16:323), 566 (Th-P16:330), 567 (Th-P16:337), 575 (Th-P16:372), 577 (Th-P16:383), 580 (Th-P16:395), 582 (Th-P16:405), 589 (Th-P17:437)

HDL Raising Drugs and HDL Mimetics 11 (Mo-WI:I, Mo-WI:2), 12 (Mo-WI:5, Mo-WI:7), 28 (Mo-W9:6), 94

(Mo-P3:218), 116 (Mo-P5:320), 121 (Mo-P5:346), 152 (Tu-W16:2), 167 (Tu-W23:5, Tu-W23:6), 178 (Tu-W29:4), 180 (Tu-S8:3), 254 (Tu-P8:318), 301 (We-PL3:2), 320 (We-W38:l), 321 (We-W38:4), 322 (We-W38:5, We-W38:6, We-W38:7), 359 (We-P11:59), 401 (We-P11:250), 413 (We-P12:307), 434 (We-P14:398), 442 (We-P14:432), 465 (Th-W49:3), 494 (Th-P15:13), 535 (Th-P15:194), 539 (Th-P15:209), 541 (Th-P15:219), 543 (Th-P15:230), 549 (Th-P16:259), 550 (Th-P16:260, Th-P16:261, Th-P16:262, Th-P16:263), 560 (Th-P16:306), 561 (Th-P16:310, Th-P16:311), 562 (Th-P16:312, Th-P16:313), 565 (Th-P16:325, Th-P16:326, Th-P16:327), 566 (Th-P16:330), 567 (Th-P16:337), 575 (Th-P16:372), 577 (Th-P16:383), 580 (Th-P16:395)

Heart Failure 95 (Mo-P3:221), 97 (Mo-P3:233), 99 (Mo-P4:242, Mo-P4:243, Mo-P4:244),

100 (Mo-P4:245), 101 (Mo-P4:249, Mo-P4:250, Mo-P4:251, Mo-P4:253), 153 (Tu-W16:6), 199 (Tu-P7:65), 204 (Tu-P7:89), 217 (Tu-P7:149), 241


600 Topic bulex

(Tu-P7:259), 336 (We-W45:7), 350 (We-P11:20), 354 (We-P11:39), 357 (We-Pll:53), 435 (We-P14:401), 574 (Th-P16:366), 578 (Th-P16:385), 591 (Th-P17:445)

Homocysteine 73 (Mo-Pl:123), 123 (Mo-P5:353), 127 (Mo-P5:371), 131 (Mo-P6:388), 173

(Tu-W26:7), 177 (Tu-W28:4), 193 (Tu-P7:41), 216 (Tu-P7:141, Tu-P7:143), 244 (Tu-P7:272), 271 (Tu-P10:397), 272 (Tu-P10:398, Tu-P10:399, Tu-P10:400, Tu-P10:401, Tu-P10:402), 273 (Tu-P10:403, Tu-P10:404, Tu-P10:405, Tu-P10:406, Tu-P10:407), 274 (Tu-P10:408, Tu-P10:409, Tu-P10:410, Tu-P10:411), 275 (Tu-P10:412, Tu-P10:414, Tu-P10:415, Tu-P10:416), 276 (Tu-P10:417, Tu-P10:418, Tu-P10:419, Tu-P10:420), 296 (Tu-P10:505), 308 (We-W31:5), 317 (We-W36:3), 318 (We-W36:7), 360 (We-P11:64), 397 (We-Pll:232), 400 (We-P11:248), 434 (We-P14:399), 435 (We-P14:401), 479 (Th-W56:3, Th-W56:4), 480 (Th-W56:6), 518 (Th-P 15:115, Th-P15:116), 532 (Th-P15:181), 559 (Th-P16:302), 580 (Th-P16:393), 584 (Th-P16:411)

Hyperglycemia or Hyperlipidemia: Management Choices 87 (Mo-P2:188), 108 (Mo-P4:284), 112 (Mo-P5:302), 115 (Mo-P5:315,

Mo-P5:316), 123 (Mo-P5:355), 128 (Mo-P5:375), 177 (Tu-W28:6), 196 (Tu-P7:55), 294 (Tu-P10:495), 346 (We-Pll:I, We-P11:4), 347 (We-P11:6, We-Pll:7), 353 (We-P11:34), 354 (We-Pll:41), 356 (We-P11:46), 358 (We-P11:56), 364 (We-Pll:82), 369 (We-P11:107), 437 (We-P14:413), 438 (We-P14:414), 442 (We-P14:433), 447 (We-P14:456), 454 (We-P14:488), 511 (Th-P15:85), 516 (Th-P15:107), 528 (Th-P15:163), 551 (Th-P16:266), 557 (Th-P16:290), 572 (Th-P16:357)

(Tu-W24:3), 169 (Tu-W25:l), 190 (Tu-P7:24), 195 (Tu-P7:50), 197 (Tu-P7:58), 225 (Tu-P7:185), 231 (Tu-P7:213), 236 (Tu-P7:234), 242 (Tu-P7:262), 248 (Tu-P7:289), 257 (Tu-P8:330), 270 (Tu-P10:393), 271 (Tu-P10:395, Tu-P10:396), 277 (Tu-P10:422), 278 (Tu-P10:425, Tu-P10:426, Tu-P10:427), 283 (Tu-P10:451), 284 (Tu-P10:452), 287 (Tu-P10:467), 291 (Tu-P10:482), 295 (Tu-P10:504), 299 (Tu-P10:518), 309 (We-W32:2), 310 (We-W32:6), 326 (We-W41:I), 327 (We-W41:4, We-W41:5, We-W41:6), 393 (We-Pll:216), 396 (We-Pll:228), 405 (We-P11:270, We-P11:271), 406 (We-Pll:272, We-P11:273, We-P11:274, We-P11:275), 407 (We-P11:276, We-P11:277), 413 (We-P12:307), 416 (We-P13:318), 459 (Th-W46:l), 460 (Th-W46:4), 463 (Th-W48:3), 532 (Th-P15:179), 539 (Th-P15:210), 549 (Th-P16:257)

Immunity 5 (Su-$3:3), 23 (Mo-W7:5), 29 (Mo-W10:4), 54 (Mo-PI:41), 97 (Mo-P3:233),

113 (Mo-P5:307), 195 (Tu-P7:50), 224 (Tu-P7:178), 235 (Tu-P7:231, Tu-P7:232), 251 (Tu-P8:301), 270 (Tu-P10:393), 271 (Tu-P10:395), 277 (Tu-P10:421, Tu-P10:423), 278 (Tu-P10:425, Tu-P10:426, Tu-P10:427, Tu-P10:428), 280 (Tu-P10:437, Tu-P10:438), 287 (Tu-P10:466), 289 (Tu-P10:474), 291 (Tu-P10:484), 299 (Tu-P10:518), 326 (We-W41:2), 327 (We-W41:6), 328 (We-W41:7), 349 (We-Pll:16), 352 (We-P11:30), 405 (We-P11:271), 407 (We-P11:276), 413 (We-P12:304), 481 (Th-W57:l), 493 (Th-P15:7), 521 (Th-P15:131), 526 (Th-P15:151), 589 (Th-P17:436)

Individual Response to Antiplatelet Agents 91 (Mo-P2:207), 141 (Mo-P6:434), 392 (We-Pll:212), 397 (We-Pll:235),

398 (We-P11:236, We-P11:239), 527 (Th-P15:157)

Hypertension 51 (Mo-Pl:26), 53 (Mo-Pl:37), 56 (Mo-Pl:47, Mo-Pl:48), 57 (Mo-Pl:55), 60

(Mo-Pl:66, Mo-Pl:67), 62 (Mo-Pl:75), 64 (Mo-Pl:86), 76 (Mo-Pl:137), 77 (Mo-PI:140, Mo-PI:141), 100 (Mo-P4:248), 106 (Mo-P4:275), 108 (Mo-P4:281), 112 (Mo-P5:300), 118 (Mo-P5:331), 124 (Mo-P5:356), 127 (Mo-P5:371), 195 (Tu-P7:48), 197 (Tu-P7:56), 206 (Tu-P7:100), 211 (Tu-P7:119), 213 (Tu-P7:130), 219 (Tu-P7:157), 220 (Tu-P7:160), 232 (Tu-P7:215), 240 (Tu-P7:254, Tu-P7:255), 243 (Tu-P7:265), 252 (Tu-P8:309), 258 (Tu-P9:335), 263 (Tu-P9:359), 269 (Tu-P9:386), 275 (Tu-P10:414, Tu-P10:416), 293 (Tu-PlO:492), 296 (Tu-P10:508), 297 (Tu-PIO:512), 298 (Tu-P10:516), 313 (We-W34:4), 347 (We-P11:6, We-Pll:7), 348 (We-Pll:14), 350 (We-P11:23), 355 (We-Pll:45), 356 (We-Pll:48), 357 (We-P11:53), 360 (We-P11:64), 373 (We-P11:126), 375 (We-P11:133, We-P11:136), 376 (We-P11:139, We-P11:140), 379 (We-Pll:151), 382 (We-P11:166, We-Pll:167), 383 (We-Pll:168, We-Pll:169, We-Pll:170, We-P11:171, We-P11:172), 384 (We-P11:173, We-Pll:174, We-Pll:175), 385 (We-Pll:177, We-Pll:178, We-P11:179, We-Pll:180, We-Pll:181), 386 (We-P11:182, We-Pll:183, We-P11:185, We-Pll:186), 387 (We-Pll:188, We-Pll:189, We-P11:190), 388 (We-P11 : 191, We-P11 : 192, We-P11 : 193, We-P11:194), 389 (We-P11:195, We-Pll:196, We-Pll:197, We-P11:198, We-P11:199), 390 (We-P11:201), 402 (We-Pll:256), 408 (We-P12:283), 409 (We-P12:286), 417 (We-P13:321), 418 (We-P13:327), 419 (We-P13:333), 424 (We-P13:352), 425 (We-P13:358), 426 (We-P13:361), 437 (We-P14:410, We-P14:411), 439 (We-P14:419), 444 (We-P14:444), 454 (We-P14:486), 457 (Th-PL4:3), 468 (Th-W51:I, Th-W51:2), 469 (Th-W51:3, Th-W51:4, Th-W51:5, Th-W51:6), 512 (Th-P15:90), 523 (Th-P15:139), 571 (Th-P16:355)

Hypolipidemic Drugs in Diabetes 25 (Mo-W8:3), 58 (Mo-Pl:59), 173 (Tu-W27:l), 252 (Tu-P8:309), 342

(We-S15:I, We-S15:3), 346 (We-P11:1), 356 (We-P11:46), 358 (We-P11:58), 359 (We-P11:59, We-P11:60, We-Pll:61, We-P11:62), 360 (We-Pll:64), 385 (We-P11:180), 445 (We-P14:449), 557 (Th-P16:290), 565 (Th-P16:326), 566 (Th-P16:333), 569 (Th-P16:345)

Immune System 21 (Mo-W6:4), 23 (Mo-W7:5), 29 (Mo-W10:3), 32 (Mo-W12:3), 33

(Mo-W12:4, Mo-W12:7), 54 (Mo-PI:41), 86 (Mo-P2:182), 92 (Mo-P2:211), 98 (Mo-P4:235), 124 (Mo-P5:357), 143 (Mo-P6:443), 145 (Mo-P6:449), 157 (Tu-W18:4, Tu-W18:5), 167 (Tu-W24:l), 168

Inflammation 5 (Su-$3:3), 6 (Su-$3:4), 7 (Mo-PLI:3), 14 (Mo-W2:4, Mo-W2:7), 18

(Mo-W4:6), 24 (Mo-W7:6, Mo-W7:7), 30 (Mo-W10:7, Mo-W11:2), 31 (Mo-Wll:3), 33 (Mo-W12:4), 54 (Mo-PI:41), 71 (Mo-PI:ll4), 72 (Mo-PI:120), 76 (Mo-Pl:136), 79 (Mo-Pl:153), 84 (Mo-P2:172, Mo-P2:174, Mo-P2:175), 85 (Mo-P2:176), 86 (Mo-P2:180, Mo-P2:182), 87 (Mo-P2:186), 88 (Mo-P2:193), 93 (Mo-P2:214, Mo-P2:215), 96 (Mo-P3:229), 98 (Mo-P4:235, Mo-P4:236), 99 (Mo-P4:243), 101 (Mo-P4:250), 110 (Mo-P4:292), 126 (Mo-P5:366), 142 (Mo-P6:437, Mo-P6:43% Mo-P6:440), 143 (Mo-P6:441, Mo-P6:443), 151 (Tu-ML5:I), 155 (Tu-W17:5), 157 (Tu-W18:4), 159 (Tu-W19:4), 164 (Tu-W21:7), 165 (Tu-W22:6), 169 (Tu-W25:1), 170 (Tu-W25:3), 173 (Tu-W26:6), 175 (Tu-W27:5), 189 (Tu-P7:21), 190 (Tu-P7:24), 193 (Tu-P7:39), 195 (Tu-P7:49, Tu-P7:50), 199 (Tu-P7:65), 200 (Tu-P7:70), 202 (Tu-P7:79), 203 (Tu-P7:84, Tu-P7:85), 207 (Tu-P7:104), 212 (Tu-P7:125, Tu-P7:126), 213 (Tu-P7:131), 216 (Tu-P7:144), 219 (Tu-P7:154), 221 (Tu-P7:165), 223 (Tu-P7:172, Tu-P7:176), 224 (Tu-P7:178, Tu-P7:180), 225 (Tu-P7:185), 226 (Tu-P7:187, Tu-P7:189), 227 (Tu-P7:191, Tu-P7:194), 229 (Tu-P7:201), 230 (Tu-P7:209), 232 (Tu-P7:215, Tu-P7:217), 233 (Tu-P7:222), 234 (Tu-P7:227, Tu-P7:228), 235 (Tu-P7:230, Tu-P7:231, Tu-P7:232), 236 (Tu-P7:234), 237 (Tu-P7:238, Tu-P7:241), 240 (Tu-P7:253), 242 (Tu-P7:260, Tu-P7:261, Tu-P7:262), 243 (Tu-P7:265, Tu-P7:266, Tu-P7:268), 246 (Tu-P7:279), 247 (Tu-P7:284), 248 (Tu-P7:289, Tu-P7:290), 251 (Tu-P8:301), 253 (Tu-P8:312), 256 (Tu-P8:327), 264 (Tu-P9:366), 270 (Tu-P10:393), 271 (Tu-P10:395, Tu-P10:396), 274 (Tu-P10:410), 276 (Tu-PlO:420), 277 (Tu-PlO:421, Tu-PlO:422, Tu-P10:424), 278 (Tu-PlO:426, Tu-P10:427, Tu-P10:428, Tu-P10:429), 279 (Tu-P10:430, Tu-P10:431, Tu-P10:432, Tu-P10:433), 280 (Tu-P10:434, Tu-P10:435, Tu-P10:436, Tu-P10:437, Tu-P10:438), 281 (Tu-P10:43% Tu-P10:440), 282 (Tu-P10:443, Tu-P10:444, Tu-P10:445, Tu-P10:446), 283 (Tu-P10:447, Tu-P10:448, Tu-P10:449, Tu-P10:450, Tu-P10:451), 284 (Tu-PlO:452, Tu-P10:453, Tu-P10:454, Tu-P10:455), 285 (Tu-P10:456, Tu-P10:457, Tu-P10:458, Tu-P10:459), 286 (Tu-P10:461, Tu-P10:462, Tu-P10:463, Tu-P10:464), 287 (Tu-P10:465, Tu-P10:466, Tu-P10:467, Tu-P10:468), 288 (Tu-P10:469, Tu-P10:470, Tu-P10:471, Tu-P10:472, Tu-P10:473), 289 (Tu-P10:474, Tu-P10:475, Tu-P10:477), 290 (Tu-P10:478, Tu-P10:481), 291 (Tu-PlO:482, Tu-P10:484), 293 (Tu-PlO:492), 294 (Tu-P10:495, Tu-P10:497), 297 (Tu-P10:509), 303 (We-ML6:I), 309 (We-W32:l, We-W32:2, We-W32:3, We-W32:4, We-W32:5), 310 (We-W32:6, We-W32:8), 311 (We-W33:5),


Topic bulex 601

314 (We-W35:2), 317 (We-W36:5), 323 (We-W39:3), 326 (We-W41:2), 327 (We-W41:5, We-W41:6), 328 (We-W41:7), 329 (We-W42:6), 349 (We-P11:16), 354 (We-P11:41), 355 (We-P11:45), 358 (We-P11:55), 359 (We-P11:60), 360 (We-P11:64), 361 (We-P11:72), 363 (We-P11:79), 364 (We-Pll:84), 372 (We-P11:121, We-P11:122), 378 (We-P11:149), 380 (We-Pll:156), 382 (We-Pll:165), 383 (We-P11:170), 387 (We-P11:187, We-Pll:190), 388 (We-Pll:192), 391 (We-P11:205, We-P11:206), 393 (We-P11:216), 394 (We-P11:220), 396 (We-P11:228), 400 (We-P11:245), 401 (We-Pll:253), 405 (We-P11:270), 406 (We-P11:274), 407 (We-P11:276), 411 (We-P12:296), 412 (We-P12:302), 413 (We-P12:304, We-P12:306, We-P12:307), 414 (We-P12:308, We-P12:311), 419 (We-P13:330), 420 (We-P13:335, We-P13:337), 421 (We-P13:340), 423 (We-P13:350), 432 (We-P14:390), 433 (We-P14:391, We-P14:392), 447 (We-P14:454), 448 (We-P14:459), 450 (We-P14:469), 452 (We-P14:479), 457 (Th-PL4:3), 459 (Th-W46:l), 463 (Th-W48:4, Th-W48:6), 464 (Th-W48:7), 470 (Th-W51:7), 471 (Th-W52:4), 479 (Th-W56:2), 480 (Th-W56:5, Th-W56:6), 483 (Th-W58:1), 486 (Th-W59:4), 487 (Th-W60:3), 488 (Th-W60:8), 490 (Th-W61:6), 518 (Th-P15:116), 525 (Th-P15:147), 526 (Th-P15:151, Th-P15:153), 529 (Th-P15:167), 534 (Th-P15:188), 544 (Th-P15:232), 551 (Th-P16:264), 562 (Th-P16:314), 569 (Th-P16:343), 570 (Th-P16:348, Th-P16:349), 571 (Th-P16:354), 572 (Th-P16:356, Th-P16:357, Th-P16:360), 573 (Th-P16:363), 574 (Th-P16:368), 575 (Th-P16:373), 578 (Th-P16:385), 580 (Th-P16:393), 581 (Th-P16:400), 584 (Th-P16:413, Th-P16:414), 586 (Th-P17:423), 589 (Th-P17:435, Th-P17:436)

Insulin Resistance: Incidence and Evaluation 3 (Su-$2:2, Su-$2:3), 13 (Mo-W2:2), 17 (Mo-W4:3), 66 (Mo-Pl:94), 79

(Mo-PI:150, Mo-PI:151), 101 (Mo-P4:252), 120 (Mo-P5:338), 137 (Mo-P6:416), 139 (Mo-P6:424), 142 (Mo-P6:436), 164 (Tu-W22:1), 165 (Tu-W22:4), 172 (Tu-W26:3), 187 (Tu-P7:11, Tu-P7:13), 197 (Tu-P7:57), 210 (Tu-P7:115), 224 (Tu-P7:178), 263 (Tu-P9:358), 274 (Tu-P10:409), 312 (We-W33:6), 328 (We-W42:2), 347 (We-P11:6, We-P11:7), 351 (We-P11:27), 356 (We-P11:46), 360 (We-P11:65, We-P11:66, We-P11:67, We-P11:68), 361 (We-P11:69, We-P11:70, We-Pll:71, We-P11:72, We-Pll:73), 362 (We-P11:74, We-Pll:75, We-P11:76), 363 (We-P11:78, We-P11:79, We-P11:81), 364 (We-P11:82, We-P11:83, We-P11:84, We-Pll:85, We-P11:86), 365 (We-P11:87, We-Pll:88), 371 (We-P11:114, We-Pll:115), 375 (We-Pll:135), 376 (We-Pll:137), 378 (We-Pll:149), 408 (We-P12:282), 415 (We-P13:312), 421 (We-P13:338), 427 (We-P13:368), 429 (We-P13:374), 430 (We-P14:378), 506 (Th-P15:61), 510 (Th-P15:83), 511 (Th-P15:85), 512 (Th-P15:91), 520 (Th-P15:126), 580 (Th-P16:396)

Intracellular Lipid Trafficking 21 (Mo-W6:3), 26 (Mo-W9:I, Mo-W9:2), 27 (Mo-W9:3, Mo-W9:4), 28

(Mo-W9:6), 30 (Mo-Wll:I), 165 (Tu-W23:l), 167 (Tu-W23:7), 237 (Tu-P7:239), 257 (Tu-P8:328, Tu-P8:331), 330 (We-W43:2), 331 (We-W43:5), 472 (Th-W52:7), 492 (Th-P15:I, Th-P15:2, Th-P15:3), 493 (Th-P15:6, Th-P15:7, Th-P15:8, Th-P15:9), 494 (Th-P15:10, Th-P15:I 1, Th-P15:12), 495 (Th-P15:15), 498 (Th-P15:27), 507 (Th-P15:67), 508 (Th-P15:70), 514 (Th-P15:100, Th-P15:99), 515 (Th-P15:103), 516 (Th-P15:107), 520 (Th-P15:125), 524 (Th-P15:142), 539 (Th-P15:209), 540 (Th-P15:216), 541 (Th-P15:218, Th-P15:219), 542 (Th-P15:225), 543 (Th-P15:226), 544 (Th-P15:233), 574 (Th-P16:367)

IVUS 9 (Mo-ML2:I), 11 (Mo-WI:3), 41 (Mo-S6:I), 42 (Mo-$6:3, Mo-$6:4), 146

(Mo-P6:454), 265 (Tu-P9:370), 266 (Tu-P9:372, Tu-P9:373), 307 (We-W31:1, We-W31:2), 308 (We-W31:6), 314 (We-W34:7), 457 (Th-PL4: 2)

LDL Apheresis 123 (Mo-P5:355), 554 (Th-P16:279), 562 (Th-P16:314, Th-P16:315), 563

(Th-P16:316, Th-P16:317, Th-P16:318, Th-P16:319), 564 (Th-P16:320)

Lifestyle 47 (Mo-PI:12), 58 (Mo-Pl:56, Mo-Pl:58), 63 (Mo-PI:81), 111 (Mo-P5:296,

Mo-P5:297), 113 (Mo-P5:303, Mo-P5:307), 118 (Mo-P5:331,

Mo-P5:332), 119 (Mo-P5:333, Mo-P5:334, Mo-P5:335), 120 (Mo-P5:338, Mo-P5:340, Mo-P5:341, Mo-P5:342), 132 (Mo-P6:393), 141 (Mo-P6:435), 163 (Tu-W21:6), 170 (Tu-W25:3), 177 (Tu-W28:4, Tu-W28:5), 178 (Tu-W29:6), 189 (Tu-P7:19), 215 (Tu-P7:139), 221 (Tu-P7:165), 258 (Tu-P9:336), 259 (Tu-P9:340), 264 (Tu-P9:363), 265 (Tu-P9:368), 292 (Tu-PlO:488), 370 (We-Pll:110), 376 (We-Pll:140), 377 (We-P11:143), 381 (We-Pll:160), 382 (We-Pll:167), 385 (We-P11:178), 386 (We-P11:185), 388 (We-P11:194), 422 (We-P13:342), 423 (We-P13:347), 428 (We-P13:372), 431 (We-P14:385), 442 (We-P14:432), 443 (We-P14:439, We-P14:440), 444 (We-P14:441), 446 (We-P14:452, We-P14:453), 447 (We-P14:458), 449 (We-P14:465)

Lipases 14 (Mo-W3:I), 15 (Mo-W3:2), 16 (Mo-W3:4, Mo-W3:5, Mo-W3:7), 38

(Mo-W15:2), 132 (Mo-P6:396), 133 (Mo-P6:397), 134 (Mo-P6:403), 137 (Mo-P6:415), 165 (Tu-W22:7), 228 (Tu-P7:199), 232 (Tu-P7:216), 255 (Tu-P8:321), 294 (Tu-P10:499), 299 (Tu-P10:518), 306 (We-W30:5), 374 (We-P11:130), 416 (We-P13:317), 495 (Th-P15:14), 496 (Th-P15:20, Th-P15:21), 497 (Th-P15:22, Th-P15:23, Th-P15:24, Th-P15:25), 498 (Th-P15:26, Th-P15:29, Th-P15:30), 504 (Th-P15:52), 507 (Th-P15:69), 511 (Th-P15:87), 513 (Th-P15:94), 535 (Th-P15:193), 537 (Th-P15:200), 547 (Th-P15:248)

Lipid Lowering Agents and Body Weight/Size 25 (Mo-W8:3), 111 (Mo-P5:297), 115 (Mo-P5:313), 186 (Tu-P7:9), 329

(We-W42:3), 378 (We-P11:146), 382 (We-P11:164), 407 (We-P12:280), 409 (We-P12:286), 431 (We-P14:384, We-P14:386), 438 (We-P14:414), 442 (We-P14:432), 449 (We-P14:465), 454 (We-P14:485), 468 (Th-W51:2), 552 (Th-P16:271), 564 (Th-P16:324), 567 (Th-P16:334), 579 (Th-P16:390)

Lipidomics 35 (Mo-W14:1), 205 (Tu-P7:95), 236 (Tu-P7:235), 561 (Th-P16:307), 581

(Th-P16:400), 587 (Th-P17:427, Th-P17:428), 588 (Th-P17:429, Th-P17:431, Th-P17:432)

Lipids and Inflammation 5 (Su-S3:I), 8 (Mo-PLI:4), 13 (Mo-W2:I), 14 (Mo-W2:4), 15 (Mo-W3:2), 21

(Mo-W6:5), 22 (Mo-W6:6, Mo-W6:7), 23 (Mo-W7:5), 31 (Mo-W11:3), 32 (Mo-Wll:7), 47 (Mo-PI:12, Mo-PI:9), 63 (Mo-Pl:79), 67 (Mo-Pl:97), 74 (Mo-PI:130), 75 (Mo-Pl:135), 84 (Mo-P2:173), 88 (Mo-P2:189), 90 (Mo-P2:200), 91 (Mo-P2:203), 93 (Mo-P2:216), 94 (Mo-P3:219), 95 (Mo-P3:223), 96 (Mo-P3:230), 99 (Mo-P4:241), 101 (Mo-P4:250), 113 (Mo-P5:307), 125 (Mo-P5:363, Mo-P5:364), 127 (Mo-P5:371), 128 (Mo-P5:377), 134 (Mo-P6:402), 142 (Mo-P6:438), 145 (Mo-P6:449), 152 (Tu-W16:I, Tu-W16:4), 153 (Tu-W16:5), 157 (Tu-W18:6, Tu-W18:7), 158 (Tu-W19:3), 159 (Tu-W19:7), 160 (Tu-W20:3), 165 (Tu-W22:7), 167 (Tu-W24:1), 168 (Tu-W24:3, Tu-W24:4, Tu-W24:5), 169 (Tu-W24:7), 170 (Tu-W25:5), 171 (Tu-W25:7), 173 (Tu-W26:5), 175 (Tu-W27:5), 183 (Tu-S11:3), 189 (Tu-P7:21), 194 (Tu-P7:46), 195 (Tu-P7:47, Tu-P7:49), 197 (Tu-P7:56), 200 (Tu-P7:70), 202 (Tu-P7:81), 205 (Tu-P7:93, Tu-P7:94), 208 (Tu-P7:109), 209 (Tu-P7:110), 212 (Tu-P7:126), 219 (Tu-P7:156), 221 (Tu-P7:167), 222 (Tu-P7:171), 224 (Tu-P7:180, Tu-P7:181), 225 (Tu-P7:182, Tu-P7:183, Tu-P7:184, Tu-P7:185), 226 (Tu-P7:186, Tu-P7:187, Tu-P7:189), 227 (Tu-P7:191, Tu-P7:192, Tu-P7:193), 228 (Tu-P7:195, Tu-P7:197, Tu-P7:199), 229 (Tu-P7:201, Tu-P7:203, Tu-P7:204), 230 (Tu-P7:205, Tu-P7:206, Tu-P7:207, Tu-P7:208, Tu-P7:209), 231 (Tu-P7:211, Tu-P7:212, Tu-P7:213, Tu-P7:214), 232 (Tu-P7:216, Tu-P7:217, Tu-P7:218, Tu-P7:219), 233 (Tu-P7:220, Tu-P7:221, Tu-P7:223), 234 (Tu-P7:224, Tu-P7:226, Tu-P7:227), 235 (Tu-P7:229), 236 (Tu-P7:234, Tu-P7:235, Tu-P7:236, Tu-P7:237), 237 (Tu-P7:238, Tu-P7:240), 241 (Tu-P7:256), 242 (Tu-P7:261, Tu-P7:264), 243 (Tu-P7:266), 247 (Tu-P7:283), 250 (Tu-P8:296), 256 (Tu-P8:324, Tu-P8:325, Tu-P8:327), 257 (Tu-P8:329, Tu-P8:330), 267 (Tu-P9:378), 270 (Tu-P10:391), 278 (Tu-P10:425), 279 (Tu-P10:432), 280 (Tu-P10:436), 281 (Tu-P10:441, Tu-P10:442), 282 (Tu-P10:443), 284 (Tu-P10:453, Tu-P10:455), 285 (Tu-P10:457), 287


602 Topic bulex

(Tu-P10:465), 289 (Tu-P10:476), 291 (Tu-P10:482, Tu-P10:484), 295 (Tu-P10:504), 296 (Tu-P10:507), 297 (Tu-P10:509), 303 (We-ML6:I), 309 (We-W32:4L 310 (We-W32:7, We-W32:8L 313 (We-W34:5, We-W34:6L 315 (We-W35:5), 319 (We-W37:5), 327 (We-W41:3, We-W41:5), 355 (We-Pll:42), 380 (We-P11:157), 388 (We-P11:192), 391 (We-P11:204), 393 (We-Pll:217), 394 (We-P11:219), 395 (We-P11:223), 397 (We-P11:234), 406 (We-P11:272, We-Pll:273), 407 (We-P11:277), 412 (We-P12:298), 415 (We-P13:313), 419 (We-P13:331), 423 (We-P13:350), 435 (We-P14:400), 436 (We-P14:406), 437 (We-P14:412), 442 (We-P14:435), 445 (We-P14:448), 447 (We-P14:454), 448 (We-P14:459), 450 (We-P14:468, We-P14:469), 451 (We-P14:472), 460 (Th-W46:3, Th-W46:4, Th-W46:5), 464 (Th-W48:7, Th-W48:8), 479 (Fh-W56:2L 487 (Th-W60:2), 488 (Th-W60:6), 489 (Th-W61:3, Th-W61:4), 490 (Th-W61:6), 493 (Th-P15:8, Th-P15:9), 494 (Fh-P15:10, Th-P15:13), 495 (Th-P15:14), 497 (Th-P15:24), 498 (Th-P15:27), 501 (Th-P15:42), 502 (Th-P15:45), 504 (Th-P15:54), 508 (Th-P15:73), 512 (Th-P15:92), 513 (Th-P15:93), 514 (Th-P15:100, Th-P15:97), 516 (Th-P15:108, Th-P15:109), 517 (Th-P15:111), 518 (Fh-P15:116), 520 (Th-P15:125), 521 (Th-P15:128, Th-P15:131), 522 (Th-P15:133), 526 (Fh-P15:151, Th-P15:153), 529 (Th-P15:166, Th-P15:167), 533 (Fh-P15:183L 534 (Th-P15:188), 537 (Th-P15:199, Th-P15:200, Th-P15:201), 538 (Th-P15:208), 539 (Th-P15:209, Th-P15:210), 541 (Fh-P15:218L 543 (Th-P15:231), 544 (Th-P15:236), 547 (Th-P15:247), 549 (Th-P16:257), 556 (Th-P16:286), 559 (Th-P16:299), 561 (Th-P16:307), 563 (Th-P16:319), 566 (Fh-P16:330L 567 (Th-P16:335), 570 (Th-P16:349), 571 (Th-P16:355), 572 (Fh-P16:358L 574 (Th-P16:368), 575 (Th-P16:373), 577 (Fh-P16:382L 581 (Th-P16:400), 582 (Th-P16:402), 584 (Th-P16:414), 586 (Fh-P17:422L 590 (Th-P17:438)

Lipids and Stroke 17 (Mo-W4:2), 18 (Mo-W4:4, Mo-W4:7), 47 (Mo-PI:8), 56 (Mo-Pl:48), 57

(Mo-Pl:55), 66 (Mo-PI:91, Mo-Pl:95), 68 (Mo-PI:102, Mo-PI:104), 69 (Mo-PI:105), 80 (Mo-Pl:154), 107 (Mo-P4:278, Mo-P4:280), 108 Mo-P4:281, Mo-P4:282), 109 (Mo-P4:287), 140 (Mo-P6:428), 194

(Tu-P7:45), 196 (Tu-P7:55), 230 (Fu-P7:205), 232 (Tu-P7:219), 237 (Tu-P7:239), 295 (Tu-P10:504), 445 (We-P14:447), 468 (Th-W50:6), 473 (Th-W53:5), 502 (Th-P15:43), 529 (Th-P15:167), 531 (Th-P15:174), 543 (Th-P15:231), 572 (Th-P16:358), 579 (Th-P16:389, Th-P16:390), 586 (Th-P17:422)

Lipolysis 14 (Mo-W3:I), 20 (Mo-W5:4), 38 (Mo-W15:2), 40 (Mo-S4:I), 134

(Mo-P6:403), 228 (Tu-P7:199), 318 (We-W37:l), 321 (We-W38:3), 492 (Th-P15:4), 493 (Th-P15:9), 495 (Th-P15:14), 496 (Th-P15:19), 497 (Th-P15:23, Th-P15:24), 498 (Fh-P15:30), 506 (Fh-P15:62), 507 (Th-P15:66, Th-P15:67, Th-P15:69), 513 (Fh-P15:96), 540 (Th-P15:213), 547 (Th-P15:248), 561 (Fh-P16:311)

Lipoprotein Metabolism in Renal Disease 127 (Mo-P5:371), 140 (Mo-P6:428), 418 (We-P13:325), 454 (We-P14:487),

517 (Th-P15:ll2, Th-P15:113), 518 (Th-P15:114, Th-P15:115, Th-P15:ll6), 520 (Th-P15:123), 565 (Th-P16:327), 575 (Fh-P16:370)

Lipoprotein Oxidation 29 (Mo-W10:5), 67 (Mo-PI:100, Mo-Pl:99), 84 (Mo-P2:172, Mo-P2:173), 87

(Mo-P2:188), 88 (Mo-P2:189), 126 (Mo-P5:365), 127 (Mo-P5:370), 139 (Mo-P6:425), 147 (Mo-P6:460), 157 (Fu-W18:7), 175 (Tu-W27:7), 188 (Tu-P7:15), 189 (Tu-P7:20), 192 (Fu-P7:37), 193 (Fu-P7:40), 197 (Tu-P7:58), 200 (Tu-P7:70), 215 (Fu-P7:140), 221 (Tu-P7:167), 229 (Tu-P7:201), 231 (Tu-P7:213), 233 (Tu-P7:222, Tu-P7:223), 237 (Tu-P7:240), 255 (Tu-PS:320), 269 (Tu-P9:385), 288 (Fu-P10:473), 293 (Tu-P10:494), 294 (Tu-P10:499), 295 (Tu-P10:501), 296 (Tu-P10:505), 322 (We-W38:6), 332 (We-W44:3), 333 (We-W44:4), 353 (We-P11:33), 354 (We-Pll:37, We-P11:39), 365 (We-P11:90), 378 (We-P11:148), 414 (We-P12:310), 416 (We-P13:320), 419 (We-P13:331), 422 (We-P13:345), 433 (We-P14:394), 434 (We-P14:395, We-P14:396), 435 (We-P14:400, We-P14:403), 436 (We-P14:407), 438 (We-P14:415), 445 (We-P14:446, We-P14:447), 451 (We-P14:472), 452 (We-P14:476), 459 (Th-W46:1,

Th-W46:2), 460 (Th-W46:3, Th-W46:5, Th-W46:6, Th-W46:7), 464 (Th-W48:7), 470 (Th-W51:7), 473 (Th-W53:4), 481 (Th-W57:l), 492 (Th-P15:3), 501 (Th-P15:39), 502 (Th-P15:45, Th-P15:46, Th-P15:47), 506 (Th-P15:65), 508 (Th-P15:74), 514 (Th-P15:99), 515 (Th-P15:102), 518 (Th-P15:ll4), 520 (Th-P15:126, Th-P15:127), 521 (Th-P15:128, Th-P15:129, Th-P15:130, Th-P15:131, Th-P15:132), 522 (Th-P15:133, Th-P15:135, Th-P15:136), 523 (Th-P15:138, Th-P15:139, Th-P15:140), 524 (Th-P15:141, Th-P15:143), 525 (Th-P15:145, Th-P15:146, Th-P15:147, Th-P15:148, Th-P15:149), 526 (Th-P15:150, Th-P15:151, Th-P15:152, Th-P15:153, Th-P15:154), 527 (Th-P15:155, Th-P15:156, Th-P15:157), 528 (Th-P15:159, Th-P15:160, Th-P15:161, Th-P15:162, Th-P15:163), 529 (Th-P15:164, Th-P15:165, Th-P15:166), 531 (Th-P15:177), 536 (Th-P15:196), 539 (Th-P15:212), 540 (Th-P15:215), 543 (Th-P15:228), 546 (Th-P15:245), 557 (Th-P16:292), 559 (Th-P16:298), 560 (Th-P16:305), 566 (Th-P16:331), 567 (Th-P16:335), 571 (Th-P16:353), 580 (Th-P16:393), 585 (Th-P16:416), 586 (Th-P17:423), 587 (Th-P17:424), 588 (Th-P17:433)

Lipoprotein Partide Size: Modulation and Impact oil Atherosderosis 14 (Mo-W2:4L 70 (Mo-PI:109L 94 (Mo-P3:218L 152 (Tu-W16:2L 347

(We-P11:8), 371 (We-P11:117), 431 (We-P14:382), 438 (We-P14:418), 440 (We-P14:423), 460 (Th-W46:6L 474 (Th-W54:l, Th-W54:2), 475 (Th-W54:3, Th-W54:4), 476 (Th-W54:7), 489 (Th-W61:5L 499 (Th-P15:31, Th-P15:34), 500 (Th-P15:35, Th-P15:36, Th-P15:37, Th-P15:38), 501 (Th-P15:41, Th-P15:42), 502 (Th-P15:44, Th-P15:45), 503 (Th-P15:48, Th-P15:51), 504 (Th-P15:53L 518 (Th-P15:114L 529 (Th-P15:164L 531 (Th-P15:176L 534 (Th-P15:186L 535 (Th-P15:191L 537 (Th-P15:202, Th-P15:203), 538 (Th-P15:204), 541 (Th-P15:218L 542 (Th-P15:224L 547 (Th-P15:248L 552 (Th-P16:271L 559 (Th-P16:300, Th-P16:301), 575 (Th-P16:370, Th-P16:373), 579 (Th-P16:391L 583 (Th-P16:407)

Lipoprotein Receptors and Cell Signalling 26 (Mo-W9:2), 27 (Mo-W9:3, Mo-W9:5), 28 (Mo-W9:7), 32 (Mo-W12:3), 34

(Mo-W13:4), 87 (Mo-P2:188), 94 (Mo-P3:220), 149 (Tu-PL2:I), 150 (Tu-PL2:4), 153 (Tu-W16:7), 166 (Tu-W23:2), 186 (Tu-P7:7), 202 (Tu-P7:82), 229 (Tu-P7:203), 231 (Tu-P7:214), 237 (Tu-P7:238), 240 (Tu-P7:252), 255 (Tu-PS:320), 276 (Tu-P10:418), 310 (We-W32:8), 330 (We-W43:l), 331 (We-W43:3, We-W43:5, We-W43:6), 365 (We-P11:91), 392 (We-P11:210), 406 (We-Pll:275), 415 (We-P13:314), 438 (We-P14:418), 464 (Th-W49:l), 466 (Th-W49:7), 475 (Th-W54:6), 482 (Th-W57:7), 489 (Th-W61:4), 490 (Th-W61:7), 494 (Th-P15:10, Th-P15:ll), 498 (Th-P15:27), 508 (Th-P15:70), 513 (Th-P15:93, Th-P15:94, Th-P15:95), 514 (Th-P15:100, Th-P15:97, Th-P15:99), 515 (Th-P15:102, Th-P15:103, Th-P15:104), 516 (Th-P15:106, Th-P15:107, Th-P15:109), 517 (Th-P15:110, Th-P15:ll 1), 522 (Th-P15:134), 523 (Th-P15:137, Th-P15:139), 528 (Th-P15:161), 538 (Th-P15:205, Th-P15:208), 542 (Th-P15:222), 543 (Th-P15:229), 548 (Th-P16:251)

Lipoproteins and Atherosderosis 7 (Mo-PLI:I, Mo-PLI:2), 12 (Mo-WI:4), 14 (Mo-W2:4), 16 (Mo-W3:6), 27

(Mo-W9:5), 28 (Mo-W9:6, Mo-W9:7), 31 (Mo-Wll:5), 34 (Mo-W13:4), 35 (Mo-W13:5, Mo-W13:6), 36 (Mo-W14:2), 37 (Mo-W14:4, Mo-W14:6), 39 (Mo-W15:5), 42 (Mo-$6:3), 47 (Mo-PI:9), 48 (Mo-PI:16), 49 (Mo-PI:18, Mo-PI:19), 53 (Mo-Pl:35, Mo-Pl:37, Mo-Pl:38), 54 (Mo-PI:41), 55 (Mo-Pl:43, Mo-Pl:44), 59 (Mo-Pl:62), 61 (Mo-Pl:69), 63 (Mo-Pl:79), 66 (Mo-Pl:94), 67 (Mo-PI:100, Mo-Pl:97, Mo-Pl:98, Mo-Pl:99), 68 (Mo-PI:101, Mo-PI:102, Mo-PI:103, Mo-PI:104), 69 (Mo-PI:105, Mo-PI:106, Mo-PI:107, Mo-PI:108), 70 (Mo-PI:109, Mo-PI:110, Mo-PI:111, Mo-PI:112), 71 (Mo-PI:ll3, Mo-PI:ll4, Mo-PI:115), 72 (Mo-PI:ll8), 74 (Mo-Pl:128), 75 (Mo-Pl:134), 79 (Mo-Pl:149, Mo-PI:150), 81 (Mo-Pl:158), 82 (Mo-Pl:163), 84 (Mo-P2:171, Mo-P2:174), 94 (Mo-P3:218, Mo-P3:219), 95 (Mo-P3:224), 99 (Mo-P4:241), 106 (Mo-P4:274), 108 (Mo-P4:281, Mo-P4:282), 113 (Mo-P5:303, Mo-P5:304, Mo-P5:305), 115 (Mo-P5:313), 118 (Mo-P5:332), 119 (Mo-P5:333), 122 (Mo-P5:348, Mo-P5:350), 126 (Mo-P5:365), 128 (Mo-P5:374), 130 (Mo-P6:383, Mo-P6:386), 131 (Mo-P6:390), 132 (Mo-P6:393), 133 (Mo-P6:398), 134 (Mo-P6:401,

XIV bttemational Symposium on Atherosclerosis, Rome, Italy, June 18-22, 2006

Topic bulex 603

Mo-P6:404), 135 (Mo-P6:405, Mo-P6:408, Mo-P6:409), 136 (Mo-P6:410), 139 (Mo-P6:426), 140 (Mo-P6:427, Mo-P6:428, Mo-P6:429, Mo-P6:430), 141 (Mo-P6:431, Mo-P6:433), 145 (Mo-P6:451), 147 (Mo-P6:458), 149 (Tu-PL2:I), 162 (Tu-W21:2), 166 (Tu-W23:3, Tu-W23:4), 169

(Tu-W24:7), 171 (Tu-W25:7), 173 (Tu-W27:l), 178 (Tu-W29:6), 183

(Tu-Sll:3), 186 (Tu-P7:8), 192 (Tu-P7:37), 193 (Tu-P7:40), 194 (Tu-P7:45), 196 (Tu-P7:54, Tu-P7:55), 197 (Tu-P7:56), 198 (Tu-P7:60), 200 (Tu-P7:72), 202 (Tu-P7:78, Tu-P7:81), 205 (Tu-P7:94), 208 (Tu-P7:109), 210 (Tu-P7:116), 213 (Tu-P7:128), 220 (Tu-P7:159), 222

(Tu-P7:168), 224 (Tu-P7:181), 225 (Tu-P7:183), 227 (Tu-P7:191, Tu-P7:192, Tu-P7:194), 228 (Tu-P7:200), 232 (Tu-P7:216, Tu-P7:217, Tu-P7:219), 233 (Tu-P7:220), 236 (Tu-P7:237), 245 (Tu-P7:276), 247 (Tu-P7:285), 251 (Tu-P8:303), 253 (Tu-P8:312), 255 (Tu-P8:319, Tu-P8:321), 256 (Tu-P8:325), 257 (Tu-P9:332), 261 (Tu-P9:349, Tu-P9:352), 262 (Tu-P9:355), 264 (Tu-P9:363), 266 (Tu-P9:373), 275

(Tu-P10:414, Tu-P10:415), 293 (Tu-P10:492), 294 (Tu-P10:497, Tu-P10:499), 307 (We-W31:3), 310 (We-W32:8), 311 (We-W33:4), 313 (We-W34:3), 314 (We-W34:7), 315 (We-W35:4), 319 (We-W37:5), 320 (We-W37:6), 321 (We-W38:3, We-W38:4), 326 (We-W41:I), 327 (We-W41:3), 331 (We-W43:3, We-W43:4, We-W43:5, We-W43:6), 333

(We-W44:5, We-W44:6), 335 (We-W45:5, We-W45:6), 341 (We-S14:4), 342 (We-S15:I, We-S15:2), 344 (We-S16:5), 346 (We-P11:2), 347 (We-Pll:8), 349 (We-Pll:15, We-Pll:18), 354 (We-P11:39), 358 (We-Pll:58), 364 (We-P11:85), 366 (We-P11:94), 368 (We-P11:104), 370 (We-Pll:111), 374 (We-Pll:130), 377 (We-Pll:142), 380 (We-P11:155),

381 (We-Pll:161), 384 (We-P11:173), 393 (We-P11:217), 396 (We-P11:229), 397 (We-Pll:234), 400 (We-P11:245), 401 (We-P11:250), 406 (We-Pll:273), 407 (We-P12:279), 412 (We-P12:298), 414 (We-P12:311), 415 (We-P13:314), 423 (We-P13:348), 428 (We-P13:370), 434 (We-P14:398), 437 (We-P14:413), 438 (We-P14:414, We-P14:415,

We-P14:416, We-P14:418), 441 (We-P14:429), 442 (We-P14:434), 445 (We-P14:446), 446 (We-P14:450), 447 (We-P14:454), 451 (We-P14:475), 453 (We-P14:481), 460 (Th-W46:3), 464 (Th-W48:7, Th-W48:8), 467 (Th-W50:5), 468 (Th-W50:6), 473 (Th-W53:4, Th-W53:5), 474 (Th-W54:l), 475 (Th-W54:4), 482 (Th-W57:5, Th-W57:7), 483

(Th-W58:3), 488 (Th-W60:6), 489 (Th-W61:4, Th-W61:5), 490 (Th-W61:7, Th-W61:8), 491 (Th-S17:2, Th-S17:3), 492 (Th-P15:3), 493 (Th-P15:9), 494 (Th-P15:10), 495 (Th-P15:14), 498 (Th-P15:26), 499 (Th-P15:31, Th-P15:32), 500 (Th-P15:36), 501 (Th-P15:39, Th-P15:40, Th-P15:41), 502 (Th-P15:43, Th-P15:46), 503 (Th-P15:49, Th-P15:50),

504 (Th-P15:52), 505 (Th-P15:58, Th-P15:59), 508 (Th-P15:72), 509 (Th-P15:75), 510 (Th-P15:79, Th-P15:83), 511 (Th-P15:86), 513 (Th-P15:93), 514 (Th-P15:97), 515 (Th-P15:102), 516 (Th-P15:108, Th-P15:109), 517 (Th-P15:110, Th-P15:ll2), 518 (Th-P15:ll4, Th-P15:ll5, Th-P15:116), 519 (Th-P15:121), 520 (Th-P15:124,

Th-P15:127), 521 (Th-P15:128), 522 (Th-P15:134, Th-P15:136), 523 (Th-P15:137), 524 (Th-P15:142, Th-P15:143), 525 (Th-P15:145, Th-P15:147, Th-P15:149), 526 (Th-P15:150, Th-P15:151), 527 (Th-P15:155, Th-P15:157), 528 (Th-P15:160, Th-P15:162), 529 (Th-P15:164, Th-P15:165, Th-P15:167), 530 (Th-P15:172), 531

(Th-P15:173, Th-P15:174, Th-P15:175), 532 (Th-P15:178), 533 (Th-P15:185), 534 (Th-P15:186, Th-P15:187, Th-P15:188), 535 (Th-P15:191, Th-P15:194), 536 (Th-P15:195), 537 (Th-P15:199, Th-P15:200, Th-P15:202, Th-P15:203), 538 (Th-P15:205, Th-P15:206), 539 (Th-P15:210), 540 (Th-P15:214, Th-P15:216), 541 (Th-P15:217,

Th-P15:220, Th-P15:221), 542 (Th-P15:224), 543 (Th-P15:229, Th-P15:231), 545 (Th-P15:237, Th-P15:238, Th-P15:239, Th-P15:240), 547 (Th-P15:247), 548 (Th-P16:250, Th-P16:251, Th-P16:252, Th-P16:253), 557 (Th-P16:291), 559 (Th-P16:298, Th-P16:301), 560 (Th-P16:305), 561 (Th-P16:309, Th-P16:311), 562 (Th-P16:312), 563

(Th-P16:316), 566 (Th-P16:329), 570 (Th-P16:350), 575 (Th-P16:372, Th-P16:374), 579 (Th-P16:389, Th-P16:390, Th-P16:391), 580 (Th-P16:396), 581 (Th-P16:400), 582 (Th-P16:403, Th-P16:404, Th-P16:406), 584 (Th-P16:415), 585 (Th-P16:416), 586 (Th-P17:422), 587 (Th-P17:428), 588 (Th-P17:429, Th-P17:432), 589 (Th-P17:434)

Lp(a) 13 (Mo-W2:3), 18 (Mo-W4:7), 69 (Mo-PI:107, Mo-PI:108), 70 (Mo-PI:ll0),

82 (Mo-Pl:164), 116 (Mo-P5:322), 124 (Mo-P5:359), 136 (Mo-P6:411), 139 (Mo-P6:426), 140 (Mo-P6:427, Mo-P6:428, Mo-P6:429), 190 (Tu-P7:27), 251 (Tu-P8:303), 290 (Tu-P10:478), 364 (We-P11:85), 399 (We-P11:242), 469 (Th-W51:5), 494 (Th-P15:12), 529 (Th-P15:168), 530 (Th-P15:169, Th-P15:170, Th-P15:171, Th-P15:172), 531 (Th-P15:173, Th-P15:175, Th-P15:176, Th-P15:177), 532 (Th-P15:179, Th-P15:180), 562 (Th-P16:315), 563 (Th-P16:316), 564 (Th-P16:321), 584 (Th-P16:411)

Menopause - Intervention 82 (Mo-Pl:167), 221 (Tu-P7:163), 256 (Tu-P8:326), 405 (We-P11:269), 407

(We-P12:278, We-P12:279, We-P12:280), 408 (We-P12:281, We-P12:282, We-P12:283), 409 (We-P12:287), 444 (We-P14:442), 484 (Th-W59:l), 485 (Th-W59:3), 486 (Th-W59:4, Th-W59:5)

Metabolic Syndrome 2 (Su-S2:I), 3 (Su-$2:2, Su-$2:3, Su-$2:4), 4 (Su-$2:5, Su-$2:6), 5 (Su-S3:I),

14 (Mo-W2:4), 25 (Mo-W8:2, Mo-W8:4, Mo-W8:5, Mo-W8:6), 28 (Mo-W9:7), 38 (Mo-W15:4), 61 (Mo-Pl:73), 63 (Mo-Pl:78), 64 (Mo-Pl:83), 65 (Mo-PI:90), 66 (Mo-Pl:94), 69 (Mo-PI:106), 75 (Mo-Pl:133), 76 (Mo-Pl:139), 83 (Mo-P2:170), 103 (Mo-P4:261), 120 (Mo-P5:337, Mo-P5:338), 126 (Mo-P5:367), 127 (Mo-P5:373), 131 (Mo-P6:388), 137 (Mo-P6:416, Mo-P6:417), 139 (Mo-P6:424), 141 (Mo-P6:431, Mo-P6:432, Mo-P6:434), 142 (Mo-P6:436), 144 (Mo-P6:446), 153 (Tu-W16:6), 154 (Tu-W17:I, Tu-W17:2), 155 (Tu-W17:3, Tu-W17:4, Tu-W17:6, Tu-W17:7), 162 (Tu-W21:I), 164 (Tu-W22:1), 165 (Tu-W22:5), 170 (Tu-W25:4), 175 (Tu-W27:5), 176 (Tu-W28:2), 186 (Tu-P7:6), 187 (Tu-P7:ll), 194 (Tu-P7:44), 196 (Tu-P7:53), 197 (Tu-P7:57), 201 (Tu-P7:77), 208 (Tu-P7:108), 214 (Tu-P7:133, Tu-P7:136), 221 (Tu-P7:165), 224 (Tu-P7:178), 226 (Tu-P7:188, Tu-P7:190), 229 (Tu-P7:204), 256 (Tu-P8:323), 260 (Tu-P9:344), 261 (Tu-P9:348), 263 (Tu-P9:359), 274 (Tu-P10:409), 277 (Tu-PlO:422), 280 (Tu-P10:435), 303 (We-ML7:I), 311 (We-W33:5), 312 (We-W33:7), 318 (We-W37:l), 320 (We-W37:7), 328 (We-W42:l), 329 (We-W42:4, We-W42:5), 342 (We-S15:I), 347 (We-P11:6, We-P11:7), 348 (We-P11:13), 349 (We-Pll:19), 353 (We-P11:34), 356 (We-P11:46), 357 (We-P11:52), 362 (We-Pll:77), 363 (We-P11:81), 365 (We-Pll:90, We-P11:91), 366 (We-P11:92, We-P11:93, We-P11:94, We-P11:96), 367 (We-P11:100, We-P11:97, We-P11:98, We-P11:99), 368 (We-P11:101, We-P11:103, We-P11:104, We-P11:105), 369 (We-P11:106, We-Pll:107, We-P11:108), 370 (We-P11:110, We-P11:111), 371 (We-P11:114, We-P11:115, We-P11:116), 372 (We-P11:119), 374 (We-P11:130, We-P11:131), 375 (We-P11:136), 376 (We-P11:137, We-P11:139), 377 (We-P11:142), 378 (We-P11:145), 379 (We-P11:150), 380 (We-Pll:156), 382 (We-P11:164), 383 (We-Pll:168, We-P11:169), 397 (We-P11:234), 407 (We-P12:280), 410 (We-P12:290, We-P12:293), 415 (We-P13:312, We-P13:313, We-P13:314, We-P13:315), 416 (We-P13:316, We-P13:317), 417 (We-P13:321, We-P13:322), 418 (We-P13:326, We-P13:327), 419 (We-P13:330, We-P13:331, We-P13:332), 420 (We-P13:336, We-P13:337), 421 (We-P13:338, We-P13:339, We-P13:340, We-P13:341), 422 (We-P13:342, We-P13:343, We-P13:344), 423 (We-P13:347, We-P13:349, We-P13:350), 424 (We-P13:353, We-P13:354, We-P13:355), 425 (We-P13:358), 426 (We-P13:361, We-P13:362, We-P13:363), 427 (We-P13:366, We-P13:367, We-P13:368), 428 (We-P13:369, We-P13:370, We-P13:371), 429 (We-P13:374), 445 (We-P14:445, We-P14:446), 469 (Th-W51:6), 471 (Th-W52:4), 475 (Th-W54:4), 479 (Th-W56:3), 489 (Th-W61:2), 499 (Th-P15:32), 507 (Th-P15:68), 508 (Th-P15:70), 509 (Th-P15:77), 510 (Th-P15:82, Th-P15:83), 511 (Th-P15:85), 512 (Th-P15:91), 518 (Th-P15:ll7), 519 (Th-P15:120), 533 (Th-P15:185), 534 (Th-P15:187), 556 (Th-P16:285), 559 (Th-P16:298), 564 (Th-P16:323), 566 (Th-P16:329), 569 (Th-P16:342), 577 (Th-P16:379, Th-P16:382)

Micropartides 75 (Mo-P1:131), 88 (Mo-P2:191), 173 (Tu-W26:4), 291 (Tu-P10:485), 292

(Tu-P10:486), 326 (We-W40:7)


- I 0 "1:1

Z

m X

604 Topic bulex

Mono- versus Polyunsaturated Fatty Acids 10 (Mo-ML3:I), 290 (Tu-P10:481), 352 (We-P11:30), 430 (We-P14:378), 438

(We-P14:415, We-P14:418), 447 (We-P14:457, We-P14:458), 448 (We-P14:459), 451 (We-P14:474), 452 (We-P14:476), 472 (Th-W53:l), 473 (Th-W53:3, Th-W53:4), 511 (Th-P15:84), 523 (Th-P15:140), 561 (Th-P 16: 307)

MRI 9 (Mo-ML2:I), 41 (Mo-S6:I), 108 (Mo-P4:281), 110 (Mo-P4:290), 156

(Tu-W18:3), 266 (Tu-P9:374, Tu-P9:375), 267 (Tu-P9:376, Tu-P9:377, Tu-P9:378, Tu-P9:379), 381 (We-P11:162), 493 (Th-P15:6), 559 (Th-P 16: 300)

MTP Inhibitors 465 (Th-W49:3), 564 (Th-P16:322)

New Areas of Investigation 18 (Mo-W4:5), 74 (Mo-Pl:127), 267 (Tu-P9:378), 323 (We-W39:4), 367

(We-Pll:100), 402 (We-Pll:255), 404 (We-P11:265), 406 (We-P11:273), 410 (We-P12:293), 430 (We-P14:381), 512 (Th-P15:88)

New Drugs, Biotech Products 25 (Mo-W8:5), 32 (Mo-Wll:7) , 33 (Mo-W12:4), 40 (Mo-$4:3), 42

(Mo-$6:4), 96 (Mo-P3:227), 209 (Tu-P7:110), 230 (Tu-P7:209), 234 (Tu-P7:224, Tu-P7:227), 253 (Tu-PS:313), 301 (We-PL3:2), 338 (We-S13:2), 391 (We-P11:205), 392 (We-Pll:211, We-Pll:212), 404 (We-Pll:265), 444 (We-P14:442), 464 (Th-W49:l), 465 (Th-W49:3, Th-W49:4), 466 (Th-W49:7), 480 (Th-W56:8), 494 (Th-P15:13), 499 (Th-P15:31), 521 (Th-P15:130), 547 (Th-P16:249), 548 (Th-P16:250, Th-P16:251, Th-P16:252, Th-P16:253), 549 (Th-P16:256), 558 (Th-P16:297), 564 (Th-P16:323, Th-P16:324), 565 (Th-P16:325, Th-P16:326, Th-P16:328), 566 (Th-P16:330, Th-P16:331, Th-P16:332, Th-P16:333), 583 (Th-P16:408), 586 (Th-P17:421), 589 (Th-P17:434)

New Mechanisms of Antithrombotic Action 85 (Mo-P2:177), 201 (Tu-P7:75), 325 (We-W40:4), 326 (We-W40:7), 392

(We-Pll:211), 413 (We-P12:307), 538 (Th-P15:208), 591 (Th-P17:444)

Nicotinic Acid 121 (Mo-P5:346), 122 (Mo-P5:347), 174 (Tu-W27:4), 178 (Tu-W29:4), 321

(We-W38:4), 359 (We-P11:59), 440 (We-P14:423), 463 (Th-W48:3), 529 (Th-P15:168), 559 (Th-P16:302), 567 (Th-P16:335, Th-P16:336, Th-P16:337), 568 (Th-P16:338, Th-P16:339)

Nitric Oxide System 14 (Mo-W2:5), 22 (Mo-W7:I), 23 (Mo-W7:4), 60 (Mo-Pl:66), 87

(Mo-P2:185), 91 (Mo-P2:206), 111 (Mo-P5:298), 142 (Mo-P6:439), 151 (Tu-ML4:I), 191 (Tu-P7:29), 192 (Tu-P7:35), 195 (Tu-P7:48), 214 (Tu-P7:134), 215 (Tu-P7:139, Tu-P7:140), 216 (Tu-P7:141, Tu-P7:143, Tu-P7:144), 217 (Tu-P7:145, Tu-P7:148, Tu-P7:149), 218 (Tu-P7:153), 219 (Tu-P7:157), 220 (Tu-P7:158), 226 (Tu-P7:189), 234 (Tu-P7:227), 260 (Tu-P9:342), 263 (Tu-P9:358), 265 (Tu-P9:367), 278 (Tu-P10:429), 293 (Tu-PlO:492), 297 (Tu-P10:509, Tu-P10:511, Tu-P10:512), 298 (Tu-P10:514, Tu-P10:515, Tu-P10:516), 312 (We-W34:2), 352 (We-P11:29, We-P11:32), 355 (We-P11:43), 357 (We-Pll:52, We-Pll:54), 386 (We-Pll:184), 439 (We-P14:420), 454 (We-P14:486), 455 (We-P14:489), 462 (Th-W48:l), 471 (Th-W52:6), 483 (Th-W58:l), 521 (Th-P15:129), 535 (Th-P15:192), 572 (Th-P16:359), 574 (Th-P16:366), 578 (Th-P16:385), 590 (Th-P17:442)

NMR Technology for Lipoproteins 113 (Mo-P5:303), 175 (Tu-W27:5), 501 (Th-P15:40)

Non-Alcoholic Steatohepatitis (NASH) 19 (Mo-W5:3), 170 (Tu-W25:4, Tu-W25:5), 318 (We-W37:l), 409

(We-P12:288, We-P12:289), 410 (We-P12:290, We-P12:291, We-P12:292), 411 (We-P12:294), 488 (Th-W61:I)

Novel Antithrombotic Agents 28 (Mo-W10:2), 29 (Mo-W10:6), 49 (Mo-P1:17), 222 (Tu-P7:169), 324

(We-W40:I), 391 (We-P11:207, We-Pll:208), 392 (We-P11:209, We-P11:210, We-P11:212), 393 (We-P11:214, We-P11:215, We-P 11:218), 439 (We-P14:420), 440 (We-P14:426)

Novel Risk Factors 5 (Su-$3:2), 14 (Mo-W2:6), 17 (Mo-W4:3), 18 (Mo-W4:5), 23 (Mo-W7:4,

Mo-W7:5), 24 (Mo-W7:6, Mo-W7:7), 35 (Mo-W13:6), 37 (Mo-W14:4, Mo-W14:5, Mo-W14:6, Mo-W14:7), 38 (Mo-W15:2), 39 (Mo-W15:5), 42 (Mo-$6:2), 47 (Mo-PI:9), 48 (Mo-PI:15), 55 (Mo-Pl:46), 58 (Mo-Pl:58), 60 (Mo-Pl:65, Mo-Pl:66), 67 (Mo-Pl:97), 68 (Mo-PI:104), 69 (Mo-PI:107), 70 (Mo-PI:ll0), 71 (Mo-PI:115, Mo-PI:116), 72 (Mo-PI:117, Mo-PI:118, Mo-PI:ll9, Mo-PI:120, Mo-PI:121), 73 (Mo-Pl:122, Mo-Pl:123, Mo-Pl:124, Mo-Pl:125), 74 (Mo-Pl:127, Mo-Pl:128, Mo-Pl:129, Mo-PI:130), 75 (Mo-PI :131, Mo-Pl:132, Mo-Pl:133, Mo-Pl:134, Mo-Pl:135), 76 (Mo-Pl:136), 77 (Mo-PI:140, Mo-PI:141, Mo-Pl:142), 78 (Mo-Pl:147), 79 (Mo-PI:151, Mo-Pl:152, Mo-Pl:153), 81 (Mo-Pl:158), 82 (Mo-Pl:167), 84 (Mo-P2:175), 85 (Mo-P2:176, Mo-P2:177), 89 (Mo-P2:195), 93 (Mo-P2:214), 100 (Mo-P4:245, Mo-P4:246), 103 (Mo-P4:258), 104 (Mo-P4:264), 105 (Mo-P4:268, Mo-P4:269, Mo-P4:271), 106 (Mo-P4:274), 107 (Mo-P4:277), 111 (Mo-P5:297), 119 (Mo-P5:336), 121 (Mo-P5:343), 123 (Mo-P5:353), 126 (Mo-P5:365, Mo-P5:366), 127 (Mo-P5:371), 131 (Mo-P6:391), 132 (Mo-P6:394), 133 (Mo-P6:399), 138 (Mo-P6:421), 142 (Mo-P6:436, Mo-P6:437), 143 (Mo-P6:444), 145 (Mo-P6:452), 146 (Mo-P6:454), 149 (Tu-PL2:3), 169 (Tu-W25:l), 170 (Tu-W25:3), 171 (Tu-W25:6), 177 (Tu-W28:5), 180 (Tu-SS:2), 185 (Tu-P7:3), 186 (Tu-P7:6), 189 (Tu-P7:21), 203 (Tu-P7:86), 204 (Tu-P7:88), 206 (Tu-P7:100, Tu-P7:96), 207 (Tu-P7:105), 209 (Tu-P7:110, Tu-P7:111), 216 (Tu-P7:144), 218 (Tu-P7:151), 222 (Tu-P7:168), 227 (Tu-P7:194), 229 (Tu-P7:204), 231 (Tu-P7:213), 232 (Tu-P7:217), 235 (Tu-P7:229), 236 (Tu-P7:235), 238 (Tu-P7:245), 246 (Tu-P7:279), 261 (Tu-P9:349), 262 (Tu-P9:355, Tu-P9:356), 264 (Tu-P9:365), 265 (Tu-P9:368), 269 (Tu-P9:385), 273 (Tu-P10:405), 277 (Tu-P10:423), 279 (Tu-P10:432), 281 (Tu-P10:440, Tu-P10:442), 282 (Tu-P10:445, Tu-P10:446), 283 (Tu-P10:449, Tu-P10:451), 285 (Tu-P10:458), 287 (Tu-P10:466), 288 (Tu-P10:470, Tu-P10:473), 289 (Tu-P10:474), 290 (Tu-P10:479, Tu-P10:480, Tu-P10:481), 291 (Tu-P10:482, Tu-P10:483, Tu-P10:484), 292 (Tu-P10:489), 293 (Tu-P10:491), 295 (Tu-P10:501), 298 (Tu-P10:515), 306 (We-W30:6), 307 (We-W31:3), 309 (We-W32:3), 313 (We-W34:4, We-W34:5), 315 (We-W35:4), 317 (We-W36:4, We-W36:6), 318 (We-W36:7), 324 (We-W39:5), 330 (We-W42:7), 333 (We-W44:4, We-W44:7), 335 (We-W45:5), 336 (We-W45:7), 349 (We-P11:15), 351 (We-P11:24), 358 (We-P11:56), 369 (We-P11:108), 379 (We-P11:150), 383 (We-P11:171), 384 (We-Pll:176), 389 (We-Pll:195), 395 (We-P11:224), 400 (We-P11:248), 406 (We-P11:275), 408 (We-P12:281, We-P12:284, We-P12:285), 410 (We-P12:293), 411 (We-P12:294, We-P12:296), 412 (We-P12:301, We-P12:302), 413 (We-P12:303, We-P12:304, We-P12:306), 416 (We-P13:320), 417 (We-P13:321), 418 (We-P13:328), 420 (We-P13:337), 429 (We-P13:375), 446 (We-P14:451), 463 (Th-W48:4), 466 (Th-W50:I), 472 (Th-W53:2), 475 (Th-W54:3), 479 (Th-W56:2), 484 (Th-W58:5, Th-W58:6), 488 (Th-W60:6), 496 (Th-P15:IS), 508 (Th-P15:72), 511 (Th-P15:86), 516 (Th-P15:109), 519 (Th-P15:121), 520 (Th-P15:124), 522 (Th-P15:134), 532 (Th-P15:IS1), 546 (Th-P15:244), 560 (Th-P16:305), 569 (Th-P16:343), 574 (Th-P16:369), 577 (Th-P16:382), 584 (Th-P16:414), 585 (Th-P17:418), 588 (Th-P17:430), 590 (Th-P17:442)

Novel Technologies for Risk Determination 36 (Mo-W14:3), 224 (Tu-P7:178), 332 (We-W44:l), 335 (We-W45:5), 400

(We-P11:246), 510 (Th-P15:79), 520 (Th-P15:127), 587 (Th-P17:426), 588 (Th-P17:429, Th-P17:430, Th-P17:432, Th-P17:433)

Nuclear Receptors 7 (Mo-PLI:2), 20 (Mo-W6:I), 27 (Mo-W9:4), 35 (Mo-W13:7), 38

(Mo-W15:4), 137 (Mo-P6:415), 166 (Tu-W23:2), 168 (Tu-W24:3, Tu-W24:4), 185 (Tu-P7:3), 186 (Tu-P7:8, Tu-P7:9), 202 (Tu-P7:81), 210 (Tu-P7:116), 228 (Tu-P7:195), 239 (Tu-P7:248), 242 (Tu-P7:261), 253


Topic bulex 605

(Tu-P8:313), 254 (Tu-P8:314, Tu-P8:315, Tu-P8:316, Tu-P8:317, Tu-P8:318), 255 (Tu-P8:319, Tu-P8:320, Tu-P8:321, Tu-P8:322), 256 (Tu-P8:323, Tu-P8:324, Tu-P8:325, Tu-P8:326), 257 (Tu-P8:328, Tu-P8:329, Tu-P8:331), 275 (Tu-P10:412), 320 (VVe-W37:7, We-W38:2), 331 (We-W43:4), 372 (We-Pll:119, We-Pll:120, We-P11:121), 396 (We-Pll:231), 445 (We-P14:448), 450 (We-P14:471), 455 (We-P14:489), 465 (Th-W49:4), 472 (Th-W52:7), 485 (Th-W59:3), 487 (Th-W60:2, Th-W60:3), 488 (Th-W60:8), 492 (Th-P15:3), 494 (Th-P15:I 1), 496 (Th-P15:20), 514 (Th-P15:100, Th-P15:98, Th-P15:99), 541 (Th-P15:221), 543 (Th-P15:227), 560 (Th-P16:304), 572 (Th-P16:360)

Nutritional Approaches 10 (Mo-ML3:I), 177 (Tu-W28:4, Tu-W28:6), 180 (Tu-S9:I), 223

(Tu-P7:173), 273 (Tu-P10:405), 328 (We-W42:l), 343 (We-S16:I), 408 (We-P12:281), 430 (We-P14:377, We-P14:379), 432 (We-P14:387, We-P14:390), 435 (We-P14:403), 439 (We-P14:420), 442 (We-P14:433, We-P14:435), 445 (We-P14:445), 446 (We-P14:453), 447 (We-P14:456, We-P14:458), 449 (We-P14:465), 454 (We-P14:487), 458 (Th-PL4:4), 464 (Th-W48:7), 477 (Th-W55:4)

Obesity, Hypertension and Atherosderosis 13 (Mo-W2:2), 40 (Mo-$4:2), 48 (Mo-PI:13), 55 (Mo-Pl:46), 60

(Mo-Pl:67), 66 (Mo-Pl:94), 79 (Mo-PI:150), 120 (Mo-P5:337, Mo-P5:338), 141 (Mo-P6:435), 145 (Mo-P6:453), 165 (Tu-W22:7), 176 (Tu-W28:2), 185 (Tu-P7:1, Tu-P7:3, Tu-P7:5), 186 (Tu-P7:8), 187 (Tu-P7:11), 197 (Tu-P7:56), 199 (Tu-P7:65), 202 (Tu-P7:82), 229 (Tu-P7:202), 269 (Tu-P9:387), 303 (We-ML8:I), 310 (We-W33:l), 311 (We-W33:2, We-W33:4), 330 (We-W42:7), 346 (We-P11:2), 349 (We-Pll:19), 369 (We-P11:109), 373 (We-P11:127), 374 (We-P11:128, We-Pll:129, We-Pll:131), 375 (We-Pll:132, We-Pll:134, We-P11:136), 376 (We-Pll:137), 377 (We-P11:144), 383 (We-P11:168), 384 (We-Pll:173), 385 (We-Pll:180), 386 (We-Pll:183, We-Pll:184), 387 (We-Pll:187), 407 (We-P12:280), 409 (We-P12:286), 421 (We-P13:339), 424 (We-P13:355), 427 (We-P13:368), 430 (We-P14:377), 454 (We-P14:485), 586 (Th-P17:420)

OCT 9 (Mo-ML2:1)

Omega-3 Fatty Acids 10 (Mo-ML3:I), 160 (Tu-W20:3), 180 (Tu-S9:I), 181 (Tu-S9:2, Tu-S9:3,

Tu-S9:4), 241 (Tu-P7:256), 290 (Tu-P10:481), 292 (Tu-P10:487), 303 (We-ML6:I), 316 (We-W36:l, We-W36:2), 317 (We-W36:4), 329 (We-W42:5), 334 (We-W45:2), 370 (We-P11:112), 386 (We-P11:185), 430 (We-P14:378), 438 (We-P14:416), 440 (We-P14:427), 442 (We-P14:432), 447 (We-P14:457), 448 (We-P14:459, We-P14:460, We-P14:461, We-P14:462, We-P14:463), 449 (We-P14:464, We-P14:465, We-P14:466, We-P14:467), 450 (We-P14:468, We-P14:469), 458 (Th-PL4:4), 472 (Th-W53:l, Th-W53:2), 473 (Th-W53:6), 474 (Th-W53:7), 522 (Th-P15:136), 556 (Th-P16:285), 588 (Th-P17:431)

Optimal Atherosclerosis Management 4 (Su-$2:5), 49 (Mo-PI:19), 81 (Mo-PI:160), 102 (Mo-P4:256), 109

(Mo-P4:288), 116 (Mo-P5:317, Mo-P5:318, Mo-P5:320), 117 (Mo-P5:325), 147 (Mo-P6:458), 242 (Tu-P7:260), 246 (Tu-P7:279), 284 (Tu-P10:453), 303 (We-ML8:I), 353 (We-P11:35), 366 (We-P11:92), 387 (We-Pll:189), 413 (We-P12:303), 555 (Th-P16:284), 557 (Th-P16:289)

Osteoporosis 73 (Mo-Pl:125), 217 (Tu-P7:147), 411 (We-P12:295, We-P12:296,

We-P12:297), 412 (We-P12:298)

OJodative Stress 14 (Mo-W2:5), 31 (Mo-Wll:3), 60 (Mo-Pl:64), 77 (Mo-Pl:142), 84

(Mo-P2:172), 87 (Mo-P2:185, Mo-P2:186), 88 (Mo-P2:189), 91 (Mo-P2:205), 95 (Mo-P3:221), 98 (Mo-P4:239), 99 (Mo-P4:241), 101 (Mo-P4:249), 105 (Mo-P4:267), 113 (Mo-P5:307), 127 (Mo-P5:370), 128 (Mo-P5:374), 131 (Mo-P6:388), 143 (Mo-P6:442), 147 (Mo-P6:460), 151

(Tu-ML4:1), 157 (Tu-W18:7), 173 (Tu-W26:5, Tu-W26:7), 175 (Tu-W27:5), 177 (Tu-W28:6), 188 (Tu-P7:17), 189 (Tu-P7:19), 193 (Tu-P7:42), 195 (Tu-P7:48), 198 (Tu-P7:61), 199 (Tu-P7:65), 202 (Tu-P7:78), 203 (Tu-P7:83), 207 (Tu-P7:101), 209 (Tu-P7:112, Tu-P7:ll4), 212 (Tu-P7:127), 216 (Tu-P7:141, Tu-P7:142, Tu-P7:143), 218 (Tu-P7:153), 222 (Tu-P7:169), 223 (Tu-P7:175, Tu-P7:176), 228 (Tu-P7:196), 229 (Tu-P7:203), 234 (Tu-P7:228), 238 (Tu-P7:242, Tu-P7:245), 242 (Tu-P7:260), 243 (Tu-P7:268), 245 (Tu-P7:274), 251 (Tu-P8:304), 253 (Tu-P8:312), 255 (Tu-P8:322), 269 (Tu-P9:385), 270 (Tu-P10:389, Tu-P10:392), 271 (Tu-P10:395, Tu-P10:396), 272 (Tu-P10:398), 275 (Tu-P10:412, Tu-P10:414, Tu-P10:416), 276 (Tu-P10:420), 277 (Tu-P10:423), 283 (Tu-P10:451), 284 (Tu-P10:455), 285 (Tu-P10:456), 287 (Tu-P10:468), 292 (Tu-P10:487, Tu-P10:488, Tu-P10:489, Tu-P10:490), 293 (Tu-P10:491, Tu-P10:492, Tu-P10:493, Tu-P10:494), 294 (Tu-P10:498, Tu-P10:499), 295 (Tu-P10:500, Tu-P10:501, Tu-P10:502, Tu-P10:503, Tu-P10:504), 296 (Tu-P10:505, Tu-P10:507, Tu-P10:508), 297 (Tu-P10:509, Tu-P10:510), 298 (Tu-P10:514), 328 (We-W41:7), 332 (We-W44:2), 333 (We-W44:4), 351 (We-P11:28), 352 (We-P11:29, We-P11:32), 353 (We-P11:35), 354 (We-P11:39, We-Pll:41), 355 (We-P11:43), 357 (We-P11:54), 373 (We-P11:125), 376 (We-P11:140), 378 (We-P11:148), 385 (We-Pll:178), 388 (We-P11:192), 390 (We-P11:200), 402 (We-Pll:254, We-P11:257), 405 (We-P11:271), 409 (We-P12:287), 416 (We-P13:320), 432 (We-P14:390), 433 (We-P14:392), 434 (We-P14:395, We-P14:396), 436 (We-P14:407), 438 (We-P14:415), 439 (We-P14:420), 440 (We-P14:424), 443 (We-P14:440), 445 (We-P14:447, We-P14:449), 446 (We-P14:450, We-P14:452), 452 (We-P14:476), 469 (Th-W51:3, Th-W51:4), 470 (Th-W51:7), 471 (Th-W52:6), 473 (Th-W53:4), 492 (Th-P15:5), 508 (Th-P15:71, Th-P15:74), 518 (Th-P15:115), 521 (Th-P15:131, Th-P15:132), 522 (Th-P15:136), 523 (Th-P15:137), 524 (Th-P15:143, Th-P15:144), 525 (Th-P15:146, Th-P15:147), 526 (Th-P15:150, Th-P15:153), 527 (Th-P15:157), 528 (Th-P15:160), 529 (Th-P15:164, Th-P15:166), 546 (Th-P15:245), 547 (Th-P15:246), 551 (Th-P16:264), 552 (Th-P16:269), 556 (Th-P16:286), 569 (Th-P16:344), 573 (Th-P16:362), 575 (Th-P16:371), 578 (Th-P16:388), 580 (Th-P16:393), 585 (Th-P16:416), 586 (Th-P17:423), 587 (Th-P17:425), 589 (Th-P17:436), 590 (Th-P17:440)

P450 Metabolyzing System 367 (We-P11:99), 562 (Th-P16:312), 576 (Th-P16:377)

Pathophysiology of Lipids and Lipoproteins 34 (Mo-W13:4), 54 (Mo-PI:40, Mo-Pl:42), 73 (Mo-Pl:124), 135

(Mo-P6:409), 136 (Mo-P6:413), 146 (Mo-P6:457), 180 (Tu-SS:2), 228 (Tu-P7:199), 230 (Tu-P7:205), 266 (Tu-P9:373), 267 (Tu-P9:377), 296 (Tu-P10:506), 359 (We-P11:62), 365 (We-Pll:91), 442 (We-P14:434), 491 (Th-S17:I), 498 (Th-P15:28), 499 (Th-P15:34), 500 (Th-P15:38), 505 (Th-P15:57), 524 (Th-P15:142, Th-P15:143), 527 (Th-P15:158), 528 (Th-P15:159), 529 (Th-P15:165), 531 (Th-P15:177), 538 (Th-P15:204)

Pathophysiology of Thrombosis 28 (Mo-W10:I), 29 (Mo-W10:6), 86 (Mo-P2:183), 88 (Mo-P2:190), 91

(Mo-P2:204), 93 (Mo-P2:213), 164 (Tu-W21:7), 292 (Tu-P10:486), 314 (We-W35:l), 326 (We-W40:7), 344 (We-S 16:4), 390 (We-Pll:202), 392 (We-P11:210), 397 (We-P11:233), 439 (We-P14:420), 502 (Th-P15:45)

Periodontal Disease in Atherosclerosis 171 (Tu-W25:6, Tu-W25:7), 385 (We-P11:177), 411 (We-P12:296), 412

(We-P12:299, We-P12:300, We-P12:301, We-P12:302), 413 (We-P12:303, We-P12:304, We-P12:305), 463 (Th-W48:4)

Peripheral Vascular Disease 17 (Mo-W4:3), 60 (Mo-Pl:65), 62 (Mo-Pl:74), 67 (Mo-Pl:96), 81

(Mo-PI:161), 102 (Mo-P4:255, Mo-P4:256, Mo-P4:257), 103 (Mo-P4:258, Mo-P4:259, Mo-P4:260, Mo-P4:261, Mo-P4:262), 104 (Mo-P4:263, Mo-P4:264, Mo-P4:265, Mo-P4:266), 105 (Mo-P4:267, Mo-P4:268, Mo-P4:269, Mo-P4:270, Mo-P4:271), 106 (Mo-P4:272, Mo-P4:273, Mo-P4:274, Mo-P4:275), 109 (Mo-P4:287), 123 (Mo-P5:354), 132 (Mo-P6:395), 140 (Mo-P6:428), 144 (Mo-P6:447), 151


606 Topic bulex

(Tu-ML4:I), 159 (Tu-W19:6), 190 (Tu-P7:26), 191 (Tu-P7:29), 209 (Tu-P7:113), 210 (Tu-P7:116), 211 (Tu-P7:119), 218 (Tu-P7:151), 241 (Tu-P7:258), 247 (Fu-P7:286), 258 (Tu-P9:334, Tu-P9:335), 261 (Tu-P9:352), 335 (We-W45:4), 357 (We-Pll:51), 378 (We-P11:147), 382 (We-P11:167), 387 (We-Pll:189), 411 (We-P12:297), 479 (Th-W56:3), 530 (Th-P15:171), 576 (Th-P16:378)

PET 156 (Tu-W18:3), 324 (We-W39:5), 507 (Th-P15:67)

Pbarmacoeconomy 18 (Mo-W5:I), 121 (Mo-P5:344, Mo-P5:345, Mo-P5:346), 177 (Tu-W29:l),

178 (Tu-W29:2, Tu-W29:3, Tu-W29:4, Tu-W29:5)

Pbarmacogenetics of Anfiatherosderotic Drugs 30 (Mo-W10:7), 142 (Mo-P6:438), 147 (Mo-P6:458, Mo-P6:459), 195

(Tu-P7:49), 278 (Tu-PlO:429), 296 (Tu-P10:507), 498 (Th-P15:29)

Pbarmacogenetics of Antithrombotic Drugs 394 (We-P11:220)

Pharmacological Control of Lipids and Lipoproteins 81 (Mo-PI:160L 117 (Mo-P5:325L 147 (Mo-P6:458), 161 (Tu-W20:6,

Tu-W20:7), 230 (Tu-P7:205L 329 (We-W42:3), 530 (Th-P15:172), 549 (Th-P16:255, Th-P16:258), 551 (Th-P16:265, Th-P16:267), 554 (Th-P16:280L 555 (Th-P16:281, Th-P16:282, Th-P16:283, Th-P16:284), 557 (Th-P16:289L 562 (Fh-P16:313), 568 (Th-P16:338, Th-P16:339), 578 (Th-P16:386)

Pbarmacovigilmlce 1 (Su-SI:I, Su-SI:2, Su-SI:3), 2 (Su-SI:4), 47 (Mo-PI:8), 66 (Mo-PI:91),

121 (Mo-P5:345), 122 (Mo-P5:347, Mo-P5:348)

Pbytosterols, Stmlols, Stmlol Esters 146 (Mo-P6:456, Mo-P6:457), 177 (Fu-W28:5L 198 (Tu-P7:63), 317

(We-W36:6), 337 (We-S12:I, We-S12:2, We-S12:3), 338 (We-S12:4), 399 (We-P11:240), 434 (We-P14:398), 437 (We-P14:413), 444 (We-P14:442), 450 (We-P14:470, We-P14:471), 451 (We-P14:472, We-P14:473, We-P14:474, We-P14:475), 452 (We-P14:476, We-P14:477, We-P14:478, We-P14:479), 453 (We-P14:480), 454 (We-P14:484), 478 (Th-W55:7), 495 (Th-P15:16), 510 (Th-P15:80)

Plaque Stabilization, Regression and Remodeling 8 (Mo-PLI:4), 22 (Mo-W6:7), 33 (Mo-W12:4, Mo-W12:7), 80 (Mo-Pl:155,

Mo-Pl:156), 86 (Mo-P2:181), 93 (Mo-P2:213), 110 (Mo-P4:290), 145 (Mo-P6:453), 157 (Tu-W18:4, Tu-W18:6), 160 (Fu-W20:3), 193 (Tu-P7:40), 230 (Tu-P7:208), 238 (Fu-P7:245), 239 (Tu-P7:247), 241 (Tu-P7:257), 245 (Fu-P7:277), 247 (Tu-P7:284), 251 (Tu-P8:301), 266 (Tu-P9:371), 291 (Tu-P10:484), 325 (We-W40:5), 393 (We-Pll:215, We-Pll:216, We-Pll:217, We-P11:218), 482 (Fh-W57:7), 483 (Th-W58:l), 487 (Fh-W60:4), 488 (Fh-W60:8), 498 (Fh-P15:27), 548 (Th-P16:252, Th-P16:253), 579 (Th-P16:390), 585 (Fh-P16:417), 590 (Th-P17:438)

Plasma Triglycerides 12 (Mo-WI:5), 15 (Mo-W3:3), 16 (Mo-W3:7), 30 (Mo-Wll:I), 31

(Mo-W11:6), 32 (Mo-W11:7), 35 (Mo-W13:7), 37 (Mo-W14:5), 38 (Mo-W15:I, Mo-W15:2, Mo-W15:3, Mo-W15:4), 39 (Mo-W15:5), 40 (Mo-$4:2), 46 (Mo-PI:I), 51 (Mo-Pl:28), 53 (Mo-Pl:37, Mo-Pl:38), 54 (Mo-Pl:42), 70 (Mo-PI :112), 82 (Mo-Pl:163), 130 (Mo-P6:383), 138 (Mo-P6:420, Mo-P6:422), 139 (Mo-P6:423, Mo-P6:425), 144 (Mo-P6:445, Mo-P6:448), 193 (Tu-P7:41), 196 (Tu-P7:55), 197 (Tu-P7:57), 254 (Tu-P8:316, Tu-P8:317), 256 (Fu-P8:326), 305 (We-W30:3), 306 (We-W30:5, We-W30:7), 321 (We-W38:3), 335 (We-W45:6), 353 (We-P11:34), 363 (We-P11:80), 373 (We-P11:126), 378 (We-Pll:148), 395 (We-Pll:223), 396 (We-Pll:229), 399 (We-P11:240), 400 (We-Pll:247), 402 (We-P11:256), 407 (We-P12:279), 410 (We-P12:292), 422 (We-P13:345), 428 (We-P13:370), 435 (We-P14:402), 437 (We-P14:413), 438 (We-P14:416), 443 (We-P14:437), 448

(We-P14:461), 449 (We-P14:464), 450 (We-P14:468), 453 (We-P14:481), 474 (Th-W53:7), 486 (Th-W59:6), 491 (Th-S17:2), 497 (Th-P15:22), 498 (Th-P15:30), 500 (Th-P15:35), 504 (Th-P15:54, Th-P15:55, Th-P15:56), 505 (Th-P15:57, Th-P15:58, Th-P15:60), 506 (Th-P15:61, Th-P15:62, Th-P15:63, Th-P15:64, Th-P15:65), 507 (Th-P15:66, Th-P15:67, Th-P15:68, Th-P15:69), 508 (Th-P15:72), 509 (Th-P15:76, Th-P15:78), 510 (Th-P15:80, Th-P15:82), 511 (Th-P15:84, Th-P15:86, Th-P15:87), 512 (Th-P15:89, Th-P15:90, Th-P15:92), 518 (Th-P15:117, Th-P15:ll8), 520 (Th-P15:123), 521 (Th-P15:129), 534 (Th-P15:186), 538 (Th-P15:204), 543 (Th-P15:227), 544 (Th-P15:235), 545 (Th-P15:239), 559 (Th-P16:300), 560 (Th-P16:303, Th-P16:306), 564 (Th-P16:323), 567 (Th-P16:334), 576 (Th-P16:378), 577 (Th-P16:383), 580 (Th-P16:395), 584 (Th-P16:412), 587 (Th-P17:428)

Platelets 28 (Mo-W10:I, Mo-W10:2), 29 (Mo-W10:6), 89 (Mo-P2:198), 90

(Mo-P2:199, Mo-P2:200, Mo-P2:201, Mo-P2:202), 91 (Mo-P2:204, Mo-P2:205, Mo-P2:206, Mo-P2:207), 92 (Mo-P2:208), 99 (Mo-P4:241), 142 (Mo-P6:437), 147 (Mo-P6:460), 164 (Tu-W21:7), 171 (Tu-W26:l), 172 (Tu-W26:2, Tu-W26:3), 173 (Tu-W26:4, Tu-W26:6, Tu-W26:7), 195 (Tu-P7:47), 202 (Tu-P7:82), 203 (Tu-P7:85), 283 (Tu-P10:447), 284 (Tu-P10:452), 291 (Tu-P10:485), 326 (We-W40:6), 329 (We-W42:4), 353 (We-P11:35), 355 (We-Pll:45), 363 (We-P11:78), 389 (We-Pll:196), 390 (We-Pll:202, We-P11:203), 392 (We-P11:210, We-P11:211, We-Pll:212), 394 (We-Pll:222), 397 (We-P11:235), 398 (We-P11:236), 402 (We-P11:258), 403 (We-P11:260, We-P11:261), 413 (We-P12:305), 414 (We-P12:308), 416 (We-P13:316), 434 (We-P14:397), 444 (We-P14:444), 469 (Th-W51:4), 524 (Th-P15:144), 525 (Th-P15:147), 583 (Th-P16:408), 591 (Th-P17:444)

Pleiotropic Effects of LDL Lowering 9 (Mo-MLI:I), 27 (Mo-W9:3), 173 (Tu-W26:5), 245 (Tu-P7:276), 339

(We-S13:3), 548 (Th-P16:254), 563 (Th-P16:317), 565 (Th-P16:325), 568 (Th-P16:341), 569 (Th-P16:342, Th-P16:343, Th-P16:346), 570 (Th-P16:348, Th-P16:349), 572 (Th-P16:358, Th-P16:359), 578 (Th-P16:386), 580 (Th-P16:396), 581 (Th-P16:399)

Plethysmography 73 (Mo-P1:122), 218 (Tu-P7:150), 268 (Tu-P9:381), 377 (We-P11:144), 444

(We-P14:441), 569 (Th-P16:346)

Polypharmacy 175 (Tu-W27:7), 553 (Th-P16:272)

Post-Prmldial Lipemia and Lipoprotein Remnants 30 (Mo-W 11 : 1, Mo-W11:2), 31 (Mo-W 11:4, Mo-W11:6), 39 (Mo-W 15:6),

135 (Mo-P6:408), 137 (Mo-P6:417), 138 (Mo-P6:422), 226 (Tu-P7:187), 399 (We-P11:240), 416 (We-P13:319), 417 (We-P13:324), 435 (We-P14:402), 447 (We-P14:457), 448 (We-P14:459), 497 (Th-P15:25), 504 (Th-P15:55), 505 (Th-P15:57), 506 (Th-P15:63), 508 (Th-P15:71, Th-P15:72, Th-P15:73, Th-P15:74), 509 (Th-P15:75, Th-P15:77, Th-P15:78), 510 (Th-P15:79, Th-P15:80, Th-P15:81, Th-P15:82, Th-P15:83), 511 (Th-P15:84, Th-P15:85, Th-P15:86, Th-P15:87), 512 (Th-P15:88, Th-P15:89, Th-P15:90), 515 (Th-P15:104), 519 (Th-P15:121), 540 (Th-P15:213), 558 (Th-P16:294), 567 (Th-P16:334)

PPAR Agonists/Antagonists 14 (Mo-W2:7), 38 (Mo-W15:4), 137 (Mo-P6:417), 138 (Mo-P6:419), 164

(Tu-W22:1), 173 (Tu-W27:1), 186 (Tu-P7:6), 252 (Tu-P8:309), 256 (Tu-P8:323), 257 (Tu-P8:331), 320 (We-W37:7), 331 (We-W43:3), 342 (We-S15:2), 360 (We-P11:65), 371 (We-Pll:115, We-Pll:l l7, We-P11:118), 372 (We-P11:119, We-P11:120, We-P11:121, We-P11:122), 373 (We-P11:123, We-P11:125), 396 (We-P11:231), 433 (We-P14:392), 487 (Th-W60:2), 494 (Th-P15:I 1), 496 (Th-P15:20), 516 (Th-P15:108), 543 (Th-P15:231), 559 (Th-P16:298, Th-P16:299), 561 (Th-P16:309), 570 (Th-P16:350), 572 (Th-P16:360)

PPARdelta Agonists 252 (Tu-P8:309), 373 (We-P11:124)

XIV International Symposium on Atherosclerosis, Rome, Italy, June 18-22, 2006

Topic bulex 607

Prevalence 25 (Mo-W8:2), 50 (Mo-Pl:24), 53 (Mo-Pl:35), 55 (Mo-Pl:43), 78

(Mo-Pl:146), 83 (Mo-P2:170), 105 (Mo-P4:271), 154 (Tu-W17:2), 155 (Tu-W17:4, Tu-W17:5, Tu-W17:7), 366 (We-P11:95), 369 (We-P11:106), 370 (We-Pll:113), 371 (We-P11:114), 375 (We-P11:136), 376 (We-Pll:138), 383 (We-Pll:168), 420 (We-P13:334, We-P13:337), 422 (We-P13:343), 423 (We-P13:346, We-P13:347, We-P13:349, We-P13:350), 424 (We-P13:352, We-P13:353), 425 (We-P13:357, We-P13:358, We-P13:359), 426 (We-P13:360, We-P13:361, We-P13:363), 427 (We-P13:364, We-P13:365, We-P13:367), 428 (We-P13:372), 429 (We-P13:375)

Prevention 63 (Mo-Pl:78), 64 (Mo-Pl:86), 82 (Mo-Pl:165), 96 (Mo-P3:230), 114

(Mo-P5:308), 120 (Mo-P5:342), 144 (Mo-P6:446), 201 (Tu-P7:77), 214 (Tu-P7:133), 257 (Tu-P9:332), 262 (Tu-P9:356), 275 (Tu-P10:415), 343 (We-S16:I), 368 (We-P11:102), 370 (We-Pll:110, We-Pll:112), 376 (We-Pll:138), 386 (We-Pll:183), 398 (We-P11:236), 408 (We-P12:282), 422 (We-P13:342), 428 (We-P13:369), 429 (We-P13:373, We-P13:374), 430 (We-P14:378), 432 (We-P14:389), 434 (We-P14:398), 440 (We-P14:423), 443 (We-P14:437), 447 (We-P14:456), 449 (We-P14:464), 450 (We-P14:469), 453 (We-P14:482), 506 (Th-P15:64), 519 (Th-P15:120)

Probiotics 440 (We-P14:424, We-P14:425)

Probucol 11 (Mo-WI:3), 238 (Tu-P7:242), 320 (We-W38:2), 575 (Th-P16:370,

Th-P16:371, Th-P16:372)

Proteases and Extracellular Matrix 21 (Mo-W6:5), 22 (Mo-W6:6), 92 (Mo-P2:210), 153 (Tu-W16:8), 156

(Tu-W18:2), 170 (Tu-W25:3), 190 (Tu-P7:25), 194 (Tu-P7:46), 214 (Tu-P7:134), 215 (Tu-P7:137), 220 (Tu-P7:158), 234 (Tu-P7:224), 237 (Tu-P7:241), 238 (Tu-P7:242, Tu-P7:243, Tu-P7:244, Tu-P7:245), 239 (Tu-P7:246, Tu-P7:247, Tu-P7:248, Tu-P7:249), 240 (Tu-P7:251, Tu-P7:252, Tu-P7:253, Tu-P7:254, Tu-P7:255), 241 (Tu-P7:256, Tu-P7:257, Tu-P7:259), 242 (Tu-P7:260, Tu-P7:261, Tu-P7:262, Tu-P7:263, Tu-P7:264), 243 (Tu-P7:265, Tu-P7:266, Tu-P7:267, Tu-P7:268), 244 (Tu-P7:269, Tu-P7:270, Tu-P7:271, Tu-P7:272, Tu-P7:273), 245 (Tu-P7:274, Tu-P7:275, Tu-P7:276, Tu-P7:277), 246 (Tu-P7:282), 247 (Tu-P7:283), 248 (Tu-P7:287), 250 (Tu-P8:298), 294 (Tu-P10:497), 312 (We-W33:7), 315 (We-W35:5), 316 (We-W35:6), 318 (We-W37:2), 325 (We-W40:5), 331 (We-W43:6), 411 (We-P12:296), 413 (We-P12:305), 439 (We-P14:422), 463 (Th-W48:2), 464 (Th-W49:2), 479 (Th-W56:4), 481 (Th-W57:2, Th-W57:3), 482 (Th-W57:7), 489 (Th-W61:4), 508 (Th-P15:73)

Proteomics 5 (Su-$3:2), 6 (Su-$3:4), 35 (Mo-W14:I), 88 (Mo-P2:191), 101 (Mo-P4:249),

202 (Tu-P7:82), 503 (Th-P15:50), 559 (Th-P16:299), 589 (Th-P17:435, Th-P17:436, Th-P17:437), 590 (Th-P17:438, Th-P17:441, Th-P17:443), 591 (Th-P17:445)

Randomized Controlled Trials and Meta-Analyses: Relevance to Clinical Practice

122 (Mo-P5:349, Mo-P5:350, Mo-P5:351), 123 (Mo-P5:353), 125 (Mo-P5:364), 159 (Tu-W19:4), 160 (Tu-W20:2), 161 (Tu-W20:4, Tu-W20:7), 174 (Tu-W27:2), 176 (Tu-W28:3), 179 (Tu-W29:7), 182 (Tu-S10:3), 321 (We-W38:4), 334 (We-W45:2), 551 (Th-P16:266), 578 (Th-P16:388), 581 (Th-P16:399)

Regulation of Cholesterol Absorption 18 (Mo-W4:4), 31 (Mo-W11:6), 39 (Mo-W15:6, Mo-W15:7), 146

(Mo-P6:456, Mo-P6:457), 188 (Tu-P7:18), 234 (Tu-P7:224), 254 (Tu-P8:317, Tu-P8:318), 303 (We-ML8:I), 305 (We-W30:I), 337 (We-S12:I), 343 (We-S16:2), 359 (We-P11:60), 450 (We-P14:471), 453 (We-P14:480), 482 (Th-W57:6), 495 (Th-P15:16, Th-P15:17), 496 (Th-P15:18), 515 (Th-P15:102), 539 (Th-P15:209), 543 (Th-P15:227), 558 (Th-P16:297)

Remnant Lipoprotein Metabolism 15 (Mo-W3:3), 20 (Mo-W5:4), 30 (Mo-W11:1), 32 (Mo-W11:7), 38

(Mo-W15:I), 39 (Mo-W15:5), 95 (Mo-P3:224), 135 (Mo-P6:408), 152 (Tu-W16:2), 407 (We-P12:278), 435 (We-P14:404), 492 (Th-P15:5), 493 (Th-P15:6), 495 (Th-P15:15), 503 (Th-P15:51), 507 (Th-P15:66, Th-P15:69), 508 (Th-P15:70), 509 (Th-P15:76), 510 (Th-P15:79, Th-P15:83), 511 (Th-P15:86), 512 (Th-P15:88, Th-P15:90), 513 (Th-P15:96), 514 (Th-P15:98), 518 (Th-P15:ll7, Th-P15:118), 519 (Th-P15:ll9, Th-P15:120, Th-P15:121, Th-P15:122), 520 (Th-P15:125), 540 (Th-P15:213), 545 (Th-P15:239), 558 (Th-P16:294)

Reverse Cholesterol Transport 7 (Mo-PLI:2), 11 (Mo-WI:2, Mo-WI:3), 12 (Mo-WI:4, Mo-WI:6), 25

(Mo-W8:4), 27 (Mo-W9:4, Mo-W9:5), 28 (Mo-W9:6, Mo-W9:7), 35 (Mo-W13:5, Mo-W13:6), 39 (Mo-W15:8), 69 (Mo-PI:105), 71 (Mo-PI:113), 104 (Mo-P4:265), 133 (Mo-P6:398), 149 (Tu-PL2:2), 153 (Tu-W16:7), 162 (Tu-W21:2), 166 (Tu-W23:4), 167 (Tu-W23:5, Tu-W23:6, Tu-W23:7), 168 (Tu-W24:3), 225 (Tu-P7:185), 227 (Tu-P7:191), 234 (Tu-P7:224), 254 (Tu-P8:316, Tu-P8:317), 255 (Tu-P8:319), 256 (Tu-P8:324, Tu-P8:325), 257 (Tu-P8:330), 305 (We-W30:2), 320 (We-W38:1, We-W38:2), 322 (We-W38:5, We-W38:7), 331 (We-W43:7), 492 (Th-P15:3), 494 (Th-P15:13), 495 (Th-P15:14, Th-P15:15), 515 (Th-P15:102), 516 (Th-P15:105), 526 (Th-P15:154), 528 (Th-P15:161, Th-P15:162), 534 (Th-P15:186, Th-P15:190), 537 (Th-P15:202), 538 (Th-P15:205, Th-P15:207), 539 (Th-P15:210, Th-P15:211, Th-P15:212), 540 (Th-P15:214, Th-P15:215), 541 (Th-P15:219, Th-P15:220, Th-P15:221), 542 (Th-P15:222, Th-P15:223, Th-P15:224, Th-P15:225), 543 (Th-P15:226, Th-P15:227, Th-P15:228, Th-P15:229, Th-P15:230), 544 (Th-P15:232, Th-P15:233, Th-P15:235, Th-P15:236), 547 (Th-P15:248), 550 (Th-P16:262), 561 (Th-P16:30% Th-P16:311), 566 (Th-P16:330), 575 (Th-P16:372), 582 (Th-P16:405)

Rheumatoid Arthritis 413 (We-P12:307), 414 (We-P12:309, We-P12:310, We-P12:311), 423

(We-P13:350)

Small Dense LDL 13 (Mo-W2:3), 36 (Mo-W14:2), 53 (Mo-Pl:37), 145 (Mo-P6:451), 338

(We-S13:I), 351 (We-P11:26), 359 (We-P11:59), 368 (We-P11:104, We-P11:105), 414 (We-P12:310), 431 (We-P14:382), 466 (Th-W49:6), 474 (Th-W54:l), 475 (Th-W54:3, Th-W54:4, Th-W54:6), 493 (Th-P15:9), 499 (Th-P15:32), 500 (Th-P15:35, Th-P15:36), 501 (Th-P15:42), 502 (Th-P15:44, Th-P15:46, Th-P15:47), 503 (Th-P15:48, Th-P15:49, Th-P15:50, Th-P15:51), 504 (Th-P15:52), 506 (Th-P15:61), 507 (Th-P15:66), 529 (Th-P15:164, Th-P15:165), 559 (Th-P16:298, Th-P16:301), 567 (Th-P16:337), 575 (Th-P16:370), 579 (Th-P16:390), 580 (Th-P16:397)

Soluble and Insoluble Fibers 440 (We-P14:427), 442 (We-P14:433), 451 (We-P14:473, We-P14:474), 453

(We-P14:481, We-P14:482), 478 (Th-W55:7)

Specific Populations 16 (Mo-W3:7), 37 (Mo-W14:4), 46 (Mo-PI:3), 50 (Mo-Pl:22, Mo-Pl:23), 51

(Mo-Pl:27), 52 (Mo-Pl:33), 54 (Mo-Pl:39), 55 (Mo-Pl:43, Mo-Pl:44), 56 (Mo-PI:50), 58 (Mo-Pl:56), 61 (Mo-PI:70), 63 (Mo-Pl:78), 64 (Mo-Pl:84, Mo-Pl:85), 65 (Mo-Pl:89), 66 (Mo-Pl:92), 67 (Mo-Pl:97), 68 (Mo-PI:103), 70 (Mo-PI:ll0), 71 (Mo-PI:115), 78 (Mo-Pl:144, Mo-Pl:145, Mo-Pl:146, Mo-Pl:147, Mo-Pl:148), 79 (Mo-Pl:149, Mo-PI:151, Mo-Pl:152), 80 (Mo-Pl:154, Mo-Pl:155, Mo-Pl:156, Mo-Pl:157), 81 (Mo-Pl:159, Mo-PI:160, Mo-PI:161, Mo-Pl:162), 82 (Mo-Pl:164, Mo-Pl:165, Mo-Pl:167), 88 (Mo-P2:193), 91 (Mo-P2:207), 101 (Mo-P4:250, Mo-P4:251, Mo-P4:253), 103 (Mo-P4:262), 106 (Mo-P4:274), 107 (Mo-P4:278, Mo-P4:279), 108 (Mo-P4:283), 109 (Mo-P4:289), 111 (Mo-P4:295), 112 (Mo-P5:301), 114 (Mo-P5:311, Mo-P5:312), 116 (Mo-P5:318, Mo-P5:322), 117 (Mo-P5:323), 122


608 Topic bulex

(Mo-P5:351), 123 (Mo-P5:354, Mo-P5:355), 124 (Mo-P5:356, Mo-P5:357, Mo-P5:358, Mo-P5:359, Mo-P5:360), 125 (Mo-P5:361, Mo-P5:362, Mo-P5:363, Mo-P5:364), 126 (Mo-P5:365, Mo-P5:366, Mo-P5:367, Mo-P5:368), 127 (Mo-P5:372, Mo-P5:373), 129 (Mo-P6:379), 130 (Mo-P6:385), 132 (Mo-P6:393), 134 (Mo-P6:401), 135 (Mo-P6:409), 138 (Mo-P6:418), 142 (Mo-P6:437), 146 (Mo-P6:454), 161 (Tu-W20:6), 163 (Tu-W21:3), 198 (Tu-P7:60), 204 (Tu-P7:87), 207 (Tu-P7:104), 208 (Tu-P7:108), 218 (Tu-P7:151), 236 (Tu-P7:233), 237 (Tu-P7:239), 262 (Tu-P9:355), 273 (Tu-P10:405), 279 (Tu-P10:433), 284 (Tu-PlO:455), 285 (Tu-PlO:458), 292 (Tu-PlO:489), 307 (We-W31:2), 309 (We-W32:2), 333 (We-W44:7), 335 (We-W45:3, We-W45:4, We-W45:5), 358 (We-P11:57), 371 (We-Pll:114), 377 (We-P11:143), 378 (We-P11:145), 380 (We-Pll:155), 381 (We-P11:160), 388 (We-Pll:194), 390 (We-P11:201), 396 (We-Pll:229), 399 (We-P11:241), 402 (We-P11:255), 407 (We-P12:278), 408 (We-P12:281, We-P12:284), 414 (We-P12:308), 418 (We-P13:325, We-P13:328), 422 (We-P13:342), 423 (We-P13:347), 427 (We-P13:367), 446 (We-P14:453), 447 (We-P14:458), 461 (Th-W47:l), 470 (Th-W52:2), 473 (Th-W53:6), 476 (Th-W54:7), 484 (Th-W58:6, Th-W58:7), 506 (Th-P15:64), 520 (Th-P15:123), 545 (Th-P15:238), 546 (Th-P15:245), 551 (Th-P16:265, Th-P16:267), 565 (Th-P16:325), 567 (Th-P16:337), 568 (Th-P16:341), 576 (Th-P16:375), 581 (Th-P16:401)

Statins 1 (Su-SI:I, Su-SI:2, Su-SI:3), 2 (Su-SI:4), 4 (Su-$2:6), 5 (Su-S3:I), 9

(Mo-MLI:I), 12 (Mo-WI:4), 25 (Mo-WS:3, Mo-WS:5, Mo-WS:6), 36

(Mo-W14:3), 44 (Mo-$7:3, Mo-$7:4), 84 (Mo-P2:175), 97 (Mo-P4:234), 99 (Mo-P4:243), 101 (Mo-P4:251), 107 (Mo-P4:278), 115 (Mo-P5:316), 116 (Mo-P5:321, Mo-P5:322), 118 (Mo-P5:329, Mo-P5:330), 121 (Mo-P5:344), 122 (Mo-P5:348, Mo-P5:350), 142 (Mo-P6:438), 147

Mo-P6:459, Mo-P6:460), 157 (Tu-W18:6), 159 (Tu-W19:5), 161 Tu-W20:4, Tu-W20:6, Tu-W20:7), 162 (Fu-W20:8), 173 (Tu-W26:5), 174 Tu-W27:2, Tu-W27:3, Tu-W27:4), 175 (Fu-W27:7), 178 (Tu-W29:2,

Tu-W29:3, Tu-W29:5), 179 (Tu-W29:7), 181 (Tu-S10:I, Tu-S9:4), 182 (Tu-S10:2, Tu-S10:3), 183 (Tu-S11:2), 186 (Tu-P7:9), 191 (Tu-P7:29), 193 (Tu-P7:40), 201 (Tu-P7:74), 209 (Fu-P7:113), 217 (Tu-P7:148, Tu-P7:149), 218 (Tu-P7:152), 219 (Tu-P7:157), 232 (Fu-P7:215), 247

(Tu-P7:286), 248 (Tu-P7:289), 250 (Tu-PS:299, Tu-PS:300), 259 (Tu-P9:339), 264 (Tu-P9:363), 267 (Tu-P9:376), 278 (Tu-P10:429), 285 (Tu-P10:457), 286 (Tu-P10:463, Tu-P10:464), 318 ONe-W37:2), 320 ONe-W38:2), 323 ONe-W39:3), 329 ONe-W42:5), 332 ONe-W44:3), 338 We-S13:I, We-S13:2), 343 ONe-S15:4), 346 ONe-P11:1), 359 We-Pll:59, We-P11:60, We-P11:61), 360 ONe-P11:64), 385 We-Pll:IS0), 391 ONe-P11:204), 414 ONe-P12:311), 433 ONe-P14:394),

460 (Th-W46:6), 463 (Fh-W48:6), 482 (Fh-W57:6, Th-W57:7), 487 (Th-W60:3), 488 (Fh-W60:7), 499 (Fh-P15:33), 500 (Fh-P15:35), 510 (Th-P15:79), 530 (Th-P15:170), 548 (Fh-P16:254), 549 (Th-P16:255, Th-P16:257, Th-P16:259), 550 (Th-P16:261), 551 (Fh-P16:265, Th-P16:266, Th-P16:267), 552 (Th-P16:270), 553 (Fh-P16:272, Th-P16:273, Th-P16:274), 554 (Th-P16:276, Th-P16:278, Th-P16:280), 555 (Th-P16:281, Th-P16:282, Th-P16:283), 556 (Fh-P16:285, Th-P16:286), 558 (Th-P16:294, Th-P16:295), 560 (Fh-P16:303), 561 (Th-P16:308), 564 (Th-P16:323), 567 (Th-P16:336), 568 (Fh-P16:339, Th-P16:340, Th-P16:341), 569 (Th-P16:342, Th-P16:343, Th-P16:344, Th-P16:346), 570 (Th-P16:347, Th-P16:348, Th-P16:349, Th-P16:350), 571 (Th-P16:351, Th-P16:352, Th-P16:354, Th-P16:355), 572 (Th-P16:357, Th-P16:358, Th-P16:359, Th-P16:360), 573 (Th-P16:361, Th-P16:363, Th-P16:364), 574 (Th-P16:365, Th-P16:366, Th-P16:367), 575 (Th-P16:374), 576 (Fh-P16:375, Th-P16:376, Th-P16:377, Th-P16:378), 577 (Fh-P16:379, Th-P16:380, Th-P16:381, Th-P16:382, Th-P16:383), 578 (Fh-P16:384, Th-P16:385, Th-P16:386, Th-P16:387, Th-P16:388), 579 (Fh-P16:392), 580 (Th-P16:393, Th-P16:396, Th-P16:397), 581 (Fh-P16:398, Th-P16:400, Th-P16:401), 582 (Th-P16:402, Th-P16:403, Th-P16:405, Th-P16:406), 583 (Th-P16:407, Th-P16:408, Th-P16:409, Th-P16:410), 584 (Th-P16:411, Th-P16:412, Th-P16:413, Th-P16:414, Th-P16:415), 585 (Th-P16:416, Th-P16:417)

Stem Cells and the Atherosderotic Plaque 23 (Mo-W7:3), 32 (Mo-W12:I), 33 (Mo-W12:6, Mo-W12:7), 96 (Mo-P3:229,

Mo-P3:230), 207 (Tu-P7:103), 462 (Th-W48:l), 471 (Th-W52:5)

Stem Cells in Myocardial Infarction 32 (Mo-W12:2), 97 (Mo-P3:231, Mo-P3:232, Mo-P3:233)

Stem Cells in the Failing Heart 97 (Mo-P3:232), 289 (Tu-P10:477)

Stroke 16 (Mo-W4:I), 17 (Mo-W4:3), 18 (Mo-W4:4), 78 (Mo-P1:145), 93

(Mo-P2:213, Mo-P2:216), 107 (Mo-P4:276, Mo-P4:278, Mo-P4:280), 108 (Mo-P4:282, Mo-P4:283, Mo-P4:284, Mo-P4:285), 109 (Mo-P4:286, Mo-P4:287, Mo-P4:288, Mo-P4:289), 110 (Mo-P4:290), 176 (Tu-W28:3), 182 (Tu-S10:3), 248 (Tu-P7:289), 258 (Tu-P9:335), 272 (Tu-P10:401), 286 (Tu-P10:462), 291 (Tu-P10:483), 318 ONe-W36:7), 335 ONe-W45:4), 357 ONe-P11:51, We-Pll:53), 395 ONe-P11:227), 397 ONe-P11:235), 401 ONe-P11:253), 402 ONe-P11:255), 479 (Th-W56:3), 484 (Th-W58:7, Th-W59:l)

Surrogate Endpoints 6 (Su-$3:4), 42 (Mo-$6:4), 67 (Mo-PI:100), 99 (Mo-P4:243), 101

(Mo-P4:253), 122 (Mo-P5:350), 163 (Tu-W21:4), 218 (Tu-P7:150), 257 (Tu-P9:332), 268 (Tu-P9:382, Tu-P9:384), 269 (Tu-P9:386, Tu-P9:387), 283 (Tu-P10:449), 284 (Tu-P10:454), 285 (Tu-P10:460), 307 ONe-W31:I), 308 ONe-W31:4), 322 ONe-W39:l), 323 ONe-W39:3), 383 ONe-P11:170), 428 ONe-P13:372), 457 (Th-PL4:3), 469 (Th-W51:6), 480 (Th-W56:7, Th-W56:8), 544 (Th-P15:232)

Thrombotic Risk and Risk Factors 29 (Mo-WIO:3), 77 (Mo-Pl:143), 84 (Mo-P2:173, Mo-P2:175), 85

(Mo-P2:177L 88 (Mo-P2:192L 91 (Mo-P2:206, Mo-P2:207L 93 (Mo-P2:213L 151 (Tu-ML5:IL 189 (Tu-P7:21L 196 (Tu-P7:51L 201 (Tu-P7:75L 261 (Tu-P9:351), 281 (Tu-P10:442L 283 (Tu-P10:447L 291 (Tu-P10:482L 329 ONe-W42:4L 348 ONe-P11:llL 355 ONe-Pll:43, We-P11:45L 370 ONe-Pll:110L 378 ONe-Pll:146L 394 ONe-Pll:221L 395 ONe-P11:223, We-P11:224, We-P11:226, We-Pll:227L 396 ONe-P11:231L 397 ONe-P11:232L 398 ONe-P11:236, We-P11:237, We-P11:238L 407 ONe-P12:279L 413 ONe-P12:305L 414 ONe-P12:309L 502 (Th-P15:45L 516 (Th-P15:106L 563 (Th-P16:318)

Tissue Factor 28 (Mo-W10:I), 29 (Mo-W10:5), 92 (Mo-P2:209, Mo-P2:211), 93

(Mo-P2:212), 196 (Tu-P7:51), 291 (Tu-P10:485), 292 (Tu-P10:486), 326 ONe-W40:6), 390 ONe-P11:202, We-Pll:203), 391 ONe-P11:206), 403 ONe-P11:263), 407 ONe-P12:279), 440 ONe-P14:425), 446 ONe-P14:451)

Unstable Plaque 7 (Mo-PLI:3), 18 (Mo-W4:5, Mo-W4:6), 21 (Mo-W6:2), 22 (Mo-W6:7), 24

(Mo-W7:7), 33 (Mo-W12:7), 52 (Mo-Pl:32), 85 (Mo-P2:176, Mo-P2:178, Mo-P2:179), 86 (Mo-P2:181, Mo-P2:184), 93 (Mo-P2:213, Mo-P2:215, Mo-P2:216), 106 (Mo-P4:272), 108 (Mo-P4:285), 117 (Mo-P5:324), 143 (Mo-P6:443), 145 (Mo-P6:449, Mo-P6:452), 146 (Mo-P6:454), 156 (Tu-W18:I, Tu-W18:2), 157 (Tu-W18:4, Tu-W18:5, Tu-W18:6), 159 (Tu-W19:7), 160 (Tu-W20:3), 167 (Tu-W24:l), 168 (Tu-W24:2), 170 (Tu-W25:3), 183 (Tu-S11:3), 190 (Tu-P7:25), 228 (Tu-P7:196), 237 (Tu-P7:241), 240 (Tu-P7:253), 241 (Tu-P7:257), 242 (Tu-P7:262), 244 (Tu-P7:269, Tu-P7:271, Tu-P7:273), 245 (Tu-P7:274), 246 (Tu-P7:278, Tu-P7:279, Tu-P7:280, Tu-P7:281, Tu-P7:282), 247 (Tu-P7:283, Tu-P7:285), 248 (Tu-P7:287, Tu-P7:288, Tu-P7:289, Tu-P7:290), 251 (Tu-P8:301), 253 (Tu-P8:310, Tu-P8:311), 256 (Tu-P8:327), 266 (Tu-P9:371), 270 (Tu-P10:391), 276 (Tu-P10:420), 278 (Tu-P10:425), 280 (Tu-P10:437), 286 (Tu-P10:461), 288 (Tu-P10:470, Tu-P10:473), 294 (Tu-P10:497), 309 ONe-W32:1, We-W32:2, We-W32:3, We-W32:4), 316 ONe-W35:6L 318 ONe-W37:2L 325 ONe-W40:5), 339 ONe-S13:3L 349 ONe-P1 l:16L 390 ONe-Pll:203), 393 ONe-Pll:218), 406 ONe-Pll:274), 416 ONe-P13:320L 460 (Th-W46:7), 463 (Th-W48:2), 481 (Th-W57:2,

XIV bztemational Symposium on Atherosclerosis, Rome, Italy, June 18-22, 2006

Topic bulex 609

Th-W57:3), 498 (Th-P15:27), 514 (Th-P15:98), 517 (Th-P15:ll0), 523 (Th-P15:137), 533 (Th-P15:184), 549 (Th-P16:256), 579 (Th-P16:389),

587 (Th-P17:426)

Valvular Disease 44 (Mo-$7:5), 100 (Mo-P4:245), 109 (Mo-P4:288), 110 (Mo-P4:291,

Mo-P4:293, Mo-P4:294), 111 (Mo-P4:295), 157 (Tu-W18:7), 236

(Tu-P7:233), 242 (Tu-P7:264), 271 (Tu-P10:396), 328 (We-W41:7), 350 (We-P11:20), 415 (We-P13:313), 529 (Th-P15:166)

Vegetable Proteins 10 (Mo-ML3:2), 317 (We-W36:4), 343 (We-S16:2), 344 (We-S16:3,

We-S16:4, We-S16:5), 434 (We-P14:399), 440 (We-P14:427), 442 (We-P14:433), 453 (We-P14:483), 454 (We-P14:484, We-P14:488), 477 (Th-W55:3, Th-W55:4), 478 (Th-W55:6, Th-W55:7)


Documents

Topic index